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Mechanisms leading to fatigue have been the subject of immense research 
investigation. However, the exact mechanisms causing the development of fatigue, 
remain largely unknown and fiercely debated. Herein we identify plasma 
metabolites and neuromuscular factors associated with exercise-induced fatigue, 
and assess potential nutritional strategies which may help delay the onset of fatigue.  
The role of individual metabolites in the development of fatigue were assessed 
using metabolomic profiling of plasma during a constant endurance cycling bout in 
Chapter 3. Analyses revealed important associations between fatigue-onset with 
free fatty acids, tryptophan and glucose. The contribution of central- and peripheral-
fatigue mechanisms during isoenergetic constant and self-paced cycling trials was 
assessed in Chapter 4. Central fatigue was similar following each protocol, but total 
fatigue was shown to be greater following self-paced cycling. 
Importantly, the serotonin precursor tryptophan has been implicated in the onset of 
fatigue, and tryptophan is displaced from albumin when lipid concentrations 
increase; this may explain the association between increased lipid concentration and 
fatigue observed in Chapter 3. Therefore, using a branched-chain amino acids 
(BCAA) supplement, we manipulated the free-tryptophan (unbound) passage 
across the blood brain barrier (Chapter 5). We observed greater endurance capacity 
with the BCAA compared to a placebo, although this was independent of changes 
in central fatigue. 
In an attempt to mitigate the decrease in blood glucose concentrations in endurance 
cycling (observed in Chapter 3), a mixed-carbohydrate comprising starch and 
disaccharides was ingested before and immediately after a prolonged cycling bout 
(Chapter 6). We hypothesised that this mixed-carbohydrate beverage would 
minimise hypoglycaemia when compared to an isocaloric glucose beverage and 
improve overall performance. Although blood glucose and insulin were 
significantly different between conditions, there were no differences in exercise 
performance or fatigue markers between conditions. The significance of these 
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Chapter 1 Introduction  
Exercise-induced fatigue is characterised by sensations of tiredness and decrements 
in muscle performance and function [1]. Fatigue that is associated with alterations 
at or the distal of neuromuscular junction (NMJ) may be broadly categorised as 
peripheral fatigue [2], while changes within the central nervous system (CNS) that 
are associated with the onset of fatigue may broadly be classified as ‘central 
fatigue’. Peripheral fatigue is characterised by significant changes in metabolites, 
ions and electrolytes within both the intra-cellular and inter-cellular compartments 
of skeletal muscle [1, 3, 4]. Central fatigue on the other hand, is characterised by a 
progressive reduction in voluntary activation of the skeletal muscle during exercise 
[5]. Performing a maximal voluntary contraction (MVC) before and after 
exhaustive exercise provides a reliable measure to detect exercise-induced fatigue 
[6]. The contribution of central fatigue in turn, can then be assessed by 
systematically combining the MVC with an electrical stimulation technique known 
as twitch interpolation [7].  
Despite significant advances in the field, considerable debate regarding the 
underlying mechanisms and origins of exercise-induced fatigue continues (i.e., [8-
15]). The overarching aim of this dissertation is to assess and identify factors 
associated with the onset of fatigue during prolonged cycle-exercise, using 
techniques designed to assess both peripheral (i.e., metabolomics) and central (i.e., 
neuromuscular assessments) parameters of fatigue.     
 
2 
1.1 Specific Aims of the Studies 
Study one (Chapter 3): Changes in the plasma metabolome during and following 
constant cycling to exhaustion 
This chapter will adopt a targeted metabolomics approach, which will enable the 
simultaneous assessment of >100 metabolites prior to and at the point of fatigue-
onset. This chapter is specifically focused on assessing metabolites associated with 
the ‘Central Fatigue Hypothesis’ [16]. This theory is of particular interest since it 
provides a possible feedback mechanism between metabolites associated with 
peripheral fatigue, and the decreased voluntary activation associated with central 
fatigue. Specifically, the theory proposes that an increase in free fatty acids 
displaces the amino acid tryptophan from its transporter albumin, and in so doing, 
increases the transport of tryptophan into the CNS. Tryptophan is the precursor to 
serotonin which has been long-recognised as playing a role in exercise-induced 
fatigue [1, 3, 16]. We hypothesise that the free fatty acids, tryptophan and 5-
methoxy-3-indoleacetic acid (the end product of serotonin catabolism) will 
demonstrate significant increases with exercise and fatigue onset.   
 
Study two (Chapter 4): Neuromuscular fatigue following isoenergetic prolonged 
constant versus self-paced cycling exercise. 
The primary purpose of this study is to investigate the changes in neuromuscular 
fatigue following two modes of isoenergetic prolonged exercise at constant and 
self-paced cycling. Constant power time-to-exhaustion (TTE) protocols and self-
paced time-trials (TT) are widely used to assess cycling performance and fatigue 
[1]. The validity of the TTE protocols has however been questioned on the basis 
that cyclists rarely maintain constant power output during competition [17]. 
Additionally, the TT has demonstrated higher repeatability and lower variability 
than compared to TTE trials [17] although this may be dependent on an appropriate 
pacing strategy during the TT [18]. We hypothesise that performance will be 
superior (higher power output; shorter time to completion) in the TT, and this will 




Study Three (Chapter 5): The effect of acute branched-chain amino acids (BCAA) 
supplementation during isoenergetic prolonged cycling exercise on cycling 
performance and neuromuscular fatigue. 
The primary purpose of this study is to investigate the effects of acute branched-
chain amino acids (BCAA) supplementation on prolonged cycling time trial (TT) 
performance and neuromuscular changes associated with the BCAA and TT 
performance. Supplementation with BCAA allows the manipulation of serotonin 
concentration in the CNS, since the BCAA compete with TRP for entry into the 
CNS. Specifically, the BCAA and TRP use the same transporter for entry into the 
CNS and will outcompete the TRP, therefore resulting in reduced CNS serotonin 
levels. In accordance with the Central Fatigue Hypothesis above therefore, this 
should result in delayed fatigue and improved performance. Supplementation with 
BCAA has to date been shown to either improve performance [19-21] or have no 
effect on performance [22, 23], and these contradicting results may be associated 
with large heterogeneity in methodology and small samples. We hypothesise that 
BCAA will improve performance during the TT, and be associated with reduced 
levels of central fatigue.    
 
Study four (Chapter 6): Metabolic and performance responses to the ingestion of 
different carbohydrates during prolonged exercise. 
The primary purpose of this study was to investigate the metabolic and performance 
effects of a mixed-carbohydrate (CHO; starch and sugars) product on prolonged 
endurance performance compared to a glucose control solution (GLU). Despite the 
intense research conducted on the role of CHO supplementation and performance, 
the benefits of ingesting CHO within the final hour of exercise is still unclear. Some 
studies have demonstrated an ergogenic benefit [24, 25] while others have shown 
no improvement [26-28], or even an impairment in endurance performance [29, 30]. 
Such impaired exercise performance has been attributed to the existence of rebound 
hypoglycemia, reduced fat oxidation and inhibition of lipolysis by elevated plasma 
insulin concentrations [31]. While the ingestion of complex CHO (or more slowly 
4 
digested CHO) has been explored as a potential ergogenic aid [32] due to the more 
prolonged nature of glucose release, the combination of complex CHO with simple 
CHO on prolonged exercise performance has not been explored. We hypothesised 
that a mixture of complex and simple CHO would result in significant 
improvements in TT performance as compared to ingestion of an isocaloric mixture 
of only simple CHO.  
 
1.2 Significance of the Thesis 
The mechanisms underpinning exercise-induced fatigue are varied, complex and 
incompletely understood. While significant advances have been made and much 
knowledge generated within this field, important questions remain. Much work in 
the field has focused on either a few metabolites implicated in peripheral fatigue or 
on neuromuscular assessment of central fatigue, but limited research exists which 
has attempted to bridge these fields in an attempt to answer the remaining questions. 
By adopting techniques which enable the assessment of the plasma metabolome 
and neuromuscular parameters associated with the onset of fatigue, we will attempt 
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Chapter 2 Literature Review 
Exercise-induced fatigue is characterised by sensations of tiredness and decrements 
in muscle performance and function [1]. The fatigue experienced during exercise is 
distinct from the general fatigue experienced by the estimated 7-45 % of the 
population [2-6], because of its transient and replicable nature. A unique feature of 
exercise-induced fatigue is that both the perception and duration of fatigue may be 
manipulated by altering intrinsic components (i.e., exercise mode, exercise 
intensity, exercise duration) of the exercise bout. Despite our advanced 
understanding of exercise-induced fatigue, the mechanisms underpinning fatigue, 
and the interaction of these mechanisms in inducing fatigue, remain largely 
unknown and fiercely debated [7-24]; although it is generally understood to involve 
some complex interaction between central and peripheral factors [25, 26].  
 
2.1 Fatigue 
Early studies attempting to identify causes of fatigue commonly focused on 
peripheral factors [27]. These factors are associated with alterations at or below the 
neuromuscular junction (NMJ) [28] and are thought to be initiated within the 
muscle itself [29], or involve factors (i.e., neurotransmitters, membrane associated 
electrolyte imbalance) which may affect muscle function [30-32]. Fatigue induced 
by so-called peripheral factors is named “peripheral fatigue” and typically involves 




2.1.1 Energetics of Peripheral Fatigue 
As a consequence to the early identification of adenosine triphosphate (ATP) as the 
body’s energy currency in combination with the rapid depletion of these stores 
(reviewed in [33]), resulted in much of the early work in fatigue focusing on the 
depletion of ATP and mechanisms associated with repletion of these stores [27, 33-
36]. The phosphagen (ATP-PCr) system does not require oxygen to replenish ATP 
and provides near-instantaneous energy to maintain ATP stores [37], but is limited 
in capacity (~5-7 seconds at high-intensity). Specifically, phosphocreatine (PCr) 
levels are significantly reduced in the first 5-6 seconds of maximal intensity 
exercise [38, 39] and this is more pronounced in type 2 muscle fibres [40-42]. While 
a clear temporal relationship between PCr and fatigue exists, the importance of PCr 
is further supported by the improvement in sprint performance and delay in the 
onset of fatigue during repeated sprint exercise [43, 44].  
Muscle glycogen depletion has long been implicated in the onset of fatigue during 
exercise [35, 45, 46], and the ingestion of glucose unequivocally improves 
performance during prolonged (>90 minutes) exercise by reducing the rate of 
glycogen utilisation [47-49].  Indeed, the ratio of blood-borne glucose and glucosyl-
moieties derived from glycogen as substrates for glycolysis are largely influenced 
by (i) the intensity of exercise, wherein higher intensity exercise relies more greatly 
on muscle glycogen [50, 51]; (ii) muscle fibre type, wherein type 2 fibres rely more 
heavily on muscle glycogen [50-52]; (iii) duration of exercise, wherein the 
contribution of muscle glycogen declines in parallel with a decrease in muscle 
glycogen availability [51]. While the stores of muscle glycogen are much more 
substantive than the PCr stores, muscle glycogen may be “depleted” (note that these 
stores and other energetic substrates do not reach below ~10 %) within a few 
minutes of intense exercise [51, 53-55].  
Muscle glycolysis can also be supported by blood borne glucose and indeed the 
uptake of glucose may rise to 20- to 35-fold after 40-60 minutes of work [56]. 
Despite constituting a small store per se (~5 g total), blood glucose may contribute 
as much as 30-50 % of the total energetics used during prolonged exercise [57]. In 
order to maintain these demands and avoid hypoglycaemia, hepatic glucose output 
increases 2- to 3-fold during moderate intensity and hepatic gluconeogenesis 
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concomitantly increases by 20-25 % [58]. Irrespective of these additional processes, 
liver glycogen, as with muscle glycogen, is depleted during prolonged exercise [59] 
and at this stage, the onset of fatigue is inevitable [60]. This depletion is associated 
with “hitting the wall” which generally occurs around the 32 kilometres mark 
during a marathon [61], although this speculated “cause-and-effect” is based only 
on theory and temporal associations.  
Importantly, mitochondrial respiration plays the dominant role during prolonged 
exercise, and as a result of the increased availability of pyruvate (along with other 
substrates, amino acids and free fatty acids (FFA), reduced form of nicotinamide 
adenine dinucleotide (NADH) and oxygen, muscle pyruvate is almost exclusively 
oxidised during prolonged exercise [1, 34]. Unsurprisingly, mitochondrial 
respiration and more broadly, muscle oxidative capacity is increased with training 
and may therefore explain at least part of the improved performance during 
prolonged exercise after a period of training [62-64]. Likewise, a hypoxic 
environment which is sufficient to induce hypoxemia, will reduce mitochondrial 
capacity as a result of the reduced availability of oxygen and results in reduced 
performance acutely [1, 65]. This will directly increase the accumulation of so-
called “waste products” which the early researchers in the field of fatigue describe 
[66] and specifically “lactic acid” [67]. Lactate accumulation occurs when the rate 
of pyruvate formation exceeds the rate of pyruvate entry and utilisation in 
mitochondrial respiration and is associated with an elevated ratio of reduced form 
to oxidized form of nicotinamide adenine dinucleotide (NADH:NAD+) and 
hydrogen ions (H+) accumulation [68]. The temporal association of lactate 
accumulation and H+ formation led to the erroneous theory of “lactic acid” as being 
the H+ donor, however other mechanisms including rapid catabolism of ATP to 
adenosine diphosphate (ADP) contribute to the increased H+ concentration [69] and 
only lactate (salt) is formed, not lactic acid. The accumulation of H+ in excess of 
the buffering capacity of the tissue has detrimental effects on oxygen delivery [70], 
inhibition of glycolysis and glycogenolysis by inhibiting phosphofructokinase 
(PFK) [63] and displaces calcium ions (Ca2+) from troponin, thus directly reducing 
the ability of the muscle to contract [71]. In concert with the increase in the 
concentration of hydrogen ions ([H+]), there is an increase in the concentration of 
inorganic phosphate ([Pi]) associated with the increased rates of glycolysis and the 
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catabolism of ATP. The increase in [Pi] deteriorates force capacity and is associated 
with fatigue [72, 73], possibly due to inorganic phosphate (Pi) inhibiting cross-
bridge detachment and, along with H+, reducing myofibrillar Ca2+ sensitivity [74] 
and pH that forms acid phosphate, H2PO4 [28].  
 
2.1.2 Electrolytes and Ions in Peripheral fatigue 
During intense exercise, there may be an increase in ammonia (NH4+) which is 
related to the deamination of adenosine monophosphate (AMP) to inosine 
monophosphate (IMP) by AMP deaminase [28, 34, 75]. The increase in NH4+ 
inhibits pyruvate dehydrogenase and isocitrate dehydrogenase enzymes, thus, 
attenuating oxidative metabolism [76]. Ammonia therefore needs to be neutralised 
(i.e., conversion of pyruvate to alanine) and/or eliminated swiftly [77]. This occurs 
by the formation and subsequent excretion of urea via the urea cycle [34]. However, 
this cycle requires the liver and kidneys and therefore multiple steps including the 
transport of NH4+ from the muscle in the form of alanine and glutamine are required 
prior to the elimination of NH4+. Importantly, NH4+ is also produced when the 
energetic contribution of amino acids is increased, such as during the latter stages 
of endurance events, wherein the deamination of amino acids is required for the 
oxidation of these compounds [34].  
Excitation-contraction coupling (ECC) is the process linking the muscle contraction 
(mechanical) to the propagation of the action potential (AP; electrical signal) [78]. 
The AP has been the focus of many previous reviews (i.e., [79]) which have 
concluded that muscle fibre excitability is dependent on the AP threshold produced 
when sodium ions (Na+) rushes into (influx) the fibre during depolarization of the 
membrane (in response to acetylcholine receptor activation) and potassium ions 
(K+) subsequently rushes out (efflux) [80, 81]. When sodium influx occurs and the 
depolarization threshold is reached, the sodium-gated channel deactivates quickly 
(~1-2 milliseconds) followed by the activation of the potassium-gated channel [79]. 
Besides Na+ and K+, chloride ions (Cl-) are also involved as a repolarizing agent 
during the repolarization phase [82]. These electrolytes have long been investigated 
as potential mediators of fatigue [30-32]. More recent studies on isolated muscles 
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of animals have confirmed an important role for the balance between intracellular 
and extracellular; concentration of sodium ions ([Na+]) and concentration of 
potassium ions ([K+]), respectively, in the development of fatigue during high-
frequency stimulation [83]. The influx of Na+ increases rapidly during exercise and 
is fibre-type specific leading to a more rapid rise in K+ efflux in the fast twitch fibres 
(i.e., extensor digitorum longus) than slow twitch muscles (i.e., soleus) and an 
associated increase in interstitial and plasma [K+] [83, 84].  The intensity of work 
plays an important role in this process, with the loss of K+ progressively increasing 
during intense exercise [85]. This leads to a reduced capacity for excitability due to 
the decrease of chemical gradient and slow inactivation of sodium channels [86]. 
Chloride ions plays an important role (along with K+) in re-establishing the 
membrane potential and enabling a subsequent AP; at rest, Cl- contributes nearly 
80 % of this “inhibitory current” [79]. 
A critical component of the ECC is the Ca+2 release from the sarcoplasmic 
reticulum (SR) which occurs in response to the AP and the associated reuptake of 
Ca2+, which has itself been the subject of much scrutiny relating to its role in muscle 
fatigue [87]. The rate of Ca2+ release is fibre-dependent, wherein fast-twitch fibres 
(i) release Ca2+ three times faster [88]; (ii) contain twice as many SR and 4- to 8-
fold more calcium ATPase compared to slow-twitch muscle fibres [89, 90]. 
Exercise at moderate intensity can depress Ca2+ release by ~15-20 %, while intense 
activity results in ~35% depression in Ca2+ release [91-93]. Concurrent with these 
changes in Ca2+ release, intense muscular contraction increases [Pi] which has been 
proposed to enter the SR and bind with Ca2+, leading to calcium phosphate (CaPi) 
precipitation and reduction in available Ca2+ for SR release [40, 74, 78].  
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2.1.3 Central Fatigue 
Alterations within the central nervous system (CNS) that are associated with the 
onset of fatigue are broadly classified as ‘central fatigue’. Central fatigue can be 
defined as a progressive reduction in voluntary activation of muscle during exercise 
[26]. Central fatigue may occur at various levels and for several reasons including: 
(i) loss of recruitment of high threshold motor units [94, 95]; (ii) reduced central 
drive [96]; (iii) blocked central conduction from demyelination or motor neuron 
dropout [97]; and (iv) increased negative feedback from muscle afferent types iii 
and iv sensory neurons [98]. As a consequence of the many proposed levels and 
reasons for central fatigue, the measurement of central fatigue is equally 
challenging.  
 
2.1.3.1 Calculations for Central Fatigue Assessment 
Maximal voluntary contraction (MVC) is considered the “gold standard” for 
measuring muscle force and fatigue, as it is highly reproducible in both non-
fatigued and fatigued conditions [99]. By systematically combining MVC with 
electrical stimulation, the occurrence of central fatigue can be detected and 
quantified using burst superimposition and twitch interpolation techniques. In this 
case, the definition of central fatigue is specific to the progressive exercise-induced 
reduction in maximal voluntary activation of a muscle [100]. There have been a 
number of protocols which have been adopted using twitch interpolation, and there 
are distinct differences in these protocols especially the number of interpolated 
stimuli. Merton (1954) developed and introduced the twitch interpolation technique 
which utilized the single twitch stimuli. This method has been widely adopted by 
other researchers. Subsequently, train stimulations have been adopted using a burst 
superimposition technique as it produces a larger plateau torque, is more sensitive 
[101] and valid [102]. However, these repeated stimulations can be painful [103, 
104] and unbearable to participants [105].  
It has been suggested that doublet, triplet and quadruplet stimulations are more 
reliable compared to single twitch stimulations as it reduces variability [106] and is 
less painful compared to train stimulation protocols. Increasing the number of 
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interpolated stimuli, increases the superimposed torque [107, 108], signal-to-noise 
ratio [109], and thus, makes it more readily detected [110]. The most often used 
calculations to determine central fatigue based on burst superimposition technique 
and twitch interpolation technique are Central Activation Ratio (CAR) and 
Voluntary Activation Level (VAL), respectively. 
 
2.1.3.1.1 Central Activation Ratio (CAR) 
CAR is calculated using the following equation: 
= MVC / (MVC + Superimposed stimulation amplitude) 
Thus, if CAR equals 1.0, it indicates a full activation of the stimulated muscle [101], 
while any extra torque resulting from the supramaximal electrical stimulation (i.e., 
a CAR value of less than 1.0) indicates a failure of full activation by the brain [111]. 
This method has been questioned as it compares superimposed torque with 
voluntary torque, and additional torque may possibly occur from synergistic 
muscles that are not recruited during electrical stimulation [112]. 
 
2.1.3.1.2 Voluntary Activation Level (VAL) 
VAL has been reported to be more sensitive than the CAR [113] and can be 
calculated as follows: 
 = [1 – (superimposed stimulation amplitude/ resting stimulation amplitude)] x 100 
Further studies showed that using the potentiated doublet as a reference rather than 
the resting doublet was more valid and reproducible [99] since it can be assumed 
that the potentiated doublet (occurring within approximately 5 seconds after the 
MVC) and the MVC will be equally potentiated. For cases where superimposed 
stimulation is being elicited slightly before or after MVC, a correction is applied, 
as superimposed amplitude tends to increase at torques which are below maximal 
[114]. This relationship has been proposed to be linear [115] although this is not 
universally accepted (reviewed in [116]). Accordingly, a correction has been 
16 
proposed to this technique [114] and appears to be more valid and reliable [99], 
such that VAL is calculated as: 
= [1 – (superimposed stimulation amplitude x voluntary torque level just before the 
superimposed doublet/maximal voluntary torque)/potentiated doublet amplitude] x 
100 
 
2.1.3.2 Central Fatigue Assessment in Dynamic Exercise 
Classically, studies on exercise-induced fatigue of quadriceps muscles were done 
on isokinetic dynamometers [96, 117-120] or modified chairs [102, 112, 121-123] 
where the assessments of fatigue were conducted. Additionally, the mode of 
exercise to induce fatigue were typically either isometric [99, 119, 120, 124] and/or 
isokinetic [125-130] muscle contractions. Recently, twitch interpolation technique 
has been used extensively to assess fatigue induced by dynamic exercise such as 
cycling [96, 117, 118, 131, 132] and running [133-138] since they represent greater 
ecological validity to sports and exercise. 
 
2.1.3.2.1 Before and After Exercise 
Neuromuscular changes can also be evaluated by assessing fatigue before and after 
exercise. Instead of performing exercise to exhaustion in the laboratory, Millet et 
al. (2002) preferred the use of an actual race-event, because each subject would be 
highly motivated to perform during the race. Ultra-marathon was chosen to induce 
the exercise-associated fatigue, because limited studies had focused on the 
neuromuscular changes after an ultra-endurance event, wherein significant central 
and peripheral fatigue are expected. In this study, neuromuscular fatigue of the knee 
extensor (KE) and plantar flexor (PF) muscles were measured one week before and 
immediately after the race. The femoral and posterior tibial nerves were stimulated 
and the maximal voluntary activation was estimated by using the twitch 
interpolation technique (VAL; resting twitch). There was 30 % reduction in MVC 
torque and 28 % reduction in voluntary activation after the race, demonstrating 
significant fatigue and this fatigue was attributed to central processes (i.e., central 
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fatigue) [135]. In a follow-up study, Millet et al. (2003) assessed central fatigue 
contributions during intermediate-duration running exercise (30-km running race). 
Single twitch and 0.5 seconds’ tetanus (20- and 80-Hz) were applied to the femoral 
nerve and handgrip force measured to assess supra-spinal fatigue. There was a 23.5 
% reduction in MVC torque and a 7.5 % reduction in VAL (potentiated twitch) 
indicating that the reduction in MVC was due to central and peripheral fatigue 
processes after this type of event.  
The same research group used a similar tetanus stimulation (20- and 80-Hz) 
protocol [136] to study road cyclists following a 140-km race [105]. The 140-km 
race took an average of 278 minutes to complete and the neuromuscular 
assessments completed between 15 and 30 minutes after the race. The MVC loss 
was small (9 %) but significant compared to the two aforementioned studies and 
there was a lack of central fatigue with no significant changes in the VAL (using 
both twitch and train stimulations). Given that the neuromuscular fatigue 
assessment was completed between 15 and 30 minutes after the race, the effects of 
metabolic (peripheral) fatigue were expected to be low. However, the twitch 
parameters of the muscle were also unchanged as evidenced by no significant 
changes in high-frequency tetanic forces. Importantly, using evoked tetanus on 
relaxed muscles is not suitable as they were too painful which only resulted in four 
participants agreeing and completing this method, thus it is not statistically 
comparable to MVC and maximal voluntary activation [105]. 
High-intensity exercise is associated with significant fatigue [94, 139] but can also 
be associated with higher eccentric loads leading to muscle damage [140]. To 
investigate the behaviour of fatigued muscles after a high-intensity exercise but 
without significant eccentric loads, an intermittent high-intensity uphill running 
protocol was designed [134]. The protocol consisted of 10 bouts of running at 120 
% of maximal aerobic velocity (MAV) with an 18 % gradient on a treadmill using 
a 1:2 minutes of work to rest ratio. This protocol produced expected metabolic 
changes with the blood lactate concentration reaching 18.4±3.6 mmol/L at the end 
of the exercise. However, there were no significant changes in VAL but greatly 
altered twitch contractile properties and the presence of low-frequency fatigue. This 
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indicated that fatigue following this type of exercise was mainly due to ECC failure 
and the contributions from central factors were insignificant [134].  
The effect of constant versus variable-intensity endurance exercise on 
neuromuscular fatigue in cycling exercise is an important consideration and has 
been studied by Lepers and colleagues. This effect is important given that a race, 
even when conducted on flat terrain, will not result in constant power output but 
rather will result in a J-shaped power curve [141]. To study this, neuromuscular 
assessments were performed before and after each trial using a doublet/paired 
stimulation instead of tetanus stimulations as the use of superimposed paired 
stimulations at 100-Hz has been shown to be as sensitive as quintuplets for detecting 
muscle inactivation [112]. The first study recruited male triathletes who were asked 
to cycle for 30 minutes at self-selected cadence to achieve 75 % of maximal aerobic 
power (MAP), one at a constant-power output and one with alternating power 
output. There were significant reductions in MVC torque and VAL, but no 
significant difference in neuromuscular fatigue between trials which was attributed 
to the low-variations of power output in alternating power output trial [118]. In a 
follow-up study using 10 well-trained cyclists completing a similar protocol (33 
minutes corresponding to 70 % MAP) with the exception of greater variance in the 
cycling intensities during variable power output trial. The MVC torque and VAL 
reduced significantly in variable intensity trial compared to constant intensity trial. 
Unfortunately, by using the twitch interpolation technique, the study was unable to 
verify if the central fatigue was produced from supraspinal and/or spinal 
mechanisms [26]. This study concluded that high-variations of power output 
including efforts above the MAP altered neuromuscular fatigue and cardiovascular 
responses compared to constant power cycling exercise [132]. 
While laboratory-based tasks are generally considered to have reduced ecological 
validity, cycling time-trials (TT) are generally considered to be more closely 
aligned with race characteristics and result in similar power characteristics to races 
when compared to constant-power outputs [1]. As expected, a 4-km TT (short high-
intensity) showed a higher contribution of peripheral fatigue while in 20- and 40-
km TT (long low-intensity), a higher degree of central fatigue contributed to the 
exercise-induced fatigue [142]. Central fatigue was measured with twitch 
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interpolation technique (VAL) which indicated a reduction in firing frequency (-11 
%, -10 %, -7 % for 20-, 40- and 4-km TT, respectively) and transcranial magnetic 
stimulation to assess corticospinal function (-12 %, -10 %, -6 % for 20-, 40- and 4-
km TT, respectively). The overall results indicated that the duration and distance of 
an exercise protocol produces different neuromuscular alterations. 
Finally, while exercise characteristics may alter neuromuscular activation, 
environmental factors can clearly also play a role. Exposure to heat is a common 
phenomenon experienced by endurance athletes and is associated with fatigue and 
hyperthermia [1]. Periard, Caillaud and Thompson (2011) conducted a study to 
compare central and peripheral fatigue during exercise with and without 
hyperthermia. To isolate the effect of the exercise, eight male participants immersed 
their body in a warm water bath until the rectal temperature reached 39.5 °C. On 
separate days, the participants performed cycling time-to-exhaustion (TTE) at 60 
% maximal oxygen and neuromuscular assessments were conducted before and 
after the hyperthermia inducing phase.  It was demonstrated that VAL reduced 
similarly in both trials but the force production showed a greater decrease in the 
exercise protocol with hyperthermia and was associated with an increase in 
cardiovascular strain. However, in this study, the tetanus stimulation was delivered 
to the muscle directly instead of femoral nerve stimulation [143] and the use of 
electrical muscle stimulation may lead to partial or different spatial recruitment 
[123, 144, 145]. The reason is that the electrical muscle stimulation uses surface 
electrodes placed over the targeted muscle to directly depolarise muscle terminal 
axonal branches while electrical nerve stimulation directly stimulates nerve trunk 
of targeted muscle [146]. 
 
2.1.3.2.2 During Exercise 
Neuromuscular fatigue assessment during exercising requires the participants to 
stop cycling for specific time intervals in order to conduct the neuromuscular 
assessment [96]. Nine endurance-trained cyclist or triathletes cycled for 5 hours at 
55 % of MAP and neuromuscular assessments were conducted before, each hour 
during cycling, immediately at the end of cycling and 30 minutes post-exercise. The 
neuromuscular assessment took about 10 minutes to complete. During the 5 hours 
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of prolonged cycling exercise, ECC properties were altered as early as the first hour 
of cycling, as reflected by significant reductions in MVC. However, the muscle 
excitability was reduced only after 4 hours of cycling as indicated through a 
significantly lower M-wave peak compared to the resting condition. The VAL also 
showed a significant fall in the final hour of cycling phase reflecting the decrease 
in neural drive and possibly a result of the accumulation of brain serotonin and 
spinal or supraspinal mechanisms [96]. Similar to the aforementioned study, Place, 
Lepers, Deley and Millet (2004) used running to assess exercise-induced fatigue 
and evoked tetanic contractions (20-Hz, 80-Hz) together with single twitch and 
doublet stimulations. In Place et al. (2004)’s study, MVC loss was highly correlated 
with VAL, and similar to Lepers et al. (2002), significant reductions occurred after 
4 hours of exercise. Potentiation effects occurred after exercise, however, tetanic 
stimulations at 80-Hz were not affected, suggesting that the MVC loss was from 
central activation and/or muscle excitability and not at the cross bridge-level [147]. 
 
2.1.3.2.3 Recovery 
Presland, Dowson, and Cairns (2005) have applied MVC and tetanus interpolation 
technique to quantify muscle fatigue and the occurrence of central fatigue, 
respectively. Neuromuscular fatigue assessments were performed immediately 
after and during recovery following prolonged constant cycling TTE at 70 % of 
peak oxygen uptake (VO2peak) exercise every 10 minutes, for up to 30 minutes. The 
participants were healthy men and physically active but not well-trained. The MVC 
torque declined about 44-82 % at post-exercise compared to the resting value, 
remained unchanged at 10 minutes post-exercise, and only partially recovered after 
30 minutes while central fatigue persisted [148]. These findings suggested that the 
total fatigue processes persisted for the 30 minutes, despite partial recovery of 
MVC, but the central fatigue had not changed.  This study used 3 methods to 
quantify central fatigue with varying results; tetanus interpolation technique (33 %), 
the relative decline of MVC and peak tetanic force (54 %) and extrapolating linear 
regression line of central fatigue data (58 %). Peripheral fatigue was demonstrated 
by the decrement in peak stimulated MVC torque, which fell by about 20 %. 
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Interestingly, exhaustion was closely linked with subjective ratings of perceived 
exertion (RPE).    
Another study investigated the effect of altering the recovery strategy from exercise 
on fatigue characteristics. In this study, the investigators used an intermittent high-
intensity exercise as the mode of fatiguing exercise before applying recovery 
interventions to the neuromuscular function which were passive (remain seated for 
20 minutes), active (running at 50 % MAV) and low-frequency 
electromyostimulation on both lower limbs. Participants performed an all-out 
running test (running TTE at 90 % MAV), to see if any interventions would delay 
fatigue and improve subsequent performance. There were no significant differences 
among the three recovery interventions. Surprisingly, MVC torque 45 minutes after 
exercise (after applying the recovery interventions) was lower compared to 
immediately after exercise and the pattern was not associated with the changes in 
VAL, which may be due to an incomplete restoration of ECC [133]. These results 
(lack of effect of recovery strategies) may have arisen since this type of exercise is 
likely to be associated with high eccentric loads and may therefore have induced 
significant eccentric-damage; therefore, the recovery mode is unlikely to have an 
immediate effect and the MVC remained depressed for the whole recovery 
duration.  
 
2.1.3.3 Central Fatigue Hypothesis 
Previously, Eric Newsholme and colleagues proposed the ‘Central Fatigue 
Hypothesis’ [149], which has been at the core of a large body of the fatigue-related 
research literature. The authors suggested that an increased serotoninergic activity 
in the CNS, specifically 5-hydroxytryptamine (5-HT or serotonin), during physical 
activity reduces exercise capacity, consequently, leading to a decrement in 
performance [149]. Serotonin (5-HT) is well-known for its effects on sleepiness, 
mood, arousal and lethargy [150] but it has been shown that an increased 
concentration of 5-HT in the brain during prolonged exercise is associated with 
fatigue [151] in both rats [152, 153] and human studies [154, 155]; although the 
latter is much more complicated to study and requires sampling of cerebrospinal 
fluid (CSF). 
22 
The production of 5-HT is directly related to the concentration of its amino acid 
precursor, tryptophan (TRP). When free tryptophan (f-TRP) is transported into the 
CNS through the blood-brain barrier (BBB) via large neutral amino acid (LNAA) 
transporter [156], this may result in an increased production of 5-HT following two 
reactions catalysed by TRP hydroxylase and aromatic amino acid carboxylase 
respectively [157]. While most TRP circulates in the plasma lightly bound to 
albumin, it is the f-TRP which can bind to the LNAA for entry into the CNS [150].  
The increased concentration of FFA during prolonged exercise however, may 
displace TRP from albumin, resulting in a parallel increase in f-TRP in plasma [158] 
as shown in Figure 2.1. Therefore, with progressive increase of FFA contribution 
to exercise energetics (i.e., latter stages of endurance exercise; ~>30-40 minutes) 
there is an increased ratio of f-TRP:BCAA which allows for more f-TRP to be 
transported across the BBB, resulting in potentially increased synthesis of 5-HT 
(Figure 2.1) [159].  
 
 





Serotonin-containing neurons are widely distributed throughout the brain. The 
enzyme TRP hydroxylase is not saturated by its substrate TRP under normal resting 
conditions [160], the increase of TRP centrally therefore, leads to an increase in 
both the synthesis and release of 5-HT which has been shown in both animal [161-
163] and human [164] studies. Although, under non-homeostatic conditions such 
as exercise the contribution of brain 5-HT to exercise-induced fatigue is 
complicated, and can only be directly assessed in animal studies which has been 
elegantly reviewed by Meeusen and De Meirleir (1995). Catabolism of 5-HT occurs 
via monoamine oxidase (MAO) and aldehyde dehydrogenase and results in the 
formation of 5-hydroxyindoleacetic acid (5-HIAA), which is ultimately excreted in 
the urine [165]. It is the ratio of f-TRP and 5-HIAA which may be used to assess 5-
HT synthesis and catabolism, respectively, however, accurate measures require 
CSF and or direct measurement of the neurons within the brain. However, since 
total TRP, f-TRP and 5-HIAA are also present in plasma, the measurements are 
typically conduced in humans although their validity may be questioned [164] and 
the biochemical processing of f-TRP to 5-HT and other products is not exclusive to 
neurons nor specific to central processes.  
 
2.1.3.4 Summary 
Maximal voluntary contraction is considered the “gold standard” in measuring 
muscle fatigue. The burst superimposition technique and twitch interpolation 
technique are the most widespread techniques used to quantify central fatigue with 
the two most commonly used formula being the CAR and VAL, respectively. VAL 
has been reported to be more reliable compared to CAR. Neuromuscular fatigue 
assessment has traditionally been conducted during isometric exercise, but has 
increasingly been applied to assess neuromuscular changes associated with 
dynamic exercise (especially cycling and running). Additionally, during post-
exercise recovery the assessment has been done at multiple time points starting 
immediately after the termination of exercise. Although important to determine, 
high eccentric loads and the associated muscle damage may compromise 
interpretation of fatigue-related data, since the techniques used to assess central and 
peripheral fatigue cannot always tease out the effect of damage. Therefore, 
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comparisons between exercises associated with high- and low-eccentric loads need 
to be carefully considered.    
It is apparent that a greater level of fatigue is demonstrated in athletes following 
race conditions when compared to laboratory conditions, although this may be 
related to the type of exercise protocol chosen (i.e., constant-power versus TT). For 
instance, while only a few studies have focused on differences in the neuromuscular 
characteristics associated with constant-power output versus alternating-power 
output, it appears that when matched for time and work, small variances in the 
power output fail to show significant differences in fatigue but when the variance 
in power output is increased (i.e., greater separation between high-power loads and 
low-power loads) then the fatigue characteristics between modes vary. The use of 
TT in laboratory-based testing may therefore be superior, as they more closely 
resemble the power characteristics of races than constant-power tests and externally 
applied variations in power (i.e., pre-determined changes in power). 
Finally, the idea of a peripheral “feedback” loop in fatigue which exists to protect 
muscle integrity is generally acknowledged [18, 166, 167] although not by all [17]. 
The hypothesis posited by Newsholme et al is therefore attractive, since it integrates 
metabolic signatures from the periphery, with the down-regulation in central drive 
experienced with fatigue. It is noteworthy that much of the literature in fatigue is 
focussed on either peripheral (metabolic) or central (using a variety of stimulation 
techniques) mechanisms, with the longer exercise duration being associated with a 
higher contribution of central factors [96] but there is limited research which has 
explored the combination of these factors despite the well acknowledged multi-




2.2 Nutritional Manipulation 
2.2.1 Branched-chain Amino Acids (BCAA) and 
Tryptophan (TRP) 
The central fatigue theory is based on the idea that increased concentration of 5-HT 
in the CNS and specifically the brain is not only associated with fatigue, but indeed 
the cause of the fatigue [151-155]. In order to assess this theory, a number of 
research studies have attempted to manipulate the 5-HT concentration in the CNS 
using amino acid supplementations.  Supplementation of BCAA in particular, leads 
to a reduced ratio in f-TRP to BCAA and should theoretically reduce the available 
f-TRP for conversion to 5-HT. This is because the rate of f-TRP entry into the brain 
is dependent on both the concentration of f-TRP as well as the concentration of 
BCAA which competes with f-TRP for entry into the brain [159] as shown in Figure 
2.2. A number of studies shown improved performance during prolonged exercise 
with BCAA supplementation [168-170], while several studies have shown no effect 
of BCAA consumption on performance during prolonged bouts of exercise [171, 
172]. The reason for these discrepancies are unknown, although differences in 





Figure 2.2 Proposed mechanisms of nutritional manipulation when BCAA is 
consumed, elevated plasma BCAA concentration which competes with f-TRP for 
entry into the brain. 
 
The landmark study on BCAA supplementation during exercise was conducted in 
the early 1990s, using a cross country (30-km) and full-marathon (42.2-km) running 
event. The primary finding was that after dichotomising runners into a slow- and 
fast-group, BCAA consumption appeared to be effective for the “slower” runners 
but not the faster runners [159]. Since runners were allowed to consume beverages 
including carbohydrate (CHO) beverages ad-libitum during the race, the findings 
of the study have been questioned [172]. Subsequently, van Hall et al. (1995) mixed 
amino acids into the CHO beverages, to avoid the effect of different quantities of 
CHO on fatigue and replicated the aforementioned study. This study was conducted 
under laboratory conditions; TTE using 4 types of supplements consisting of 6 % 
sucrose as a control and three mixtures comprising 6 % sucrose mixed with i) 3 g/L 
of TRP, or; ii) 6 g/L of BCAA (low BCAA), or; iii) 18 g/L of BCAA (high-BCAA). 
Despite each supplement increasing the concentration of respective plasma 
concentration of amino acids, there were no significant differences in TTE at 70-75 
% of maximal power output (Wmax) between trials. Importantly, the BCAA 
supplementation was estimated to reduce TRP uptake (measured by using kinetic 
parameters of transport of human brain capillaries) by ~10 % (with no difference 
between doses) while TRP ingestion increased uptake by 7- to 20-fold. 
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However, as previously mentioned, cycling TTE (open-loop) involves numerous 
motivational factors and does not represent the nature of a competition. A closed-
loop experimental design, where participants are set targets (i.e., assigned distance 
covered, work performed, calories burned) has been shown to be more reproducible 
compared to open-loop design such as cycling TTE [1]. The closed-loop design 
enables participants to plan and control the power required to complete the task 
[173], while open-loop designs may be confounded by psychological factors such 
as boredom and motivation [1]. A closed-loop study design has been used to assess 
efficacy of BCAA on exercise performance by Blomstrand et al. (1997). Eight 
endurance-trained cyclists were required to exercise for 60 minutes, at 
approximately 70 % of their maximal oxygen consumption (VO2max), followed by 
maximal work capacity for an additional 20 minutes (primary outcome measure). 
Participants consumed 150-200 ml of liquid either with BCAA (7 g/L) or placebo 
(PLA) every 15 minutes throughout the first 60 minutes-bout. While RPE was lower 
in the BCAA group compared to the PLA during sustained exercise, there was no 
significant difference in amount work done during the last 20 minutes final effort 
[174]. As outlined earlier however, the contribution of central fatigue to total 
fatigue increases with duration, therefore a 20 minutes effort is unlikely to have 
triggered significant central fatigue and may have explained the lack of effect of 
BCAA supplementation on exercise performance. Two additional studies assessing 
BCAA supplementation in longer duration events have been assessed; one study in 
a 100-km cycling TT [175] and one study during a 100-km ultra-marathon [176]. 
Despite numerous methodological differences, there were no benefits of the BCAA 
supplements on performance in either study. It is noteworthy that the participants 
in these studies consumed BCAA in tablet form before and during exercise and 
were allowed an ad-libitum access to food and fluids at the aid stations. 
Furthermore, while the BCAA tablets comprised mainly BCAA (40 % BCAA), the 
tablets contained all amino acids including TRP (~2 % of amino acids) [176]. 
To remove the confounding effects of variable gastric uptake rates, BCAA have 
also been infused during incremental exercise in individuals who previously 
completed a glycogen depleting bout of exercise [177]. Although higher blood 
lactate concentration was demonstrated at maximal power output during the BCAA 
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condition, there were no significant differences in performance during the BCAA 
infusion compared to control condition.  
The effect of longer-term feeding (six weeks) of BCAA on exercise performance 
has also been assessed in Wistar rats using three different types of diet (n=12 per 
group): control diet (C), a diet supplemented with 3.57 % of BCAA (S1), and 4.76 
% of BCAA (S2) for six weeks. Results showed that TTE was significantly longer 
(37 %) in the S1 group compared to C group, while the S2 group showed a 
significantly shorter TTE compared to other two groups. This study highlighted the 
importance of dose, and concluded that the chronic diet with a high BCAA dose 
caused hyperammonaemia and this was theorised as being the main factor leading 
to early fatigue during prolonged exercise in the high dose group [178].  
Acute supplementation of BCAA before and during exercise has also been assessed 
during warm conditions and under conditions where individuals are glycogen 
depleted [170, 179, 180]. The rationale for this assessments is based on the idea that 
these conditions increase reliance and plasma concentration of FFA [158, 181], 
which are known to compete with TRP for binding sites on albumin. Hence, when 
FFA increases in the plasma, f-TRP concentrations increase relative to total TRP. 
Consumption of BCAA supplements were found to improve exercise performance 
when exercise was initiated in a glycogen depleted state, while concurrently 
enhancing lipid oxidation and reducing respiratory exchange ratio (RER) [179]. 
Moreover, the original study conducted to investigate the effect of BCAA 
administration on fatigue during a TTE exercise bout (40 % VO2peak) following heat 
exposure (n=7 males, 6 females; passive heat: 34.4±1.8 ˚C, relative humidity: 
39±14 %; duration = 2 hours) found that the consumption of 5 mL/kg body weight 
of beverages containing either 5.88 g/L of BCAA (54 % leucine, 19 % isoleucine, 
27 % valine) or 5.88 g/L of polydextrose as PLA every hour prior to exercise and 
every half an hour while cycling improved (14±5 %) exercise TTE [170]. However, 
there was no effect on RPE scores, plasma FFA or NH4+ concentration in the BCAA 
trial. However, these results could not be replicated in a subsequent study assessing 
the combined effects of glycogen depletion and exercise performed in a warm 
environment [180]. The TTE trial was at a slightly higher workload (50 % VO2peak) 
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and interestingly, NH4+ concentrations were significantly elevated in the BCAA 
trial under these conditions. 
An alternative approach to assessing the role of f-TRP on exercise performance is 
to assess the role of f-TRP depletion which will equally result in a reduction in the 
BBB crossing of f-TRP, and should result in a reduction in the serotonergic activity. 
A comparison between an amino acid load (CON) containing alanine (5.5 g), 
arginine (4.9 g), cysteine (2.7 g), glycine (3.2 g), histidine (3.2 g), isoleucine (8.0 
g), leucine (13.5 g), lysine monohydrochloride (11.0 g), methionine (3.0 g), 
phenylalanine (5.7 g), proline (12.2 g), serine (6.9 g), threonine (6.5 g), tyrosine 
(6.9), valine (8.9 g) and trp (2.3 g)  compared with an alternate identical load 
without TRP (TD) has been investigated in cycling TTE at 55 % VO2peak in a warm 
environment; 30.1±0.5 ˚C, 30±7 % of relative humidity [182]. In response to the 
supplements, the ratio of f-TRP to BCAA the day prior, pre-exercise and post-
exercise were all lower in TD compared to CON trial, but there was no significant 
difference in TTE between these two trials. This suggests that the availability of 
TRP as a metabolic precursor for serotonergic activity was not a significant factor 
that led to fatigue during prolonged exercise in a warm environment [182]. 
 
2.2.2 Summary 
The mechanisms of fatigue are complex due to the presence of both central and 
peripheral factors. Changes which occur at the proximal area to the NMJ are 
associated with central fatigue while peripheral fatigue is related to changes at the 
distal area to the NMJ. The ‘Central Fatigue Hypothesis’ highlighted that the 
accumulation of 5-HT in the brain during prolonged exercise is associated with 
central fatigue. Numerous studies have been conducted based on this theory by 
focusing on nutritional manipulation through the supplementation of BCAA to 
delay the accumulation of 5-HT in the brain in an attempt to delay the onset of 
fatigue. Plausible reasons for the level of inconsistency in the aforementioned 
findings may be due to methodological variations, differences in BCAA 
concentrations in the supplemented beverages, forms of supplemented BCAA, 
supplement administration protocols, frequency of supplement provision and 
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differences in exercise protocols particularly with respect to the environmental 
temperature and the availability of both exogenous CHO and endogenous CHO 
(liver and muscle glycogen stores).  
The adopted exercise protocols to assess fatigue may also contribute to the 
inconsistent findings. In a study investigating various protocols, including i) cycling 
TTE at 75 % Wmax; ii) constant cycling at 70 % Wmax for 45 minutes followed by 
15 minutes TT (mixed protocol), and iii) 60 minutes TT; the coefficient of variation 
(CV) was shown to be highest in TTE trial (26.6 %), the lowest in TT protocol (3.35 
%) while mixed protocol was as reliable as the TT (3.49 %) [183]. The reliability 
of mixed protocols was also confirmed in recreationally active individuals (but non-
cyclists) [184]. To date, no study has assessed metabolic responses and quantified 
central fatigue at the point of exhaustion between isoenergetic closed-loop and 
open- loop cycling performance and the effect of BCAA supplementation in 
isoenergetic closed-loop cycling performance. 
 
2.2.3 Carbohydrate Supplementation 
Hypoglycemia and glycogen depletion have long been associated with fatigue [45] 
and decrements in performance during prolonged exercise [35, 46, 185]. 
Accordingly, the ingestion of CHO during prolonged exercise has been shown to 
delay fatigue and enhance work output [47, 48, 60, 186] while post-exercise CHO 
ingestion replenishes muscle glycogen and ensures the stores are replete prior to 
undertaking exercise [187-190] and may indeed lead to glycogen super-
compensation [191]. These strategies may be separated into pre-exercise, during 
exercise and post-exercise CHO strategies. There are some excellent reviews 
discussing the role of CHO ingestion on exercise performance [49, 185, 192] and 
while it appears that CHO consumption during exercise is most efficacious (i.e., 
least controversial regarding improved performance with CHO consumption during 





2.2.3.1 Carbohydrate Supplementation Before Exercise 
The performance benefits of ingesting CHO within an hour prior to the onset of 
exercise remain unclear. Some studies have demonstrated an ergogenic benefit 
[193, 194] while others have shown no improvement [195-197], or even an 
impairment in endurance performance [198, 199]. Such impaired exercise 
performance has been attributed to the existence of rebound hypoglycemia, reduced 
fat oxidation and inhibition of lipolysis by elevated plasma insulin concentrations 
[192]. However, well-trained cyclists who developed rebound hypoglycaemia were 
shown [200] to have no difference in power output when compared to cyclists who 
did not develop rebound hypoglycaemia. Participants (n=20) in this study ingested 
75 g of glucose 45 minutes prior to performing 20 minutes of constant-intensity 
cycling at 40 % VO2max followed by a TT to complete work output equal to 80 % 
Wmax for 40 minutes. Moreover, consuming 75 g of glucose 45 minutes prior to 
exercising at different intensities (either at 40 %, 65 % or 80 % or at maximal power 
output) showed there were no significant differences in plasma glucose and insulin 
responses between conditions [201]. Specifically, glucose concentrations decreased 
in the first 5 minutes of exercise, the glucose concentrations stabilised throughout 
the remainder of the exercise trials resulting a non-significant between-condition 
difference. Moreover, when the timing of glucose ingestion was altered (15 minutes 
pre-; 45 minutes pre-; 75 minutes pre-exercise) relative to the exercise bout and 
performance of a TT [202], there were no significant performance differences in 
the ~42 minutes TT. The effects of glucose load have also been explored by this 
group, using 0 g (control), 25 g, 75 g or 200 g consumed 45 minutes prior to an 
exercise bout consisting of 20 minutes of steady state exercise followed by a TT 
(pre-determined workload based on Wmax; 0.8 x Wmax x 2400 seconds) lasting 
approximately 43 minutes. Interestingly, the overall plasma glucose responses were 
similar across the glucose conditions, wherein hypoglycaemia was attained in the 
first 20 minutes of exercise in 6 participants, but this did not affect exercise 
performance [196]. Finally, since different types of CHO produce different types 
of plasma glucose and insulin responses due to their different glycaemic index/load 
(GI), the effect of different CHO types have also been examined by this group. 
Galactose and trehalose for example have lower GI, and these saccharides were 
compared to glucose. As expected, these saccharides showed more stable changes 
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in plasma glucose and insulin response with only one subject demonstrating 
hypoglycaemia earlier in the exercise bout, while 4 subjects had hypoglycaemia 
following the glucose supplementation [197]. Despite the differences in insulin and 
glucose concentrations however, there were no performance based differences 
across conditions, which is in agreement with a previous study [203].  
Based on these well designed and systematic assessments of CHO ingestion prior 
to exercise, it can be concluded that i) rebound hypoglycaemia does occur when 
glucose is ingested 15 minutes to 45 minutes prior to exercise, ii) the hypoglycaemia 
is independent of dose, iii) CHO type, and specifically GI alters the risk of 
hypoglycaemia such that lower GI foods reduce the risk of hypoglycaemia, iv) 
glycaemia however, appears to stabilise during exercise of at least moderate 
intensity and does not affect TT performance [192]. It is however important to note 
that i) the hypoglycaemia observed in the initial 20-minutes steady state exercise 
condition returned to normoglycaemia prior to TT performance; ii) a TT lasting less 
than 60 minutes may not be sufficient in duration to realise the ergogenic effect of 
CHO supplementation. For these reasons, alternate sources of CHO supplements 
have been investigated and continue to be of interest with a particular focus on slow 
digesting CHO sources in longer-duration events.     
 
2.2.3.2 Corn Starch 
2.2.3.2.1 Glucose and Insulin Response at Rest 
Carbon storage in plants is mainly in the form of starch which exist as semi-
crystalline granules composed of the two polymers of glucose known as amylose 
and amylopectin [204]. Amylose comprises straight chains connected by α1-4 
bonds while amylopectin has a more branching structure, connected by α1-4 bonds 
and branches of α1-6 bonds approximately every 24-30 glucose residues [205]. The 
digestibility of starch therefore is predominantly impacted by the percentage of 
amylose and amylopectin where a higher percentage of amylose content results in 
reduced plasma glucose and insulin peak in the first hour after consumption and a 
more prolonged or sustained release [206]. Typically, the ratio of 
amylose:amylopectin is usually about 20:80 [206] but in the most common 
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commercially available corn starch mixtures, the ratio of amylose:amylopectin is 
70:30 [207]. This ratio in turn, will alter the plasma glucose and insulin response, 
with less fluctuation in peak glucose levels (reduced glycaemic variability) 
observed in meals with higher amylose compared to amylopectin content, although 
the total glucose area under the curve (AUC) which is reported as mean glucose 
levels, were not significantly different between the two meals [207]. Specifically, 
the initial (first 30 minutes) plasma glucose and insulin responses were significantly 
lower in the meals with higher amylose content. Uncooked corn starch (UCCS) is 
a particularly slow-digested starch, shows a blunted response in both plasma 
glucose and insulin when compared to glucose consumption in young men [208]. 
Remarkably, the incremental AUC of plasma glucose and insulin produced in 
UCCS remain stable up to 120 minutes and has been shown to maintain 
normoglycaemia in individuals with glycogen storage disease for up to 9 hours. 
 
2.2.3.2.2 Supplementation of Corn Starch Before Exercise 
While supplementation with starchy foods prior to exercise has not been as 
extensively studied as other forms of CHO [49, 192], the experimentation with 
these slower-absorbed CHO as a pre-exercise supplement has been considered for 
a long-time due to its slow rate of absorption [209]. In one of the earlier assessments 
of corn starch as a pre-exercise supplement, the corn starch was consumed with 400 
ml of water and compared with glucose and fructose supplements [210]. The CHO 
supplements were enriched with Carbon-13 (13C) to assess oxidation rates. Fructose 
oxidation was significantly lower (54±6 %) compared to corn starch (67±9 %) and 
glucose (73±7 %) supplementation, but there was no significant difference between 
corn starch and glucose supplementation group. Plasma glucose and insulin 
response were also similar in glucose and corn starch group throughout the 60 
minutes pre-exercise period and during the prolonged (120 minutes at 60 % VO2max) 
exercise bout. Thus, the researchers concluded that corn starch did not offer an 
additional advantage over glucose as a pre-exercise meal [210]. However, the corn 
starch adopted within that study had an amylose percentage of ~8 %. It has been 
suggested that in order to see the beneficial effect of complex CHO on the 
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postprandial insulinaemic response, the tested CHO should contain at least 30 % of 
amylose [211]. 
More recently, techniques have emerged which allow the modification of starches 
(e.g. hydrothermally or acid/alcohol modified starches) and enables the 
manipulation of gastric-emptying rates and CHO availability independent of the 
amylose:amylopectin ratio [212]. The metabolic responses to supplementation with 
acid/alcohol-modified starches (MAMS), unmodified corn starches (UAMS), 
dextrose (DEX) and PLA were assessed by Johannsen and Sharp (2007). 
Endurance-trained cyclists consumed 1 g/kg body weight of supplement and cycled 
at 66.4 % VO2peak for 2 hours. Plasma glucose and insulin in DEX spiked 
significantly higher compared to other 3 trials and CHO oxidation rate was high in 
DEX and MAMS but only MAMS sustained the CHO oxidation for the 120 
minutes, while DEX sustained the oxidation for 90 minutes before falling to the 
same extent as PLA at 120 minutes [213].  
Unmodified amylomaize-7 (AMY-7) contains high percentage of amylose (70 %) 
[214] but is not recommended for use as CHO supplementation because it is 
insoluble in cold water [214] and only around 73 % digestible [210]. However, after 
undergoing partial acid and alcohol modification, amylomaize becomes soluble in 
water and up to 92 % digestible [214]. Consequently, randomised trial using AMY-
7 was conducted by Bell (2011) wherein participants ingested either AMY-7, DEX 
or PLA 45 minutes prior to exercise. Participants then cycled at 60 % Wmax for 15 
minutes followed by a TT (a workload equivalent to 15 minutes at 80 % Wmax). The 
results showed that ingestion of AMY-7 resulted in less variation in serum glucose 
and insulin concentrations compared to DEX. However, there were no differences 
in TT performance between treatments, although there was a tendency for 
participants to complete the trials faster in the AMY-7 condition [215]. 
While  UCCS is associated with problems in terms of normoglycaemia 
maintenance, palatability, digestion [216] and poor absorption [217], heat modified 
WM was shown to improve the maintenance of normoglycaemia [218, 219] and 
better tolerated [220].  The first study investigating the effect of modified WM 
supplementation on endurance exercise was therefore recently conducted using 
hydrothermally modified WM (HMS). The effect of WM was compared to 
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maltodextrin (MAL). Participants consumed the first dose of supplement 30 
minutes prior to 150 minutes cycling at 70 % VO2peak followed by a TTE trial at 
100 % VO2peak; participants then consumed the second dose immediately after 
exercise. As expected, plasma glucose and insulin spiked higher in MAL while 
HMS showed a slow and steady increased after the consumption of supplement, 
respectively, however, there were no differences in term of performance between 
HMS and MAL [221].  
 
2.2.3.3 Summary 
Hypoglycaemia and glycogen depletion has long been associated with fatigue and 
a decrement in performance during exercise of a prolonged (i.e., >60-90 minutes) 
nature. The intake of CHO during exercise, has consistently been shown to improve 
performance. However, the benefit of CHO intake immediately (i.e., within the last 
two hours prior to exercise) prior to exercise has been controversial. Researchers 
have typically speculated that CHO ingested immediately prior to exercise leads to 
hypoglycaemia, and this in turn leads to reduced exercise performance.  While 
rebound hypoglycaemia does occur in response to CHO ingestion, it appears the 
hypoglycaemia is not associated with reduced performance; at least in exercise 
trials less than 60 minutes in duration.   
Ingestion of complex CHO (i.e., slower digestible CHO) has also been explored as 
a potential ergogenic aid, due to the more prolonged nature of glucose release. 
Specifically, it may be theorised that when participants are able to ingest CHO only 
prior to an event and/or have access only to limited CHO sources during an 
endurance to ultra-endurance event, then consumption of a slower release CHO (or 
low GI) may lead to improved performance. While the relative percentage of 
amylose and amylopectin in starch can affect the digestibility and absorption rate 
of starch this may also be achieved using acid/alcohol-modified and hydrothermally 
modified starches. While research to date has been limited, investigation regarding 
the benefits of mix CHO (starch and sugars) supplementation on prolonged exercise 




While only a handful of metabolites are often described or assessed, biological 
tissues including blood are characterised by a vast array of metabolites which are 
associated with multiple interconnected metabolic pathways. Metabolomics is the 
technique used to not only assess a broad range of these metabolites, using a 
combination of different instrumentation, but to also identify and map these 
metabolites to corresponding pathways. These metabolites may be identified and 
quantified using sophisticated analytical technologies such as liquid 
chromatography-mass spectrometry (LC-MS), gas chromatography-mass 
spectrometry (GC-MS), nuclear magnetic resonance (NMR) [222] and inductively 
coupled plasma-mass spectrometry (ICP-MS; highly sensitive for the detection of 
metals and some non-metals) [223] using a targeted (examining specific markers of 
interest) or untargeted approaches (attempting to profile all of the compounds 
present with any given technique) as shown in Figure 2.3. The major advantages of 
metabolomics analysis are the substantial information which can be obtained from 
very small biological sample volumes. It is important to note that each platform, 
has the capacity to measure many metabolites; however, no one platform can 
measure all metabolites. For this reason, multi-platform approaches are favoured 
for metabolomics analysis, or using a single platform but in a different mode (i.e., 





Figure 2.3 A few analytical techniques to analyse variety group of metabolites. 
 
2.3.1 Metabolomics and Exercise 
Considering the substantial changes associated with blood metabolites during 
exercise, metabolomics analysis has the potential of becoming a powerful tool to 
map these exercise-based changes [224]. One of the first studies to utilise a 
metabolomics approach in blood samples collected at pre-, post-, 3 and 24-hour 
post-exercise (two conditions: running for 60 minutes at ~75 % VO2max max; and 
120 minutes at ~55 % VO2max) identified the medium and long-chain acylcarnitines 
as the most discriminating exercise-related metabolites in continuous endurance 
running [225]. In arguably one of the most comprehensive studies conducted in 
blood samples relative to exercise, Lewis et al. (2010) mapped the metabolic 
changes in response to acute maximal and prolonged exercise involving multiple 
pathways such as tricarboxylic acid cycle, glycogenolysis, fatty acid oxidation and 
lipolysis concurrently. An acute exercise treadmill test (ETT; Bruce protocol) was 
used [226] and the changes at the point of exhaustion (±10 minutes after termination 
of exercise) assessed. The study demonstrated an increase in glycolytic 
intermediates and products (lactate and pyruvate), lipolysis product (glycerol), 
amino acids (alanine and glutamine) and sequential products of adenine nucleotide 
catabolism such as AMP, inosine, hypoxanthine and xanthine. Conversely, there 
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was a reduction in plasma ketone body acetoacetate at the point of exhaustion in 
acute maximal exercise. The participants were divided into two different groups 
according to their fitness level based on median peak percentage of oxygen 
consumption. A greater increase in glycerol and pantothenate was found in the fitter 
participants while in less-fit participants, methionine excursions and glutamine 
concentrations were greater but lactate concentrations did not differ between both 
groups. In the same study, twenty-five participants who completed the Boston 
Marathon were randomly recruited by open e-mail invitation to local clubs and were 
used as the platform for a field study in prolonged exercise. Peripheral blood 
samples were collected before and after completing the marathon. There was a 
significant reduction in gluconeogenic amino acids (alanine, threonine, serine, 
proline, valine, histidine, glutamine, and asparagine) and unexpected increased in 
TRP metabolites (kynurenate, quinolate and anthranilate). The participants were 
also divided into two groups (fast- and slow-runner) based on their median finish 
time (240 minutes).  Fumarate which correlates with fitness level in the acute 
maximal exercise was correlated with running speed during a marathon. Greater 
excursions in span two tricarboxylic acid (TCA) cycle intermediates including 
succinate and malate were associated with the fast-runner group. This study showed 
that i) metabolites from multiple pathways may be mapped simultaneously; ii) 
based on metabolomics, there was a clear and significant distinction between the 
acute exercise changes and the prolonged exercise changes; iii) metabolomics 
analysis was able to separate the fit and unfit individuals. 
The difference in metabolic responses to high-intensity interval exercise (HIIT) and 
work-matched (isoenergetic) continuous moderate-intensity exercise has also been 
investigated using a targeted GC-MS [139]. Ten well-trained athletes were given a 
standard breakfast before HIIT or moderate exercise (MOD) trial. The total amount 
of work used in this study was obtained from a previously completed familiarisation 
trial where participants completed 10 repetitions of cycling at 80 % VO2max for 4 
minutes (work), interspersed with cycling bouts at 50 Watts for 2 minutes 
(recovery). The MOD trial consisted of cycling at 65 % VO2max. In this study, the 
metabolic changes were focused on TCA cycle, amino acids and specific non-
esterified fatty acids (NEFA). The concentration of plasma glucose, lactate, and rate 
of CHO oxidation increased significantly with HIIT only, while fat oxidation, total 
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serum NEFA showed an increase but with no significant differences between HIIT 
and MOD. With respect to TCA intermediates, malonic acid, citric acid, aconitic 
acid and succinic acid were shown to demonstrate 1.6-, 1.8-, 2- and 3-fold 
increments with HIIT, respectively. The specific NEFA changes included an 
increase in myrisctic acid, decanoic acid, dodecanoic acid, hetadecanoic acid and 
palmitoleic acid in both trials. Of particular note, there were unique changes 
associated with the HIIT trial, which included an increase in myrisctic acid and 
oleic acid; while γ-linolenic acid increased in the MOD trial only [139]. Recently, 
Bassini and Cameron (2014) coined the term sportomics and suggested sportomics 
may be used as a tool in helping athletes to manage their training and performance 
by providing a deeper understanding of metabolic changes associated with 
performance during training and competition [227]. 
 
2.3.2 Metabolomics: Nutrition and Exercise 
A metabolomics approach was adopted to assess metabolite and performance 
changes following ingestion of a banana (BAN) versus a 6 % CHO prior to 
completing a 75-km cycling test [228] in fourteen well-trained cyclists. The BAN 
or CHO drink (0.2 g CHO per kg body weight) were consumed every 15 minutes 
during exercise. Blood samples were collected immediately before and after 
exercising, and one hour after completing the time trial. The untargeted GC-MS 
approach showed 103 metabolites, of which 56 demonstrated significant 
differences across time, while only one (dopamine) was significantly different 
between the BAN and CHO trial. There were 15 metabolites which strongly 
contributed to the time-based differences, and these were related to glutathione 
production (5 metabolites); CHO, lipid and amino acid metabolism (8 metabolites); 
and TCA cycle (2 metabolites).  However, the CHO drink and BAN ingestion 
during 75-km cycling resulted in similar changes in blood glucose, markers of 
inflammation and oxidative stress, and innate immune levels, while performance 
remained largely unchanged [228].  
A series of studies have also been conducted to investigate the effects of green tea 
extracts (GTE) on metabolic responses to exercise [229, 230]. The first study 
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investigated the effects of GTE consumed as a supplement for seven days and 
containing 1200 mg total catechins and 240 mg caffeine/day on human body 
metabolism at rest and during constant, moderate-intensity exercise (56±4 % 
VO2max).  Twenty-seven physically active males involved in a PLA-controlled, 
double-blind, randomised, parallel study, were divided into two groups; GTE 
(n=13) or PLA (n=14). The participants consumed GTE or PLA for 7 days (twice a 
day) and performed cycling exercise for 2 hours a day before consuming the 
supplementations on day 8.  In this study, both targeted solid phase extraction (SPE-
LC-MS/MS) and untargeted (GC-MS AND LC-MS/MS) approaches were used. 
Metabolite profiling showed enhanced lipolysis, fat oxidation, glycolysis, activated 
TCA cycle, reduced amino acids catabolism and Cori cycle intermediates, 
suggesting that it has potential to induce aerobic energy and fat metabolism at rest. 
Surprisingly, GTE reduced fat oxidation during exercise, possibly as a result of the 
exercise response being far greater than the response to the GTE. In addition, the 
timing for supplementation affected metabolic responses at rest (blood samples 
collected a day after 8 days of supplementation) and during exercise (blood samples 
collected 2 hours and longer after supplementation). GTE also reduced the 
concentration of metabolites from the TRP pathway at rest [229]. The same 
researchers conducted a subsequent study, in an attempt to separate the chronic 
(GTE for 8 days) and acute (single dose of GTE 2 hours prior to exercise) responses 
[230]. However, the researchers were clearly able to separate the metabolic changes 
from the single GTE bolus, compared to the metabolic response to 7-day 





The application of metabolomics in exercise-based research is relatively new, and 
has demonstrated significant potential. Considering the powerful influence of 
exercise on the blood metabolome, it is unsurprising that altered metabolic profiles 
exist within and between different exercise conditions. Within the exercise-related 
research, only very few studies have utilized multiple platforms or multiple modes 
within any given platform to provide a more comprehensive metabolic profile. 
Moreover, no study to date has attempted to identify metabolites specifically 
associated with fatigue. Considering the multifaceted nature of fatigue, 
metabolomics presents as a unique technique to investigate the metabolic signature 
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3.1 List of abbreviations 
 
Abbreviation  Definition 
AABA   α-aminobutyric acid 
ACh   Acetylcholine 
AdNT   Adenine nucleotide transferase 
AHR   Aryl hydrocarbon receptor 
BABA   β-aminobutyric acid 
BW   Body weight 
CI   Confidence interval 
CHCL   Chloroform 
CNS   Central nervous system 
CVA   Canonical Variate Analysis 
ESI+/-   Electrospray ionisation positive and negative 
ESSA   Exercise and Sport Science Australia 
FDR   False discovery rate 
f-TRP   Free tryptophan 
GABA   γ- aminobutyric acid 
HR   Heart rate 
HVA   Homovanilic acid 
LC-HRMS Liquid Chromatography-High Resolution Mass 
Spectrometry  
MeOH   Methanol 
MS   Mass spectrometry 
PC   Principal component 
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PCA   Principal components analysis 
PC-CVA Principal component projection followed by Canonical 
Variate Analysis 
QC   Quality control 
QC-RSC  Quality Control-Robust Spline Correction 
RM-ANOVA  Repeated measures analysis of variance 
RPE   Ratings of perceived exertion 
RSDQC   Relative standard deviations for pooled QC injections 
RSDSample  Relative standard deviations for sample injections 
TRP   Tryptophan 
TTE   Time-to-exhaustion 
UPLC   Ultra Performance Liquid Chromatograph 






Purpose: The purpose of this study was to investigate the metabolic profile of 
plasma during prolonged constant cycling time-to-exhaustion (TTE), with the 
specific aim of identifying the metabolic profile associated with the onset of fatigue 
and ‘Central Fatigue Hypothesis’. 
Methods: Eighteen healthy and recreationally active men with an age range from 
19 to 44 years old (mean±SD age: 24.7±4.8 years old; mass 67.1±6.1 kg; height: 
171.7±4.9 cm) were recruited to this study. Participants performed prolonged 
cycling TTE at an intensity corresponding to a fixed blood lactate concentration (3 
mmol.L-1). Plasma samples collected at 10-min of exercise, prior to fatigue (last 
sample prior to fatigue; <10 min prior to fatigue), immediately post-fatigue (point 
of exhaustion) and 20-min post-fatigue were assessed using a liquid 
chromatography–mass spectrometry based metabolomics approach (positive and 
negative mode). 
Results: Participants completed ~80.9±13.6 min of cycling TTE and maintained an 
average heart rate of 143.8±8.2 bpm. Of the 1847 reproducible features, 105 
metabolites were putatively identified and confirmed, with 87 metabolites 
demonstrating a significant main effect of time. Seven clusters of associated 
metabolites were identified with four clusters: C (n=17 metabolites), D (n=13 
metabolites), F (n=11 metabolites) and G (n=17 metabolites) contributing to the 
separation between the during-exercise samples; while three clusters: E (n=18 
metabolites), F and G, contributed strongly to the separation between pre-fatigue 
and post-fatigue samples. Four clusters: A (n=20 metabolites), B (n=9 metabolites), 
D and F; demonstrated a strong downward shift in their trajectory between the post-
fatigue and 20-min post-fatigue sample. 
Conclusion: The current study identified a unique metabolic profile of plasma 
samples collected during (10-min of cycling; pre-fatigue; at fatigue) and after (20-
min post) exercise. In accordance with our hypothesis and the ‘Central Fatigue 
Hypothesis’, free-fatty acids (FFA) and tryptophan (TRP) played important roles in 
discriminating between the plasma metabolome at these time-points. 
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3.3 Introduction 
Exercise-induced fatigue is associated with transient reductions in force and power, 
culminating in reduced performance [1-6]. The magnitude and duration of exercise-
induced fatigue may be altered by manipulating intrinsic factors of exercise, such 
as the duration, type, and intensity of the exercise [7-10]. The intrinsic factors may 
in turn be modulated by factors such as sex, age, environmental conditions and the 
nutritional status and training status of the individual [5, 8, 11-18]. In response to 
the complex and interactive nature of these factors, numerous theories and models 
of exercise-induced fatigue have been proposed [7, 19-21]. Although general 
consensus indicates an underlying cause of fatigue which is likely multi-factorial in 
nature, large discrepancies between proposed models exist. Considering the relative 
ease of blood collection and the exercise-associated changes in the metabolic milieu 
of the blood [22], the identification of fatigue based biomarkers in blood presents 
as an attractive option. Indeed, a number of blood-borne biomarkers have 
previously been identified as being associated with fatigue including un-buffered 
protons, electrolytes, glucose, lactate, cytokines and amino acids (reviewed in: 
[23]). The measurement of these biomarkers has typically been restricted to 
methodologies which are highly targeted, limiting the measurement to specific 
metabolites. However, through the application of metabolomics, a global view of 
the blood metabolome may be achieved and has been applied in the exercise science 
field [22, 24-27]. Adoption of this technique led to the identification of medium and 
long-chain acylcarnitines as being the most discriminating exercise-related 
metabolites associated with continuous endurance running [22], while ketone 
bodies, argininosuccinate, niacinamide, and citrulline distinguished marathon 
running and acute short-term exercise [25].   
The application of metabolomics to assess the blood-metabolome at the onset of 
fatigue may lead to novel biomarkers or groupings of metabolites, which relate to 
the onset of fatigue.  Therefore, the primary aim of this study was to assess and 
compare the blood metabolome at the point of fatigue, with the blood metabolome 
prior to fatigue, and following 20-min of recovery. Whilst this study was designed 
to be hypothesis-generating, we sought to examine the ‘Central Fatigue Hypothesis’ 
as proposed by Newsholme and colleagues [28, 29]. Specifically, this hypothesis is 
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based on an increased concentration of free fatty acids (FFA) with prolonged 
exercise, leading to displacement of tryptophan (TRP) from albumin resulting in 
the increased availability of free TRP (f-TRP) for entry into the central nervous 
system (CNS). Tryptophan is the precursor to serotonin, an increase of which in the 
CNS has associated with fatigue in both rats [30, 31] and human studies [32, 33]. 
We, therefore, established the following hypotheses; i) that blood sampled at fatigue 
will be distinct from blood sampled prior to and subsequent to fatigue; ii) free fatty-
acids, 5-methoxy-3-indoleacetic acid (the end product of serotonin catabolism), and 
tryptophan will significantly contribute to the differences observed in the metabolic 
profile of blood, at the point of fatigue. 
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3.4 Methods and procedures 
Participants  
Eighteen healthy and recreationally active men between the ages of 18 and 44 years 
old (mean±SD age: 24.7±4.8 years old; mass 67.1±6.1 kg; height: 171.7±4.9 cm) 
were recruited for this study. Participants were initially screened for eligibility via 
email and follow-up telephone conversation. Exclusion criteria for this study 
included: diagnosis of diabetes mellitus; uncontrolled hypertension; acute (i.e., viral 
infection) or chronic inflammatory disease; currently taking medication for chronic 
health conditions. Additionally, participants were excluded (or referred to their 
General Practitioner to obtain exercise clearance) if they presented with more than 
two risk factors in stage two or checked ‘Yes’ at stage one of the Exercise and Sport 
Science Australia (ESSA) risk assessment questionnaire, or if they were identified 
as having any condition which may be exacerbated through exercise participation. 
All participants were informed about the experimental procedures and provided 
written informed consent before testing. The protocol has been approved by the 
Murdoch University Human Ethics Committee (Project number 2013/206).  
 
Research protocol design  
Participants attended the laboratory at Murdoch University on two separate 
occasions. The first visit comprised preliminary testing and familiarisation, while 
the second visit comprised the experimental session. The experimental protocol for 
this study was a single-arm trial, consisting of participants cycling at a constant 
pace at an intensity corresponding to a blood lactate concentration of 3 mmol.L-1. 
The experimental trial was performed at least 48 hours after the preliminary and 
familiarisation trials. All testing was conducted in the Exercise Physiology 




Preliminary and familiarisation trials 
Anthropometric data (height and weight; Scales Plus, Western Australia, Australia) 
was measured prior to participant’s peak oxygen uptake (VO2peak; ParvoMedics, 
Utah, USA) being determined using a continuous incremental cycle protocol. The 
protocol for the VO2peak test consisted of an initial workload of 50 W, which was 
increased 35 W in a step-wise fashion every 3 min. All testing was conducted on 
the same electromagnetically braked cycle ergometer (Velotron, Racermate Inc., 
Seattle, USA). Finger prick blood samples were collected at the end of each stage 
for measurement of blood lactate (Lactate Plus, Nova Biomedical, Massachusetts, 
USA) until the lactate concentration exceeded 4 mmol.L-1. Thereafter, the workload 
increased 35 W every minute until exhaustion (defined as not being able to maintain 
cadence above 60 rpm despite verbal encouragement). The workload corresponding 
to a blood lactate concentration of 3 mmol.L-1 (W3mM) was then interpolated from 
this test and recorded. The ratings of perceived exertion (RPE) and heart rate (HR) 
(Polar, Kempele, Finland) were measured in the last 10 s of each stage and data 
from the metabolic cart collected continuously and assessed in 15 s epochs for 
determination of VO2peak. Participants were then familiarised with the TTE cycling 
test. The workload during the TTE familiarisation was set at the predetermined 
W3mM, and where necessary, the workload was adjusted to ensure the blood lactate 
concentration was fixed at 3 mmol.L-1. The familiarisation TTE was 20 min in 
duration. The cycle ergometer setting was recorded and remained consistent 
throughout the experimental trials.  
 
Experimental trial 
Participants reported to the laboratory in the morning following a ≥10 h overnight 
fast. A HR monitor (Polar, Kemple, Finland) was placed on the chest of the 
participants. For repeated blood sampling, a venous catheter (VasoFix Safety, 
B.Braun, Melsungen, Germany) was placed into a forearm vein. A baseline blood 
sample (4 ml) was drawn 30 min before the initiation of exercise. Participants were 
provided with 7 ml.kg-1 body weight (BW) of fluid (low caloric lime cordial mixed 
with water; 1:4 ratio of cordial:water) 30 min prior to testing and 5 ml.kg-1 BW 10 
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min prior to the testing. Participants were asked to empty their bladder before the 
initiation of exercise and were provided with 2 ml.kg-1 BW every 15 min of the 
same fluid as well as ad libitum access to water. Participants performed a non-
fatiguing warm-up for 2 min on the electromagnetically braked cycle ergometer 
(Velotron, Racermate Inc., Seattle, USA) to ensure they were comfortable. 
Participants then performed the cycling TTE at an intensity corresponding to 3 
mmol.L-1. The HR, RPE, power output and cadence were recorded continuously 
throughout the exercise. Blood samples were drawn every 10 min during cycling, 
then, at the point of exhaustion (post-fatigue sample) and 20 min after the 
termination of exercise (20-min post-fatigue). The point of exhaustion was 
determined at participant’s own volition or when their cadence dropped below 60 
RPM and could not increase cadence even after receiving verbal encouragement. 
The RPE (scale 6-20 [34]) were collected throughout the trial. 
 
Blood sampling 
Approximately 4 ml of venous blood was drawn at every time point and transferred 
into 4 ml blood collection tubes containing lithium heparin (BD Vacutainer, 
Plymouth, UK) for the metabolomics analysis. These blood samples were 
immediately centrifuged at 1800 g x 10 min to collect blood plasma. These plasma 
samples were transferred into Eppendorf tubes and stored in the freezer at -80 ºC 
before being analysed in the Centre for Integrative Metabolomics & Computational 
Biology, Edith Cowan University. 
 
Sample preparation for metabolomics analyses 
Four time-points were chosen to assess the metabolic changes associated with 
fatigue. The 10-min exercise sample (i.e., participants cycling for 10 min) served 
as the baseline sample for comparisons; the pre-fatigue sample, was the final sample 
drawn prior to volitional exhaustion (pre-fatigue); the blood sample drawn 
immediately after the point of fatigue was identified as the post-fatigue sample; 
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while the final sample drawn 20 min following the exercise bout served as the 20-
min post-fatigue sample.  
Plasma samples were prepared in randomised batches according to the Bligh and 
Dyer method [35]. On the day of analysis, samples were thawed on ice, and protein 
precipitation was performed by either adding 150 µL of ice-cold LC-MS grade 
methanol containing two internal standards; D5 Tryptophan (Cambridge Isotopes 
Laboratories) and Taurocholate Sigma Aldrich (St Louis, MO, USA) to 50 µL of 
plasma for reverse phase chromatography (RP), or for hydrophilic interaction liquid 
chromatography (HILIC) by adding 150 µL of ice-cold LC-MS grade acetonitrile 
containing two internal standards; C (13) Leucine, D8 Valine. Samples were 
thermomixed at 4 °C for 60 s at 1400 rpm before centrifugation (14000 rpm) for 20 
min at 4 °C. An aliquot (50 µL) of each supernatant was transferred to separate LC 
vials and placed into the auto sampler tray at 6 °C ready for metabolomics analysis. 
Samples were analysed within 24 h. Quality control (QC) samples were prepared 
by pooling 20 µL of each plasma sample; 50 µL aliquots were then prepared as 
study samples. Quality control samples were prepared and analysed throughout the 
LC/MS runs to assess instrument drift and ‘batch-batch’ variability. Prior to data 
acquisition, the analytical sequence was randomised by the participant, and then 
time point. To monitor analytical drift and assess precision, QC samples were 
injected after every 5th sample [36].  
 
LC-high mass spectrometry 
Experiments were analysed using a Dionex UltiMate 3000 RS comprising an Ultra 
High-Pressure Liquid Chromatography Pump (UHPLC) coupled to Orbitrap 
Exactive (Thermo Fisher Scientific, CA, USA) fitted with a heated electrospray 
ionisation probe (HESI). Non-polar metabolites were separated on a RP Hypersil 
GOLD column (100 x 2.1 mm, 1.9 µm particle size; ThermoFisher Scientific, 
Runcorn, UK) with an in-line filter. Separation was performed as described by 
Dunn, Broadhurst [37]. Briefly, the eluent gradient for RP analysis, in both positive 
and negative mode, comprising water with 0.1 % formic acid (solvent A) and 
methanol with 0.1 % formic acid (solvent B) was: isocratic at 100 % A for 1.0 min, 
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followed by an increase to 100 % B in 15 min, maintained at 100 % B for 4 min. 
Initial conditions were returned over 2 mins and then held at 100 % A to equilibrate 
for 3 min. The flow rate was 0.4 mL/min for positive and 0.36 mL/min for negative; 
injection volume was 2 µL, and column oven temperature 50 °C. 
Polar metabolites were separated on HILIC Syncronis (100 x 2.1 mm, 1.9 µm 
particle size; ThermoFisher Scientific, Runcorn, UK) column with an in-line filter. 
Sample analysis in positive mode was performed using water with 0.1 % formic 
acid (solvent A) and acetonitrile with 0.1 % formic acid (solvent B). For negative 
mode, water with 10 mM ammonium acetate (solvent A) and acetonitrile (solvent 
B). Eluent gradient for HILIC was as follows: isocratic at 95 % B for 1.5 min, 95 
to 40 % B in 10.5 min, maintained at 40 % B for 2 min, returned to initial conditions 
over 1 min, and then held for 5 min for column equilibration. The flow rate was 0.3 
mL/min; injection volume 2 µL, and column oven temperature 50 °C. To avoid bias 
due to the instrument drift, the injection sequence were block randomised by 
participant and within each block by time point (baseline, pre-fatigue, post-fatigue 
and 20-min post-fatigue). To assess analytical precision, 24 QCs were injected 
throughout the sequence; four samples bracketed by one QC. 
Full scan and ddMS2 were acquired on the Orbitrap mass analyser. Full scan was 
set at 70,000 resolution and a scan range of 70 – 1000 m/z with the source and ion 
transfer conditions as follows; source heater = 350 °C, sheath gas = 35 (arbitrary 
units), aux gas = 10 (arbitrary units), capillary temperature = 350 °C, ion spray 
voltage = 3.0 kV (positive ion mode) and 2.5 kV (negative ion mode), slens = 50 % 
and AGC = 1 x 10-6.  MS/MS experiments were performed at a resolution 17,500 
on each sample with the HCD energy set at 30 eV. Data acquisition was carried out 
using Xcalibur software (Thermo Fisher Scientific, San Jose, CA, USA). Before 
analysis, the Exactive Orbitrap was externally calibrated using ready-made 
calibration solutions (ESI negative ion calibration and ESI positive ion calibration 





Data from each MS ionisation mode were grouped and pre-processed separately 
using Compound Discoverer 2.0 (Thermo Fisher Scientific, San Jose, CA, USA), 
using an untargeted metabolomics workflow. Briefly, Compound Discoverer was 
used to align total ion chromatograms along retention time using an adaptive curve, 
with a maximum shift of 0.5 min and 5 ppm mass tolerance. Detected features with 
an intensity of no less then 1,000,000 and a S/N greater than 5 in each set of data 
were extracted and merged into components according to ion adducts. Resulting 
compounds were searched for in online databases such as mzCloud, HMDB and 
KEGG for verification and annotation. Resulting data matrices were exported and 
corrected using the Quality Control-Robust Spline Correction (QC-RSC) algorithm 
[38]. Relative standard deviations were calculated for the pooled QC injections 
(RSDQC) and the sample injections (RSDSample), and the ratio of RSDSample to RSDQC 
was also calculated. To suppress the mathematical confounding effect of highly 
collinear data (and to roughly group chemically similar features, such as adducts 
and isotopes) metabolite features were combined into a single peak using a simple 
hierarchical-clustering algorithm. First, a Pearson’s correlation matrix was 
calculated, mapping the pair-wise correlation between each metabolite feature. 
Second, a retention time difference matrix was calculated, mapping the pair-wise 
difference in retention time between each metabolite feature. Features that had a 
pair-wise correlation >0.8 and pair-wise retention time difference < ± one-second 
were grouped into a single metabolite “cluster”. For each cluster, the feature with 
the largest peak-area was then used for quantification. Orphan features were 




Metabolite identifications were established prior to statistical analysis, by matching 
against an in-house MS/MS spectral library and searching online mzCloud spectral 
libraries (mzCloud, Metlin, HMDB and Massbank). This process corresponds with 
the reporting standards for chemical analysis proposed by the Metabolomics 
Standards Initiative [39]. Identified metabolites are tabulated (Table 3.1), including 
information of most probable identity and m/z. 
 
Statistical analysis 
The metabolite cluster data from both the positive and negative ionisation modes 
were combined into a single data matrix. Missing values were imputed using the k-
nearest-neighbour methodology (k=3) [40]. Data were log transformed, both to 
stabilise variance, and to approximate the multivariate normal distribution needed 
for parametric univariate and multivariate statistical modelling. 
Before any formal models were tested, principal components analysis (PCA) was 
performed on the complete data set (all identified and non-identified features), with 
scores plot labelled QC and Sample (Figure 3.1). Here the aim was to assess the 
natural multivariate variance of the data as well as identify and remove sample 
outliers resulting from either poor sample collection or instrument error. For each 
identified metabolite in turn, the null hypothesis that there were no differences in 
population means across the four-consecutive time-points was tested using repeated 
measures analysis of variance (RM-ANOVA). The method described by Benjamini 
and Hochberg [41] was used to control for the probability of false discovery, which 
is unavoidably inflated with multiple parallel statistical comparisons. A false 
discovery rate (FDR) of 0.1 was considered appropriately conservative to avoids 
false positives [42], whilst at the same time avoiding false negative results. 
Identified metabolites (name; formula; retention time) were tabulated with F-
scores, p-values, FDR-adjusted p-values (i.e., q-value) in Table 3.1.   
The identified peaks were then combined into a single multivariate discriminant 
model using Principal Component projection followed by Canonical Variate 
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Analysis (PC-CVA) [43]. PC-CVA is performed to visualise the multivariate 
covariance in the data and uncover multivariate latent structure therein. The means 
and 95% confidence interval (CI) of the mean for each subject trajectory scaled to 
unit variance are presented in the PC-CVA; time-points (clusters) are considered 
significantly different when 95% CI bands show no overlap.   Since univariately 
weak- but correlated- variables can become significant when combined into a 
multifactorial biomarker signature. The number of PCs to be projected into CVA 
space was determined by identifying the inflection point in the PCA screen plot. 
Bootstrap resampling/remodelling was used (n=500) to determine which 
metabolites significantly contributed to the optimal model (P<0.05). The loadings 
plot for PC1 and PC2 (mean±95% CI; significance identified by 95% CI bands not 
including absolute zero and indicated in red) of identified metabolites are presented 
in Figure 3.3.  
Cluster analysis was used to divide the multivariate datasets into clusters and 
presented as a circular clustergram (Figure 3.4). Association of continuous 
variables was calculated using Euclidean distance and Ward’s method, which 
results in each observation being forced into a cluster. Resultant clusters are 






Workload for the time-to-exhaustion trial was set at 110.3±23.0 W. Participants 
rode for 4853.7±813.8 sec (~80.9±13.6 min) and maintained an average HR of 
143.8±8.2 bpm. The RPE at the completion of the exercise trial was 17.9±2.8.   
 
 
Figure 3.1 Scores plot from the Principal Component Analysis (PCA). The QC 
samples clearly cluster to the right and demonstrate large homogeneity while 
samples (four plasma samples per participant) are clustered to the left and are 
clearly separated from the QC samples. The analysis was conducted on all 
(identified and non-identified) metabolites present in the plasma sample. 
 
Metabolomics Analysis 
After data cleaning and similarity clustering, Liquid Chromatography-High 
Resolution Mass Spectrometry (LC-HRMS) analysis of plasma resulted in the 
reproducible detection of 1847 features (with RSD <20%). Principal components 
analysis (PCA) showed (Figure 3.1) tight clustering of the QC samples and much 
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smaller QC-variance than sample-variance. There were no outliers detected in the 
PCA.  
Of the reproducible features, 105 metabolites were putatively identified and 
confirmed, with 87 metabolites identified as demonstrating a significant main effect 
of time (Table 3.1). The results of the PC-CVA (Figure 3.2), showed significant 
multivariate discrimination between group means. Principal Component 1 (PC1) 
explained 35% of total dataset variance and demonstrated a non-recovery trajectory 
which progressively increased (demonstrated by rightward shift) from baseline to 
pre-fatigue, at fatigue and then 20-min post-fatigue. Principal component 2 (PC2) 
explained 12% of the total dataset variance and demonstrated a recovery trajectory, 
wherein pre-fatigue and post-fatigue samples are elevated along PC2, while the 20-
min post-fatigue samples are below the baseline sample (Figure 3.2). 
The contribution of individual metabolites to the PCA plot loadings are presented 
in Figure 3.3, with seven clusters of associated metabolites (based on trajectories) 
being identified in the cluster diagram (Figure 3.4). The trajectories for each 
identified cluster are in turn plotted to provide a visual representation of the 
observed changes for these groups of metabolites. It is apparent that clusters C 
(n=17 metabolites), D (n=13 metabolites), F (n=11 metabolites) and G (n=17 
metabolites) contribute strongly to the separation between the baseline sample and 
the pre-fatigue sample; while clusters E (n=18 metabolites), F and G contributed 
strongly to the separation between pre-fatigue and post-fatigue samples. Clusters A 
(n=20 metabolites), B (n=9 metabolites), D and F demonstrated a strong downward 
shift in their trajectory between the post-fatigue and 20-min post-fatigue sample, 





Figure 3.2 Principal Component projection followed by Canonical Variate 
Analysis (PC-CVA) of identified metabolites. The mean (x) and 95% CI (dashed 
circle around x) are presented. Significant differences are determined where 95% 
CI does not overlap. Baseline (20-min steady state) is strongly separated along PC-
1 from all time points. Pre-fatigue and post-fatigue (at fatigue) are clustered closer 
although significant separation was achieved. The 20-min post-fatigue samples are 







Figure 3.3 Loadings illustrating metabolites contributing to PC1 (left) and PC2 
(right). Data are presented as mean-loading values ±95% CI. Red-coloured CIs 
identify metabolites that significantly contribute along the respective PC; blue-




Figure 3.4 Circular clustergram classifying individual metabolites into seven 





Figure 3.5 Marginal means (±95 % confidence interval) plots of each cluster relative to time. Bottom right panel provides a relative-indication of 
the timing for each blood sample to provide some reference.        
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Table 3.1 Characteristics and statistical table of each identified metabolite. Significance was based on q-value (FDR-adjusted p-values) and 
significance set at q≤0.05. All significant metabolites are bolded.   
Label Formula Molecular Weight Rt (min) QC-RSD F(3,51) p-value q-value Cluster 
Glycocholic acid C26 H43 N O6 465.30861 14.236 3.8 26.59 1.70556E-10 5.7769E-10 A 
Indole-3-acetic acid C10 H9 N O2 175.06304 7.369 3.6 26.41 1.89629E-10 6.2222E-10 A 
Carnitine C7 H15 N O3 161.10494 0.729 1.4 17.68 5.34371E-08 1.36851E-07 A 
1,7-Dimethyluric acid C7 H8 N4 O3 196.05896 6.01 3.9 16.42 1.3537E-07 3.38425E-07 A 
Tryptophan C11 H12 N2 O2 204.08924 5.665 4.4 15.03 3.89064E-07 9.28448E-07 A 
Methyl isonicotinate C7 H7 N O2 137.0476 6.833 3.9 12.98 2.03297E-06 4.35636E-06 A 
Threonine C4 H9 N O3 119.05817 0.709 3.8 12.62 2.74431E-06 5.65005E-06 A 
Glycoursodeoxycholic acid C26 H43 N O5 449.31413 15.221 3.9 10.29 2.10315E-05 4.08946E-05 A 
Carnitine C7 H15 N O3 161.10511 5.871 5.0 9.74 3.46593E-05 6.38461E-05 A 
1,3-Dimethyluric acid C7 H8 N4 O3 196.05927 4.678 4.9 9.76 3.40967E-05 6.38461E-05 A 
Glutamine C5 H10 N2 O3 146.06892 0.705 1.4 8.42 0.0001211 0.000208451 A 
Taurochenodeoxycholic acid C26 H45 N O6 S 499.29646 14.346 4.2 8.31 0.000134535 0.000224225 A 
Citrulline C6 H13 N3 O3 175.09535 0.715 3.6 7.64 0.000259192 0.000425237 A 
3-Methylhistidine C7 H11 N3 O2 169.08488 0.696 6.2 7.19 0.000406679 0.000656943 A 
Methionine C5 H11 N O2 S 149.05097 6.399 3.6 6.83 0.000588689 0.000895831 A 
Proline C5 H9 N O2 115.06336 0.755 4.2 6.72 0.000656827 0.000985241 A 
Alanine C3 H7 N O2 89.04791 0.705 3.6 3.45 0.023079315 0.027854346 A 
 
85 
Acetylcholine C7 H15 N O2 145.11 0.757 3.1 2.40 0.078132779 0.092179121 A 
4-Hydroxybenzaldehyde C7 H6 O2 122.03683 6.498 3.3 1.94 0.13487551 0.152278802 A 
Arginine C6 H14 N4 O2 174.11143 0.687 3.5 1.39 0.255345897 0.269384128 A 
Methoxyphenylacetic acid C9 H10 O3 166.06192 5.204 8.0 6.47 0.000854881 0.001264261 B 
3-Deoxy-D-glycero-D-galacto-
2-nonulosonic Acid C9 H16 O9 268.08044 5.534 6.2 5.66 0.002007363 0.002848285 B 
1,3,7-Trimethyluric acid C8 H10 N4 O3 210.07484 6.695 4.2 3.93 0.013441591 0.016801989 B 
Hexadecanamide C16 H33 N O 255.2558 1.003 7.7 3.55 0.020644493 0.025205486 B 
Oleamide C18 H35 N O 281.27157 0.992 6.0 2.19 0.100195494 0.115610185 B 
Salicylic acid C7 H6 O3 138.03065 8.86 4.9 2.14 0.105995462 0.120973082 B 
Quinic acid C7 H12 O6 192.06265 0.972 4.8 1.78 0.163200807 0.182298774 B 
myo-Inositol C6 H12 O6 180.06271 6.746 11.8 0.62 0.602365844 0.626221917 B 
Pyroglutamic acid C5 H7 N O3 129.04236 5.393 7.8 0.41 0.746162679 0.75333732 B 
2-Aminobutyric acid C4 H9 N O2 103.06357 6.535 2.3 141.64 1.00969E-24 2.12035E-23 C 
Caffeine C8 H10 N4 O2 194.08026 1.169 2.9 111.71 2.06014E-22 2.16315E-21 C 
Glycerophospho-N-palmitoyl 
ethanolamine C21 H44 N O7 P 453.28472 15.717 2.0 88.91 2.92678E-20 2.36394E-19 C 
Paraxanthine C7 H8 N4 O2 180.06447 4.899 3.7 43.50 4.32257E-14 1.97335E-13 C 
N3,N4-Dimethyarginine C8 H18 N4 O2 202.14252 0.759 4.6 25.88 2.57603E-10 8.19646E-10 C 
cis-4-Hydroxy-D-proline C5 H9 N O3 131.05815 7.669 6.2 25.36 3.51096E-10 1.08427E-09 C 
Theophylline C7 H8 N4 O2 180.06383 1.594 46.5 24.96 4.46345E-10 1.33904E-09 C 
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Norleucine C6 H13 N O2 131.09466 1.131 7.6 22.53 1.99829E-09 5.67082E-09 C 
Cholic acid C24 H40 O5 408.287 5.922 2.0 21.26 4.54299E-09 1.2553E-08 C 
Theobromine C7 H8 N4 O2 180.06458 1.426 3.3 20.50 7.52915E-09 2.02708E-08 C 
N-Ethylglycine C4 H9 N O2 103.06343 0.757 7.6 13.41 1.42506E-06 3.25285E-06 C 
Deoxycholic acid C24 H40 O4 392.29251 15.942 4.2 10.11 2.46308E-05 4.70224E-05 C 
25-Hydroxyvitamin D3 C27 H44 O2 400.33313 16.699 5.7 5.49 0.00240795 0.003326773 C 
Aminocaprylic acid C8 H17 N O2 159.12567 6.501 4.4 5.44 0.002531412 0.003451925 C 
3-Aminobenzamide C7 H8 N2 O 136.06358 0.929 14.0 5.34 0.002831835 0.003812086 C 
Tyramine C8 H11 N O 137.08403 0.686 5.9 4.81 0.005038006 0.006612383 C 
Nicotinamide C6 H6 N2 O 122.04798 1.212 12.4 1.74 0.169574302 0.185471893 C 
Creatine C4 H9 N3 O2 131.06953 6.23 5.1 73.88 1.42811E-18 8.33064E-18 D 
Indole C8 H7 N 117.05791 2.142 4.9 39.45 2.49441E-13 1.04765E-12 D 
Hippuric acid C9 H9 N O3 179.05806 2.141 4.7 32.60 6.56695E-12 2.65204E-11 D 
N-Phenylacetylglutamine C13 H16 N2 O4 264.11095 6.271 6.9 14.60 5.47929E-07 1.2785E-06 D 
Glutamic acid C5 H9 N O4 147.05285 0.712 4.6 13.35 1.50213E-06 3.35582E-06 D 
Phenylacetylglutamine C13 H16 N2 O4 264.11056 4.785 4.7 13.24 1.64006E-06 3.58763E-06 D 
Indole-3-lactic acid C11 H11 N O3 205.07351 6.779 4.0 11.48 7.30021E-06 1.47408E-05 D 
Biocytin C16 H28 N4 O4 S 372.17615 0.79 7.0 8.74 8.89013E-05 0.000155577 D 
5-Methoxy-3-indoleacetic acid C11 H11 N O3 205.07329 8.227 4.2 8.33 0.000131919 0.000223411 D 
Isoquinoline C9 H7 N 129.05768 8.567 5.9 6.94 0.000528159 0.00081554 D 
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Methyl indole-3-acetate C11 H11 N O2 189.07859 8.567 4.5 5.50 0.002371064 0.00331949 D 
Methyl jasmonate C13 H20 O3 224.14083 14.483 4.7 5.03 0.003967567 0.005273349 D 
Trimethylamine N-oxide C3 H9 N O 75.0683 0.735 5.2 4.26 0.009237247 0.011974209 D 
13-Hydroxyoctadecadienoic 
acid C18 H32 O3 296.23475 0.997 4.6 15.51 2.69498E-07 6.58077E-07 E 
13,14-Dihydro-15-keto 
Prostaglandin A2 C20 H30 O4 334.21178 16.099 6.2 12.85 2.26725E-06 4.76123E-06 E 
Citric acid C6 H8 O7 192.02623 1.28 15.1 10.60 1.58941E-05 3.14883E-05 E 
Stachydrine C7 H13 N O2 143.09455 6.769 3.2 7.04 0.000474884 0.000755497 E 
N-Methy2-pyrrolidone C5 H9 N O 99.0685 3.61 4.2 6.96 0.000513972 0.000805479 E 
Ascorbic acid C6 H8 O6 176.03168 0.758 8.2 6.25 0.00106951 0.001559702 E 
Hydroxyphenylpropionate C9 H10 O3 166.06273 0.947 3.5 4.22 0.009695545 0.012415027 E 
GABA C4 H9 N O2 103.06355 1.982 12.1 4.08 0.011370433 0.014384283 E 
3-Hydroxyanthranillic acid C7 H7 N O3 153.04245 2.119 5.0 3.75 0.016533132 0.020423281 E 
Gabapentin C9 H17 N O2 171.12577 0.846 5.8 2.76 0.051464774 0.061406833 E 
Proline C5 H9 N O2 115.06305 2.108 6.5 2.24 0.094529633 0.110284572 E 
Cortisol C21 H30 O5 362.20851 10.185 3.7 1.76 0.16675484 0.184307981 E 
Closantel C22 H14 Cl2 I2 N2 O2 661.85151 0.664 15.6 1.63 0.193741582 0.208223349 E 
Valine C5 H11 N O2 117.0786 0.718 8.2 1.63 0.194341792 0.208223349 E 
Ascorbic acid C6 H8 O6 176.03122 1.099 11.5 1.39 0.256556312 0.269384128 E 
2-(14,15-Epoxyeicosatrienoyl) 
glycerol C23 H38 O5 394.26901 1.028 4.6 0.55 0.64812167 0.667184072 E 
88 
Pipecolinic acid C6 H11 N O2 129.07898 6.956 14.6 0.47 0.704452389 0.718131076 E 
Creatinine C4 H7 N3 O 113.05894 0.742 2.0 0.39 0.762408368 0.762408368 E 
Glycerol C3 H8 O3 92.04734 0.736 6.6 262.70 5.42848E-31 5.6999E-29 F 
Acetycarnitine C9 H17 N O4 203.11545 0.761 3.9 190.89 1.03672E-27 5.44278E-26 F 
Hexanoylcarnitine C13 H25 N O4 259.17797 0.714 3.3 143.56 7.43326E-25 1.95123E-23 F 
Cyclamic acid C6 H13 N O3 S 179.06072 5.254 2.4 79.44 3.15679E-19 1.94978E-18 F 
Taurine C2 H7 N O3 S 125.0147 7.569 4.8 61.85 5.24053E-17 2.62027E-16 F 
Nicotinuric 
acid/Nicotinylglycine C8 H8 N2 O3 180.05326 2.053 5.3 31.31 1.27589E-11 4.96179E-11 F 
D-Pantothenic acid C9 H17 N O5 219.11032 4.004 5.6 29.35 3.62803E-11 1.36051E-10 F 
Decanoylcarnitine C17 H33 N O4 315.2408 0.666 4.6 18.05 4.09611E-08 1.07523E-07 F 
2-Aminoadipate C6 H11 N O4 161.06852 0.757 4.0 9.68 3.66238E-05 6.63017E-05 F 
Hypoxanthine C5 H4 N4 O 136.03845 4.089 5.3 8.84 8.06358E-05 0.000143504 F 
Xanthine C5 H4 N4 O2 152.03329 3.103 5.8 5.93 0.001499695 0.002157096 F 
Linolenic acid C18 H30 O2 278.22388 15.814 13.8 151.17 2.28763E-25 8.00671E-24 G 
Palmitic acid C16 H32 O2 256.23999 1.391 5.0 132.77 4.36642E-24 7.64124E-23 G 
Oleic acid C18 H34 O2 282.25576 17.994 8.2 120.16 4.08768E-23 6.13152E-22 G 
Linoleic Acid C18 H32 O2 280.2401 17.597 5.9 115.27 1.02935E-22 1.35102E-21 G 
Myristic acid C14 H28 O2 228.2084 1.437 4.8 112.20 1.87131E-22 2.16315E-21 G 
Myristoleic acid C14 H26 O2 226.19284 1.445 5.9 107.23 5.0742E-22 4.84355E-21 G 
Homovanillic acid C9 H10 O4 182.05707 5.597 4.0 103.26 1.15885E-21 1.01399E-20 G 
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Dodecanoate C12 H24 O2 200.17686 1.468 6.3 88.58 3.16461E-20 2.37346E-19 G 
11,14-eicosadienoic acid C20 H36 O2 308.27121 1.317 8.2 82.89 1.29287E-19 9.05009E-19 G 
2-hydroxybutyric acid C4 H8 O3 104.04752 1.435 10.1 80.29 2.52928E-19 1.65984E-18 G 
cis-11-Eicosenoic acid C20 H38 O2 310.28695 1.296 8.0 71.51 2.79034E-18 1.54203E-17 G 
Palmitoleic acid C16 H30 O2 254.22452 1.388 5.0 63.12 3.50047E-17 1.83775E-16 G 
Oleoylcarnitine (C18:1) C25 H47 N O4 425.35022 0.631 4.5 54.72 5.80338E-16 2.7698E-15 G 
Palmitoylcarnitine C23 H45 N O4 399.33391 15.722 4.5 41.66 9.41521E-14 4.11915E-13 G 
Uracil C4 H4 N2 O2 112.027 4.96 3.2 28.29 6.50317E-11 2.3546E-10 G 
2-Ketobuyric acid C4 H6 O3 102.03175 1.225 11.7 27.51 1.00809E-10 3.52832E-10 G 





The primary aim of this study was to examine the metabolic profile of plasma at the 
point of fatigue, and contrast this profile with that occurring prior to fatigue (two 
time-points: 10 min into cycling task and immediately prior to fatigue) and after a 
20-min period of recovery. The findings of the current study were i) there was a 
unique metabolic profile at fatigue, pre-fatigue (both time-points) and after 20 min 
of recovery; ii) there were 87 metabolites identified as significantly contributing to 
the unique metabolic profile associated with each time-point; iii) when associated 
metabolites were clustered together, significant trends over time were identified. In 
accordance with our hypothesis, free-fatty acids (FFA), 5-methoxy-3-indoleacetic 
acid, and TRP played important roles in discriminating between the time-points in 
the current study.     
The PC-CVA score plot (Figure 3.2) corresponding to the first two principal 
components showed that PC1 and PC2 explained 35% and 12% of the total dataset 
variance, respectively. Relationships between the location of the samples in the 
scores plots with the respective time-points were assessed by Canonical Variate 
Analysis (CVA) and visually presented using colour-coded data-points. The CVA 
revealed the plasma metabolome was significantly altered during the course of the 
study which resulted in perceptible clustering of the plasma samples from 
respective time-points. Specifically, the approach adopted herein, clearly enabled 
the discrete separation of plasma samples according to the metabolic profile 
between sampling time-points. To provide some context, the average cycle time in 
this study was 81 min; a participant cycling for 81 min, had a blood sample taken 
at 10 min (baseline), 80 min (pre-fatigue), ~82 min (post-fatigue) and 101 min (20-
min post-fatigue). Therefore, the greatest time-difference (71 min on average) 
occurred between the baseline sample and the pre-fatigue sample, while the shortest 
time-difference occurred between the post-fatigue and pre-fatigue samples which 
did not exceed 10 min on any occasion. As a consequence, the baseline samples are 
clustered further away from the other samples since their metabolic profile was 
more distinct from others, and unsurprisingly, the pre-fatigue and post-fatigue 
samples demonstrate similar metabolite profiles. It is interesting to note the 
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separation between the pre-fatigue and post-fatigue samples along PC1 only, while 
the 20-min post-fatigue samples are clearly separated along PC2. The contribution 
of each metabolite to PC1 and PC2 are illustrated in Figure 3.3 and highlight the 
influential role of lipids and metabolites associated with lipid metabolism to PC1 
in particular.  
     
Fatigue associated metabolites: Central Fatigue Hypothesis 
The relative importance of serotonin to the onset of fatigue in prolonged exercise 
has been a matter of great debate [7] since the original work by Newsholme et al. 
[28, 29]. Central to this theory is the progressive increase in the concentration of 
long chain fatty acids with exercise duration. Specifically, this hypothesis is based 
on an increased concentration of FFA with prolonged exercise, leading to 
displacement of tryptophan (TRP) from albumin resulting in the increased 
availability of free TRP (f-TRP) for entry into the central nervous system (CNS). 
Tryptophan is the precursor to serotonin, an increase of which in the CNS has 
associated with fatigue in both rats [30, 31] and human studies [32, 33].  
In the current study, the concentration of FFA progressively increased and were the 
strongest contributors (All q≤0.001) to the observed significant increase over time 
in Cluster G (Figure 3.5). Accordingly, glycerol (Cluster F) demonstrated 
significant increases (q≤0.001) reflecting an increased adipose tissue triglyceride 
catabolism; in this vein, oleic acid, the most abundant fatty acid in human adipose 
tissue [44], was one of the fatty acids which demonstrated the largest increase in 
the current study, along with linolenic acid and palmitic acid. The increase in 
palmitic acid and linoleic acid are unsurprising since palmitic acid is the most 
abundant saturated acid in human tissues [45] while linoleic acid is the most 
abundant fatty acid in plasma [45]. Concomitant with these changes in FFA, TRP 
demonstrated a significant decrease in concentration over time (Table 3.1; Cluster 
A, Figure 3.5) which may be indicative of increased CNS uptake of TRP during 
exercise as previously suggested [28, 46] and possible conversion to serotonin 
within the CNS. While speculative only, this speculation is strengthened by the 
observed increase (q≤0.001) in 5-methoxy-3-indoleacetic acid, the end product of 
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serotonin catabolism. Specifically, the major catabolic pathway of serotonin in 
humans is conversion to 5-hydroxyindole-acetaldehyde [47], which is in turn 
catabolised to 5-methoxy-3-indoleacetic acid via enzymatic conversion by 
aldehyde dehydrogenase and acetylserotonin N-methyltransferase (the same 
enzyme associated with the synthesis of melatonin), respectively. However, this is 
based on temporal associations in changes in a plasma concentration in metabolites 
in the current study only and requires confirmation in subsequent experimental 
studies. 
  
Fatigue associated metabolites: indole metabolism 
Tryptophan is a unique amino acid due to the indole ring comprising its structure 
[47]. Indeed, while conversion of TRP to serotonin is most commonly discussed in 
relation to fatigue [1, 7, 19, 28-30], the study herein identified significant increases 
in the concentration of indole (q≤0.001), indole-3-lactic acid (q≤0.001), methyl 
indole-3-acetate (q=0.003) and a decrease in indole-3-acetic acid (q≤0.001). These 
metabolites relate to alternate pathways of tryptophan metabolism and are unrelated 
to the more well-known and researched pathways of serotonin, melatonin, and 
kynurenine [47]. Tryptophan metabolites and indole have more recently [48] been 
the subject of interest due to their possible activation of the aryl hydrocarbon 
receptor (AHR). Within this, indole and indole 3-acetic acid have been identified 
as confirmed ligands of AHR, which does not exclude the possibility of the other 
metabolites playing a possible role in AHR activation. The physiological 
significance of this is that AHR activation has now been identified as playing an 
important and multifaceted role in immune regulation which involves regulation of 
both innate and adaptive immunity [48]. Future research may be warranted to 
explore whether these ‘alternate’ tryptophan metabolic pathways are responsible 





Fatigue associated metabolites: free fatty acids 
Notwithstanding the significance of the Central Fatigue Hypothesis discussed 
above, there are other possible links between FFA and the onset of fatigue. 
Specifically, oleic acid and oleoylcarnitine have demonstrated significant inhibition 
(up to 30% inhibition) of the mitochondrial transporter adenine nucleotide 
translocase (AdNT) [51]. This transporter is responsible for transporting ATP 
derived from oxidative phosphorylation, to the energy-requiring reactions in the 
cytoplasm of the cell. Palmitoylcarnitine and palmitic acid demonstrated similar 
capacity of inhibition (up to 60% inhibition) of AdNT. In the current study, oleic 
acid, palmitic acid, oleoylcarnitine, palmitoylcarnitine and acetylcarnitine all 
demonstrated significant increase (All q≤0.001; Table 3.1; Cluster F and G, Figure 
3.5). While this downregulation of AdNT by FFA and carnitine esters has long been 
acknowledged (i.e., [51]), the possible implication of this pathway to exercise-
induced fatigue has to our knowledge, not previously been explored. Free fatty 
acids, and in particular palmitoylcarnitine has also been implicated in modulating 
the activity of additional proteins of interest in the fatigue literature including the 
sodium/potassium and calcium pumps [52, 53]; albeit that much of this work has 
previously been conducted in myocardial tissues. The role of electrolytes and 
intracellular calcium concentrations in fatigue-onset has been acknowledged since 
the classical work of Bergstrom et al. [1, 7, 54, 55].   
The role of FFA in cell signalling, and in particular the role of FFA in regulating 
inflammatory pathways and pathways associated with oxidative stress has gained 
increasing interest [56-58]. Palmitoylcarnitine has been shown to increase reactive 
oxygen species [52] as well as stimulate the release of pro-inflammatory cytokines 
(interleukin-1; interleukin-6; tumour-necrosis factor alpha) [59]. Whether the 
increase in palmitoylcarnitine during exercise is involved in these previously 
reported increased concentrations of cytokines or the previously reported imbalance 
in redox status post-exercise [60] may be an important area of future research.  
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Fatigue associated metabolites: neurotransmitters 
A number of neurotransmitters have understandably been under investigation with 
respect to their involvement in fatigue. Aminobutyric acid, which may comprise 
any of three isomeric compounds including, α-aminobutyric acid (AABA), β-
aminobutyric acid (BABA), γ-aminobutyric acid (GABA) has been implicated in 
possibly playing a role in the onset of fatigue. In the current study, GABA was 
increased significantly (q=0.014) and is considered the chief inhibitory 
neurotransmitter in the mammalian central nervous system, given its general role is 
to reduce neuronal excitability [61]. It is noteworthy that 2-aminobutyric acid 
demonstrated a significant increase (q≤0.001) and has recently been shown [62] to 
increase the activity of glutathione, which plays an essential role in the maintenance 
of intracellular redox balance.  
Two additional metabolites are of particular interest in the current study, 
homovanillic acid (HVA) and acetylcholine (ACh). Homovanillic acid is the major 
metabolite of catecholamine degradation and specifically, dopamine degradation 
[63]. Dopamine, in turn, is known to play significant roles in glucose homeostasis, 
immune regulation and mood regulation, with a specific role in the reward circuitry 
of the brain [64]. Homovanillic acid demonstrated a significant increase (q≤0.001) 
in the current study. Acetylcholine, on the other hand, is the primary 
neurotransmitter associated with the motor nerve and induces the muscle action 





Fatigue associated metabolites: energy yielding pathways 
The energetics of muscular fatigue have been of particular interest for a number of 
years, particularly as it relates to “peripheral fatigue” [1, 7, 11, 19, 54, 55]. Since 
metabolites are relatively small and transporters for metabolites largely expressed 
ubiquitously, the plasma metabolome provides an interesting snapshot of 
intracellular metabolomics [25]. The contribution of amino acids to support the 
energetics of prolonged exercise is relatively small albeit not trivial [1, 19, 55]. The 
process of transamination is initiated within the muscle, and as a consequence, the 
release of alanine and glutamine from muscle far exceeds the release of other amino 
acids as these two act to transport the ammonia to the liver and kidneys. These two 
amino acids were identified as contributing to cluster A, and they demonstrated a 
slight albeit significant decrease in concentration as the exercise progressed (Table 
3.1; Figure 3.5), which likely reflects increased hepatic and renal uptake beyond the 
increased net muscle release [1]. The remaining amino acids showed variable 
responses, with some demonstrating an increase (proline, valine, glutamic acid) and 
while others a decrease (tryptophan, threonine, citrulline, methionine, proline, 
arginine). The increase in phenylacetylglutamine (q≤0.001; Cluster D) which is a 
conjugate of phenylacetate and glutamine, is noteworthy given the previously 
identified role of phenylacetate-containing medications of having a side-effect of 
fatigue, although this has not been explored in exercise-induced fatigue.  
Acetylcarnitine is synthesised in a reversible reaction involving the combination of 
carnitine and acetyl-CoA, to form acetylcarnitine and free CoA. Since acetyl-CoA 
is the primary substrate for the citric acid cycle, the decrease in carnitine (q≤0.001) 
along with the increase in acetylcarnitine (q≤0.001; forward reaction), suggests a 
reduced substrate pool for the citric acid cycle. In considering the above, it is 
important to note that citric acid, the ‘first step’ in the citric acid cycle, demonstrated 
a progressive increase with exercise (Cluster E; q≤0.001) which may suggest 
oxidative phosphorylation was indeed downregulated at a site distal to the citric 
acid cycle. Unsurprisingly, creatine showed a progressive and significant increase 




The adopted metabolomics approach enabled the distinction of plasma samples 
obtained at the point of fatigue (post-fatigue) from samples obtained prior to and 
following fatigue. The specific metabolites contributing to this distinct profile were 
then explored. In accordance with our hypothesis, FFA and TRP played influential 
roles in contributing to these distinct metabolic profiles and in so doing, lent support 
to the ‘Central Fatigue Hypothesis’.  
Additionally, the 87 identified metabolites which demonstrated significant changes 
over time generated potentially interesting avenues for future investigation, 
including, for example, some novel roles for FFA in exercise-induced fatigue onset. 
It is important to note that while the approach adopted herein was able to capture a 
large number of metabolites within the plasma samples, not every metabolite was 
captured and identified. Moreover, it is important to note that a change in the 
concentration of metabolites across time-points, and in particularly a change in the 
concentration of intermediary metabolites, does not provide information on the rate 
of appearance or disappearance of metabolites within a pathway (i.e., metabolic 
flux). Nevertheless, despite the relatively short time-frame between sampling points 
in the current study, the metabolic profile of plasma demonstrated a significant shift 
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Chapter 4 Neuromuscular fatigue 
following isoenergetic 
prolonged constant versus 
self-paced cycling exercise 
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4.1 List of abbreviations 
 
Abbreviation  Definition 
A/D   Analog-to-digital 
ATP:ADP  Ratio of adenosine triphosphate to adenosine diphosphate 
BMI   Body mass index 
BW   Body weight  
Ca2+    Calcium ions 
CAR   Central activation ratio 
CDE   Cadence 
CI   Confidence interval 
ECC   Excitation-contraction coupling 
EMG   Electromyography 
ESSA   Exercise and Sport Science Australia 
H+   Hydrogen ions 
HR   Heart rate 
MAP   Maximal aerobic power 
MVC   Maximal voluntary contraction 
PD   Peak doublet 
POST   Post-exercise 
POST20  20-min post-exercise 
PRE   Pre-exercise 
PWR   Power output 
PT   Peak twitch 
RMS   Root mean square 
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RMS.M-1   Ratio of RMS to maximal M-wave amplitude of VL 
RPE    Ratings of perceived exertion 
SD   Standard deviation 
TT   Time-trials 
TTE   Time-to-exhaustion  
VO2peak  Peak oxygen uptake 
VL    Vastus lateralis 
VAL   Voluntary activation level 
VALP Voluntary Activation Level with reference to the potentiated 
doublet 







Purpose: The purpose of this study was to compare neuromuscular changes and 
performance of a cycling time-to-exhaustion (TTE) trial to an isoenergetic cycling 
time-trial (TT) in recreationally active participants. 
Methods: Eighteen recreationally active males (mean±SD age: 24.7±4.8 years old; 
mass 67.1±6.1 kg; height 171.7±4.9cm) performed cycling TTE at an intensity 
corresponding to a blood lactate concentration of 3 mmol.L-1 (trial 1). Participants 
then performed the same amount of work as in trial 1, using a cycling TT (trial 2). 
Maximal voluntary contraction (MVC) torque, muscle Voluntary Activation Level 
(VAL), root mean square of electromyography (EMG) signal, electrically evoked 
torque and M-wave amplitude of quadriceps muscle was obtained at baseline 
(PRE), post-exercise (POST) and 20-min post-exercise (POST20). 
Results: Duration of exercise in TT (4266.6±192.4 s) was significantly (p=0.006) 
faster compared to TTE (4853.7±191.8 s) with a mean difference of 587 s. There 
was a significant main effect of time on neuromuscular parameters, with each being 
significantly lower immediately post-exercise and 20-min post-exercise compared 
to baseline, except in peak-to-peak M-wave amplitude (p=0.146). There was no 
significant interaction effect on all neuromuscular parameters (p≥0.05). Maximal 
voluntary contraction torque was the only neuromuscular which has shown a 
significant main effect of trial with greater losses of quadriceps muscle strength in 
TT compared to TTE trial. 
Conclusion: Performance in cycling TT was significantly improved compared to 
an isocaloric cycling TTE trial in young and recreationally active males, with 




Exercise-induced fatigue is directly and proportionally associated with a reduction 
in performance and muscular function [1]. The origin of the fatigue is generally 
classified as being proximal (central fatigue) and/or distal (peripheral fatigue) to the 
neuromuscular junction [2, 3]. While fatigue may be assessed using a number of 
techniques, the decrement in maximal voluntary contraction (MVC) torque before 
and after exercise [4] enables the quantification of total fatigue. The individual 
contributions of central and peripheral fatigue can then be assessed by combining 
electrical stimulation techniques with the MVC, known as the twitch interpolation 
technique [5, 6]. This combination has been widely adopted to characterise and 
identify mechanisms of neuromuscular fatigue arising from isometric exercise [7, 
8] prolonged dynamic exercise [9-11] and extreme prolonged dynamic exercise [11, 
12].  
In turn, constant power time-to-exhaustion (TTE) protocols and self-paced time-
trials (TT) are widely used to assess cycling performance [13, 14]. The validity of 
the TTE protocol, however, has been questioned on the basis that cyclists rarely 
maintain constant power output during competition [14, 15]. Additionally, the TT 
has demonstrated higher repeatability and lower variability compared to TTE trials 
[13, 16] and the TT has the benefit of enabling the cyclist to self-regulate their 
workload. If a cyclist adopts an inappropriate pacing strategy during the TT, 
however (i.e., starting too fast), performance is likely to be less than compared to a 
duration-matched TTE (~14.5min) [17].  
The assessment of neuromuscular fatigue in response to dynamic exercise has 
largely been conducted using constant-load protocols (i.e., TTE), with very few 
studies assessing neuromuscular fatigue following self-paced (i.e., TT) efforts [18-
20]. With the exception of one study [20], these have typically involved short-
duration (i.e., less than 30 min) efforts. The study by Thomas et al. [20] compared 
TT of different duration (4-km, 20-km, and 40-km) and found peripheral fatigue 
was significantly greater in short-duration TT (i.e., 4-km), while central fatigue was 
greater in longer-duration TT (i.e., >30-min); a finding corresponding with research 
adopting constant-load protocols [1]. However, direct comparison of 
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neuromuscular fatigue during constant-load and self-paced trials have, to the 
authors’ knowledge, not been conducted. While neuromuscular fatigue is 
significantly greater during highly variable exercise loads compared to constant-
load exercise [21], this difference diminishes when the variability is reduced [22]. 
Thus, the aim of the present study was to investigate and compare the 
neuromuscular fatigue associated with an isoenergetic prolonged TT and TTE 
protocol. The authors hypothesised that performance would be superior (higher 
power output; shorter time to completion) in the TT, and this would be associated 
with greater peripheral fatigue, but not central fatigue.  
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4.4 Methods and procedures 
Participants  
Eighteen healthy and recreationally active (≥2 sessions per week) males, aged 
between 19 to 44 years old were recruited to this study via local advertisement 
posted on public noticeboards. Participants were initially screened for eligibility via 
email and follow-up telephone conversation. Exclusion criteria for this study 
included: diagnosis of diabetes mellitus; uncontrolled hypertension; acute (i.e., viral 
infection) or chronic inflammatory disease; currently taking medication for chronic 
health conditions. Additionally, participants were excluded (or referred to their 
General Practitioner to obtain exercise clearance) if they presented with more than 
two risk factors in stage two or checked ‘Yes’ at stage one of the Exercise and Sport 
Science Australia (ESSA) risk assessment questionnaire, or if they were identified 
as having any condition which may be exacerbated through exercise participation. 
The Murdoch University Human Research Ethics Committee approved the study 
protocol (No. 2013/206) and all experiments were performed in accordance with 
relevant guidelines and regulations. All participants were informed about the 
experimental procedures and provided written consent prior to participation.  
 
Study design 
This study comprised two phases: i) phase one comprised a single preliminary and 
familiarisation session, and; ii) the experimental phase which consisted of TTE trial 
and a TT trial. All preliminary and experimental testing was conducted on a cycle 
ergometer (Velotron, Racermate Inc., Seattle, USA) and all trials completed at least 
three days apart in sequential (non-randomised) order. The TT was always 
performed after the TTE because the target workload for the TT was based on the 
workload achieved during the TTE trial. All testing was conducted at the Murdoch 




Preliminary testing and familiarisation 
During this session, participant’s peak oxygen uptake (VO2peak; ParvoMedics, Utah, 
USA) was determined using a continuous incremental cycle protocol. The protocol 
for the VO2peak test consisted of an initial workload of 50 W, which was increased 
35 W in a step-wise fashion every 3 min. Finger prick blood samples were collected 
at the end of each stage for measurement of blood lactate (Lactate Plus, Nova 
Biomedical, Massachusetts, USA) until the lactate concentration exceeded 4 
mmol.L-1. Thereafter, the workload increased 35 W every minute until exhaustion 
(defined as not being able to maintain cadence above 60 rpm despite verbal 
encouragement). The workload corresponding to a blood lactate concentration of 3 
mmol.L-1 (W3mM) was then interpolated from this test and recorded. The ratings of 
perceived exertion (RPE) and heart rate (HR; Polar, Kempele, Finland) were 
measured in the last 10 s of each stage and data from the metabolic cart collected 
continuously and assessed in 15 s of epochs for determination of VO2peak. 
Familiarisation with the TTE cycling test was then conducted after a 20-min period 
of recovery from the VO2peak test. The workload during the 20-min TTE 
familiarisation was set at the predetermined W3mM, and where necessary, the 
workload was adjusted to ensure the blood lactate concentration was fixed at 3 
mmol.L-1. The cycle ergometer settings and workloads were recorded and remained 
consistent throughout the experimental trials. Preliminary testing and 
familiarisation with the neuromuscular assessments (MVC; supramaximal 
electrical stimulation) were then conducted on the isokinetic dynamometer (Humac 
Norm, CSMI, Massachusetts, USA) as detailed below.  
 
Maximal voluntary contraction (MVC) 
Participants were comfortably secured in a seated position using thigh, pelvic, 
shoulder and torso straps, in order to reduce body movement during the test. The 
hip joint was positioned at an angle of 85°. The axis of the dominant knee was 
brought into line with the axis of the dynamometer exercise arm. The lateral femoral 
epicondyle was used as a bony landmark for matching the axis rotation of the 
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dynamometer shaft. The same radius for each participant was applied in all 
experimental trials. Participant’s dominant ankle was strapped and then the 
dominant knee joint angle was adjusted to 60° of flexion (0°=leg fully extended). 
Participants performed an initial warm-up using the non-fatiguing submaximal 
contraction of the quadriceps muscle group. Participants then performed 3x5 s 




A self-adhesive silver chloride electrode with a circular surface (Skintact, Leonhard 
Lang, Florida, USA) of 0.5 mm diameter was used as the cathode while a 50 cm2 
(10x5 cm) rectangular electrode (ValuTrode Cloth, Axelgaard, California, USA) 
was used as the anode for the femoral nerve stimulation. The cathode was located 
on the femoral nerve of the dominant limb and anode in the gluteal fold opposite 
the cathode. The participant’s femoral nerve was stimulated (transcutaneous 
electrical stimulation) using a constant-current stimulator (model DS7AH; 
Digitimer, Hertfordshire, England) coupled with a train/delay generator (model 
DG2A; Digitimer, Hertfordshire, England) to control frequency and duration of the 
stimulus. The stimulation site was adjusted based on the greatest visible muscle 
contraction response. Voltage was set at maximal 400 V with a stimulus duration 1 
ms, and a 10 ms delay was used during the doublet stimulations. The use of doublets 
with 10 ms delay is perceived as less painful compared to train stimulations [23]. 
The intensity of the stimulus was increased until there was no further increase in 
twitch force and the M-wave amplitude (peak-to-peak) of the vastus lateralis (VL). 
Supramaximal stimulus intensities were then conducted at 125% of this intensity 




Electromyography (EMG) recordings 
Prior to electrode placement, the participant’s skin was shaved, rubbed and cleaned 
with alcohol to minimize skin impedance over the quadriceps region of the 
participant’s dominant leg. Self-adhesive circular surface silver chloride electrodes 
(Duo-Trode; Myotronics Inc., Seattle, WA, USA) with a 10 mm diameter (an 
interelectrode center-to-center distance of 21±1 mm) was then placed over the 
muscle belly of VL. Electromyography activity was recorded using wireless 
transmitters (TeleMyo DTS EMG Sensor, Noraxon Inc., USA) and the data 
collected by the receiver (TeleMyo DTS Belt Receiver, Noraxon Inc., USA). 
Another receiver (TeleMyo 2400R G2 Receiver, USA) was used collect data from 
the isokinetic dynamometer (CSMI, Massachusetts, USA) and stimulator 
(Digitimer, Hertfordshire, England), and these were then synchronized with EMG 
muscle activity for analysis. EMG signals were analog-to-digital (A/D) converted 
using a 16-bit A/D card with a ±2.5 V range and were sampled at 1500 Hz. Raw 
EMG signals were analog bands pass filtered with a range of 10-500 Hz and were 
differentially amplified (common mode rejection ratio >90 dB at 60 Hz; impedance 
input =2 MΩ; gain 500) to maximize signal amplification. The data were stored for 




Participants arrived at the laboratory in a fasted state and having avoided vigorous 
physical activity on the day prior to the trials. On the first trial, participants recalled 
their dietary intake from the prior day (24-h food diary/recall) and were asked to 
replicate the dietary intake prior to the second trial. Thirty minutes prior to testing, 
participants consumed 7 ml.kg-1 body weight (BW) of artificially flavoured water, 
and then 5 ml.kg-1 BW of the same drink 10 min prior to testing to minimise pre-
exercise dehydration. Participants were asked to empty their bladder immediately 
before the initiation of exercise. 
Participants then performed a warm-up which included submaximal contractions of 
the dominant knee extensor muscles (~50%, 60%, 70% of MVC for 5 s at each 
intensity with 15 s interval) followed by ~10 non-fatiguing submaximal 
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contractions at the participant’s own preferred intensity. Participants were then 
given 3 single supramaximal electrical stimulations separated by 3 s (total duration 
of 9 s); prior to the doublet supramaximal electrical stimulation delivered 3 s before 
(resting doublet), during (superimposed doublet over the isometric plateau), and ~2 
s after the MVC (potentiated doublet) with total duration of 15 s; followed by 3 
single supramaximal electrical stimulations separated by 3 s [4, 5].  
Participants were then transferred to the cycle ergometer (Velotron, Racermate Inc., 
Seattle, USA) where they performed either the TTE (trial 1) or the TT (trial 2). The 
power for the TTE was set at W3mM and participants verbally encouraged to exercise 
until exhaustion (unable to maintain a cadence of 60 rpm). Participants were also 
provided with the same artificially flavoured drink at 2 ml.kg-1 BW every 15 min 
during cycling and were also provided ad libitum access to plain water. The fluid 
consumption protocol was replicated in the subsequent experimental trial (TT). The 
total work performed was recorded and then used as the target in the TT. 
Immediately after completion of the TTE and the TT, participants were transferred 
back to the isokinetic dynamometer (Humac Norm, CSMI, Massachusetts, USA) 







Neuro Assess (PRE) 
 
Cycling TTE or TT Neuro Assess (POST)  
Neuro Assess 
(POST20) 
  ↑   
 
       ↑      ↑   
↑↑↑ ↑ MVC ↑ ↑↑↑ 
 
 ↑↑↑ ↑ MVC ↑ ↑↑↑  ↑↑↑ ↑ MVC ↑ ↑↑↑ 
 
Figure 4.1 Experimental design scheme of the two modes of prolonged exercise. Small arrow, single supramaximal electrical stimulation; large 





M-wave peak-to-peak amplitude of VL and peak twitch (PT) torque were obtained 
from the average of three trials of single supramaximal electrical stimulation, and 
peak doublet (PD) torque was taken from potentiated doublet stimulations. Muscle 
Voluntary Action Level (VAL) was quantified using muscle Voluntary Activation 
Level with reference to the potentiated doublet (VALp) and with reference to the 
resting doublet (VALr) [4]. VALp was calculated as: [1 - (superimposed doublet 
amplitude/potentiated doublet amplitude)] x 100. The VAL equation was corrected 
when the superimposed doublet did not correspond with the real maximal torque, 
and in this case, VAL was calculated as: [1 – (superimposed doublet amplitude x 
voluntary torque level just before or after superimposed doublet/maximal voluntary 
torque)/potentiated doublet amplitude] x 100. This formula was used because 
superimposed amplitude tends to develop at torques lower than maximal [24], and 
has been and proven to be in a linear relationship [5]. Central Activation Ratio 
(CAR) is calculated using the following equation: [MVC / (MVC + superimposed 
doublet over isometric plateau]. If CAR equals 1.0, it indicates a full activation of 
the stimulated muscle [25]. EMG activity of the surrogate muscle of quadriceps, 
VL muscle was collected within 500 ms timeframe during MVC, quantified as root 
mean square (RMS) and normalized to M-wave peak-to-peak amplitude of VL to 
obtain the ratio of RMS to maximal M-wave amplitude (RMS.M-1) [4]. 
 
Statistical analysis 
Results are expressed as mean ± standard deviation (SD) unless otherwise noted; 
while group differences between trials or time-points are presented as mean 
differences with 95% Confidence Intervals (CI). Differences to assess changes in 
the primary outcome variables (performance; neuromuscular assessments) between 
the two trials (TT; TTE) over time (Performance: 10 workload-equivalent intervals; 
PRE, POST, POST20) were estimated using linear mixed models (LMM). The 
hypothesis of interest was the condition by time interaction (modelled as fixed 
effects; random intercept) which was examined with pairwise comparisons of the 
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estimated marginal means. Main effects for trial and time were explored and 
assessed for relevance to each outcome. Statistical significance was set at 0.05. All 




Participants were young (24.7±4.8 y), lean with normal body mass index (BMI: 
22.8±2.2 kg.m-2) and recreationally active (VO2peak: 40.9±6.1 ml.kg.min-1).  
 
 
Figure 4.2 Total duration of exercise between TTE and TT trials; white and black 
columns, respectively. Mean ± SE. 
 
Cycling performance 
Participants completed the TT (4266.6±192.4 s) significantly (p=0.003) faster than 
the TTE trial (4853.7±191.8 s; mean difference: 587 s; 95% CI: 235, 939 s) (Figure 
4.2).  Mean power output (PWR; TT: 124.5±4.5 W; TTE: 110.4±4.5 W) and 
cadence (CDE; TT: 80.0±1.9 RPM; TTE: 77.6±1.9 RPM) were significantly higher 
in TT compared to TTE (Both p≤0.001; Figure 4.3). Mean heart rate was 
significantly (p≤0.001) higher in TT (149.0±3.0 bpm) than TTE (143.8±3.0 bpm) 
and increased over time (10 averaged intervals based on a percentage of workload 
completed) in both trials (main effect of time: p≤0.001; time x trial: p=0.215). There 
was no significant trial by time interaction effects for RPE (p=0.826) and no 
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difference in the main effect of trial (TT: 13.4±0.4; TTE: 13.6±0.4, p=0.087; Figure 
4.3); but there was a significant main effect of time (p≤0.001; Figure 4.3d).  
 
 
Figure 4.3 Variations in a) power output (PWR) b) cadence (CDE) c) heart rate 
(HR) and d) ratings of perceived exertion (RPE) during TTE and TT trials. These 
variables were recorded after the total duration of exercise was divided into 10 
blocks and each of the ten periods (10–100%) data were averaged. Mean ± SE. 
*Significant time effect (p<0.05), **Significant trial effect (p≤0.001), 
***Significant interaction effect (time x trial: p<0.05). 
 
Neuromuscular fatigue 
There was no significant trial by time (baseline: PRE, post-exercise: POST and 20-
min post-exercise: POST20) interaction in MVC (p=0.500; Figure 4.4a). There was, 
however, a significant main effect of trial (p=0.005), with participants producing 
greater force during the TTE trial (mean difference: 10.52 Nm; 95% CI: 3.3, 17.7 
Nm). There was also a significant main effect of time (p≤0.001), with force 
decreasing 11.8% immediately post-exercise (17.8 Nm; 95% CI: 9.0, 26.6 Nm) and 
remaining depressed (8.6%) at 20-min post-exercise (12.9 Nm; 95% CI: 4.1, 21.7 




Figure 4.4 Changes in maximal voluntary contraction (MVC) torque b) muscle 
Voluntary Activation Level (VAL) c) Peak Twitch (PT) d) Potentiated peak doublet 
(PD) for TTE and TT at baseline (PRE), post-exercise (POST), and 20-min post-
exercise (POST 20). Mean ± SE. *Significant time effect (p≤0.001), **Significant 
trial effect (p<0.01). 
 
There was a significant main effect of time (p≤0.001) for VALp, which 
demonstrated an 11.1% and 7.9% decrease at post-exercise and 20-min post-
exercise, respectively. There was no significant interaction effect (p=0.658) or 
difference observed between trials (p=0.564; Figure 4.4b). Similarly, there was a 
significant main effect of time (p≤0.001) for CAR, which demonstrated a 4.1% and 
3.1% decrease at post-exercise and 20-min post-exercise, respectively (Table 4.1). 
There was no significant interaction effect (p=0.747) or difference observed 
between trials (p=0.505).         
There was a significant (p≤0.001) decrease in the PD over time, with a 24.2% and 
19.9% decrease at post-exercise and 20-min post-exercise, respectively, but no 
differences between trials (p=0.227) and no significant interaction (p=0.847) 
(Figure 4.4d). There was a significant (p≤0.001) decrease in the peak twitch over 
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time, with a 44.9% and 33.6% decrease at post-exercise and 20-min post-exercise, 
respectively, but no differences between trials (p=0.305) and no significant 
interaction (p=0.602) (Figure 4.4c).       
There were no significant differences in M-wave amplitude between trials 
(p=0.915) or time (p=0.146) and no significant interaction effects (p=0.813; Table 
4.1). There was a significant difference in RMS.M-1 across time (p=0.029) but not 
trial (p=0.409) and no significant interaction (p=0.91; Table 4.1).   
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Table 4.1 Mean (± SE) of muscle Voluntary Activation Level with reference to the resting doublet (VALr), Central Activation Ratio (CAR), 
root mean square normalized to the amplitude of M-wave (RMS.M-1 ratio) and M-wave peak-to-peak amplitude. # p<0.05, indicates a 
difference between PRE and POST. 
Dependent variable CP SP 
 PRE POST POST20 PRE POST POST20 
VALr (%) 85.8 ± 3.3 74.3 ± 3.3# 81.0 ± 3.3 84.5 ± 3.3 72.8 ± 3.3# 77.0 ± 3.3 
CAR (%) 95.3 ± 1.2 92.0 ± 1.2# 92.9 ± 1.2 95.6 ± 1.1 91.2 ± 1.1# 92 ± 1.1 
RMS.M-1 ratio VL 0.064 ± 0.07 0.056 ± 0.07 0.043 ± 0.07 0.056 ± 0.07 0.050 ± 0.07 0.048 ± 0.07 
M-wave peak-to-peak 
amplitude (mV) 







The purpose of the current study was to compare the performance of a cycling TTE 
trial to an isoenergetic cycling TT in recreationally active participants, as well as 
assess the associated markers of neuromuscular fatigue following the trials. The 
authors hypothesised that performance would be superior (higher power output; 
shorter time to completion) in the TT, and this would be associated with greater 
peripheral fatigue, but not central fatigue. The main findings of the study were i) 
Performance (time to complete and PWR) was significantly better in the TT than 
compared to TTE and this was not associated with differences in RPE; ii) Both TT 
and TTE induced significant decreases in maximal strength capacity of the knee 
extensors; iii) The reduction in MVC torque was associated with central and 
peripheral fatigue mechanisms, but there were no significant between-trial 
differences; iv) The reduction in MVC torque, and the central and peripheral 
mechanisms of fatigue, persisted during the 20-min recovery period.  
 
Cycling performance and physiological responses 
The current study adopted a TTE protocol which was designed to exceed 30 min in 
duration thereby inducing both central and peripheral fatigue [21, 22]. Indeed, the 
total duration of exercise in the present study was 80.9 and 71.1 min in TTE and 
TT trial, respectively. As hypothesised, time to complete the TT was significantly 
lower than compared to TTE. The parabolic power curve during the TT 
demonstrated both positive and negative pacing strategies and while the power 
output for the first 10% and last 10% of the trial was above the average power output 
for the trial (i.e., indicative of a U-shaped curve), the nadir occurred in the latter 
part of the TT (80% of completed workload; [26]). This uneven distribution of work 
during the trial, and in particular the fast finish at the end of the trial, may relate to 
the relative inexperience of these participants in cycling TT. The relatively even 
CDE throughout the TT indicates participants were more reliant on gearing rather 
than CDE to alter power in the TT. It is interesting to note the similar CDE between 
trials (TTE and TT) from approximately 40% into each effort. In accordance with 
the greater work being performed, HR was significantly higher in the TT compared 
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to TTE. Remarkably, despite the higher workload and HR during the TT, the RPE 
was no different between trials. Although perception of effort likely culminates 
from multiple physiological and psychological inputs [1], the apparent mismatch in 
the RPE-HR and RPE-workload relationships in the current study suggests either i) 
the non-cyclist participants were insensitive to these inputs and therefore possessed 
a poor ability to perceive current levels of effort, or; ii) participants were more 
sensitive to the duration of exercise rather than the workload (i.e., duration 
superseded other inputs) since the TTE took approximately 10% longer than the 
TT.  
 
Total and central fatigue parameters 
There was a significant decrease in MVC torque at post-exercise (immediately post-
exercise: 11.8% decrease; 20-min post-exercise: 8.6% decrease), and this decrease 
was similar between exercise-trials.  The reduction in MVC during the TTE trial 
was 8%, which was comparable to other studies adopting constant load cycling 
where decrements in MVC were 7% [21] to 9% [22] following 30 min cycling at 
70% of maximal aerobic power (MAP), 9-13% after cycling at 80% of MAP for 30 
min [27], 11% and 10% after cycling at 55% of MAP for 60 and 120 min, 
respectively [28]. The 16% decrease in MVC during the TT was higher than that in 
previous studies (i.e., 12.8% loss in MVC following 30 min of variable intensity 
cycling at 70% of MAP; [22]), but given the duration of exercise, this is aligned 
with expectations. The 20 min recovery was insufficient to observe recovery in 
MVC, with only minor (non-significant) increases observed between the immediate 
post-exercise and 20-min post-exercise time points (1.5% and 6.2% in TTE and TT, 
respectively).  
The neuromuscular assessment revealed significant central fatigue in response to 
the cycling trials in each parameter assessed (CAR, VALp, VALr, RMS.M-1; Figure 
4.4; Table 4.1). The VALp was adopted a priori as the primary outcome measure 
for central fatigue, and this decision was based on previous research demonstrating 
superior reproducibility in this technique [4, 29]. There was a significant main 
effect of time for VALp, which demonstrated an 11.1% and 7.9% decrease in VALp 
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at immediately after and 20-min after the cycling trials, respectively. The reduction 
in VALp suggests less motor units were recruited during the MVC both immediately 
after and 20-min after the cycling trials. There were no between-trial differences 
observed. Similar to the findings in previous research [4], VALp demonstrated to 
be more sensitive to fatigue than CAR as evidenced by the greater magnitude of 
change. The greater variance in VALr and RMS.M-1 (Table 4.1) is consistent with 
these being associated with a greater random error of measurement, although this 
was shown to be only slightly higher in VALr compared to VALp [4]. However, it 
is noteworthy that at POST20, VALr was no longer significantly different from 
baseline values (Table 4.1). While 30 min of cycling at highly variable power output 
has been shown to result in additional muscular fatigue, and in particular 
significantly greater reductions in VAL compared to constant and low variable 
cycling [21], this difference was not observed when the variability in power output 
was reduced [22]. Although the power-curves in the current study demonstrate 
some variability, the extent of this variability in the current study was not as 
significant as that adopted in the highly variable trial, which comprised ten repeat 
intervals of cycling between 50% and up to 200% of MAP [21]. Irrespective of the 
lack of significant between-trial difference, the decrements in central activation 
(VALp; and supported by VALr, CAR, RMS.M-1 measures; Table 4.1) implicate 
central fatigue in the reduction of MVC torque following the prolonged cycling 
trials, and this is in agreement with prior findings [21, 22, 27, 28, 30]. Whether the 
central fatigue originated from supra-spinal or spinal mechanisms [2], or some 
combination therefor, cannot be determined using the adopted techniques.     
It is important to acknowledge that additional factors may also contribute to central 
fatigue such as environmental temperature [31], altered hydration [32] and 
psychological status [33]. These factors may concurrently alter neural drive and 
thus alter (i.e., decrease) exercise performance. In the present study, all trials were 
conducted in a thermoneutral environment and fluids were provided prior to and 
during exercise to minimise the risk of dehydration.   
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Electrically evoked peripheral fatigue parameters 
The amplitude of the electrically evoked torque responses from single and paired 
stimulations were used in the current study to assess the level of contractile fatigue 
following the prolonged cycling trials [4]. In agreement with other studies adopting 
prolonged cycling [21, 22, 27, 28, 30], there was a significant reduction in the PT 
and PD after cycling, and this remained depressed at 20-min post-exercise. 
However, there were no significant differences between trials, which is in contrast 
to our hypothesis that TT would induce greater levels of contractile fatigue than 
TTE. The hypothesis was based on the idea that despite the total work being 
matched, the improvement in TT performance would necessitate significantly 
greater PWR during the trial. Indeed, PWR during the TT was 12.8% higher than 
in the TTE trial, however, this was not associated with differences in contractile 
fatigue.  
The mechanisms contributing to a reduction in evoked torque (PT and PD) and 
excitation-contraction coupling (ECC) failure, are believed to involve a number of 
processes including reduced calcium ions (Ca2+) release from the sarcoplasmic 
reticulum [34] and reduced myofibrillar cross-bridge interaction [35]. These 
changes may be related to the accumulation of hydrogen ions (H+) and inorganic 
phosphate [36], although energy substrates such as the reduced ratio of adenosine 
triphosphate to adenosine diphosphate (ATP: ADP) and muscle glycogen depletion 
may also play a role [37]. In contrast to previous studies which have shown PD to 
be more sensitive than PT [4, 21, 22], both PT and PD responded similarly to the 
cycling exercise. Both PT and PD have a number of disadvantages, wherein PT is 
considered less sensitive due to the higher number of stimuli required to produce 
acceptable signal-to-noise ratio [29] and easier detection [38]; while potentiated 
responses may have greater variability [39]. The present study demonstrated that 
PD appeared to recover more slowly compared to PT, which is in agreement with a 
previous study [4].  
M-wave peak-to-peak amplitude of VL was used to assess knee extensor muscle 
membrane excitability, based on prior research demonstrating that the VL muscle 
is representative of the quadriceps muscle [4]. The present study indicated muscle 
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excitability was not significantly different between trials or across time. 
Importantly, the lack of significant difference between time-points is likely due to 
the large variance in the measure. Specifically, the mean difference between 
baseline and immediately post-exercise was -30.7mV with a 95% CI of [-902.7, 
964.1]; while the difference between post-exercise and 20-min post-exercise was -
829.9 mV with a 95% CI of [-146.3, 1806.2]. Therefore, the findings indicate no 
significant differences in the M-wave amplitude across time (baseline vs. post-
exercise measures) and therefore, neuromuscular propagation was unaffected by the 
cycling trials and did not contribute to changes in PT or PD across time. However, 
this interpretation would need to be cautiously adopted in light of the large 
variances observed.  
 
Limitations 
This study had a number of strengths including the prolonged nature of the cycling 
bout, the number of participants, the isocaloric matching of the cycling trials and 
the techniques adopted to measure each outcome variable. However, the study also 
had a number of limitations. In particular, the variation in the training status of the 
participants was diverse, based on the VO2peak data, and their familiarity with 
performing TT which may have influenced the findings.  Motivations to cycle 
longer and to perform better could be one of the most crucial factors in the 
performing TT and TTE trials other than experience in pacing and cycle-fitness. 
Performance in open-loop exercise such as cycling TTE is particularly reliant on 
psychological factors compared to closed-loop exercise [13]. However, if the 
motivation was lower in the TTE versus TT, then MVC torque and VALp would be 
significantly different between trials but this was not the case in the current study. 
The time to conduct the neuromuscular fatigue assessment after the exercise 
protocol may also have affected the outcomes of the current study. In particular, the 
total time taken to perform the neuromuscular fatigue assessment immediately post-
exercise was approximately 4 min, despite the isokinetic dynamometer being 
located near (less than 10 m) the cycle ergometer. Neuromuscular fatigue 
assessment was reported in previous studies [21, 22] to occur around 1 min post-
exercise and this delay may have enabled partial recovery [30]. However, this 
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would result in a reduction in the excitation-contraction coupling (i.e., reduced PT 
and PD) and consider these measures demonstrated significant differences (indeed 
the greatest magnitude change) in the current study, this effect would likely have 
been marginal, in particular when considering that the 20-min post-exercise 
measures were found not to be significantly different across all central and 
peripheral parameters assessed. Finally, the order of the trials could not be 
randomised since the workload for the TT was based on the performance in the TTE 
trial. To negate this, the current study familiarised participants with the TTE and 
the neuromuscular assessments prior to conducting the trial. Given the similarity in 
the measures of fatigue outlined above, we do not believe this would have 
confounded results. In addition, there were no between-trial differences in any of 





The present study showed that performance in a self-paced TT was significantly 
improved compared to an isocaloric constant-paced TTE trial in young and 
recreationally active males. This improvement was not associated with any 
differences in perceived effort (RPE), despite maintaining significantly higher 
power-outputs and working at a higher physiological load (HR). The neuromuscular 
assessments revealed no significant between-trial differences, but the MVC torque 
was reduced by 11.8% immediately post exercise. This reduction in MVC torque 
was associated with a significant decrease in central fatigue (VALp: -11.1%), 
demonstrating a reduced level of neural drive to the muscle [40]. Additionally, 
peripheral factors contributed to the reduced MVC torque, with a significant 
decrease in the potentiated doublet (-24.2%) demonstrating reduced excitation-
contraction coupling; although neuromuscular propagation is unlikely to have 
significantly contributed to the fatigue. These neuromuscular changes persisted for 
at least 20 min after the termination of exercise. The fatigue experienced by 
participants in the current study were clearly associated with decrements in both 
central and peripheral parameters. Recreationally active males unaccustomed to 
cycling demonstrated superior performance when completing a self-paced TT 
(closed-loop) compared to a constant-pace TTE (open-loop) trial. Future studies 
may investigate whether trained cyclists more accustomed to these tests yield 
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Chapter 5 The effect of acute branched-
chain amino acids 
supplementation during 
isoenergetic prolonged 




5.1 List of abbreviations 
 
Abbreviation  Definition 
A/D   Analog-to-digital 
BBB   Blood-brain barrier 
BCAA   Branched-chain amino acids  
BW   Body weight  
Ca2+   Calcium ions 
CDE   Cadence 
CI   Confidence interval 
CNS    Central nervous system 
ECC   Excitation-contraction coupling  
EMG   Electromyography 
ESSA   Exercise and Sports Science Australia 
FFA   Free fatty acids 
f-TRP   Free tryptophan 
HR   Heart rate 
LSD   Least significance difference  
MAP   Maximal aerobic power 
MVC   Maximal voluntary contraction 
PD   Peak doublet 
PLA   Placebo 
POST   Post-exercise 
POST20  20-min post-exercise 
PRE   Pre-exercise/baseline 
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PT   Peak twitch 
PWR   Power output 
RPE    Ratings of perceived exertion 
SD    Standard deviation 
TRP   Tryptophan 
TT   Time-trial 
TTE   Time-to-exhaustion 
VAL   Voluntary activation level 
VL    Vastus lateralis 
VO2peak  Peak oxygen uptake 
W3mM  Workload corresponding to a blood lactate concentration of 
3 mmol.L-1 






Purpose: To investigate the effects of acute branched-chain amino acids (BCAA) 
supplementation during isoenergetic prolonged self-paced cycling time-trial (TT) 
on cycling performance and neuromuscular fatigue. 
Methods: Eighteen recreationally active men (mean±SD age: 24.7±4.8 years old; 
mass 67.1±6.1 kg; height 171.7±4.9cm) participated in this study. Participants 
performed constant cycling time-to-exhaustion (TTE) at an intensity corresponding 
to 3 mmol.L-1 of blood lactate concentration. The total work completed were 
recorded and participants performed self-paced cycling TT (randomised and 
double-blinded) aimed to complete same amount of work in the shortest time 
possible with ingestion either BCAA (7g.L-1) or a placebo (PLA) solution. Maximal 
voluntary contraction (MVC), muscle voluntary activation level (VAL) and 
electrically evoked torque using single (PT) and doublet (PD) stimulations were 
assessed at baseline (PRE), immediately post-exercise (POST) and 20-min post-
exercise (POST20). 
Results: Time to completion in BCAA (3978.7±166.7 s) was significantly (p=0.04) 
lower compared to PLA (4266.6±192.4 s). There was a significant effect of time on 
MVC, VAL, PT and PD which the parameters were significantly lower at point of 
exhaustion (MVC: -23.5±6.7 Nm; p≤0.001; VAL: -9.7±1.8 %; p≤0.001; PT: -
15.7±2.0 Nm; p≤0.001; PD: -18.4±4.6 Nm; p=0.002) and 20-min post-exercise 
(MVC: -15.6±6.7 Nm; p=0.002; Nm; VAL: -7.4±1.8 %; p≤0.001; PT: -11.4±2.0 
Nm; p≤0.001; PD: -14±4.6 Nm; p=0.015) when compared to pre-exercise values. 
There was no significant interaction between (trial x time) or difference between 
trial. 
Conclusion: Acute BCAA supplementation significantly improved performance in 
prolonged cycling TT among recreationally active individuals without any notable 




The mechanisms contributing to the onset of fatigue during prolonged exercise [1] 
are complex and involve both central and peripheral factors (as demonstrated in 
Chapter 4 and [2]). The contribution of central factors to the onset of fatigue (central 
fatigue) increases concomitant with the duration of exercise [3]. Central fatigue is 
associated with supraspinal and spinal sites connecting the brain to the working 
muscle via complex neural networks [4]. Although typically investigated in 
isolation, it appears likely that an important interplay between the peripheral and 
central factors occurs during the onset of fatigue. Indeed one such hypothesis, 
known as the ‘Central Fatigue Hypothesis’ [5] suggests that an increased 
concentration of a single neurotransmitter, serotonin (5-hydroxytryptamine; 5-HT) 
in the central nervous system (CNS), may largely explain the onset of central 
fatigue. The precursor to 5-HT is tryptophan (TRP), and the rate of 5-HT synthesis 
is proportional to the rate of TRP entry into the CNS. Tryptophan entry into the 
CNS in turn, is proportional to the amount of free TRP (unbound TRP; f-TRP) and 
the concentration of the branched-chain amino acids (BCAA; isoleucine, leucine, 
and valine) which compete for entry into the CNS with TRP.  
The large majority of TRP circulating in the plasma is loosely bound to albumin, 
but TRP may be displaced from albumin by an increase in plasma free fatty acids 
(FFA) which outcompetes the TRP leading to increased concentration of f-TRP [6].  
The increased f-TRP may now enter the CNS via specific transporters in the blood-
brain barrier (BBB), which also transport the BCAA. Since increased lipolysis and 
the associated increased FFA concentration is not observed in exercise lasting less 
than 30 min, this mechanism of stimulating central fatigue is likely to only occur in 
prolonged exercise [7]. Importantly, studies on central fatigue have been done in 
both rats [8, 9] and humans [10, 11], but only the outcome of animal studies have 
concurred with the ‘Central Fatigue Hypothesis’ while discrepancy exists in human 
studies. This discrepancy is due to the complexity in measuring the changes in 
neurotransmitters in the CNS, and specifically in the motor cortex of the brain in 
humans.  Despite the equivocal nature of the findings however, researchers 
observing diminished central activation following prolonged exercise, often 
implicate serotonergic activity in the reduced corticospinal impulses [3, 12, 13]. An 
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additional approach to assess the relative contribution or importance of the ‘Central 
Fatigue Hypothesis’ to exercise-induced fatigue, is to manipulate the transport of f-
TRP into the CNS, by increasing the BCAA concentrations.    
The effectiveness of BCAA in reducing the concentration of 5-HT synthesis in the 
brain and thus, delaying fatigue remains unclear. Some studies indicate that BCAA 
can contribute to improving performance [14-16] while others have failed to 
demonstrate improvements in performance [1, 7, 17-19]. Large heterogeneity in 
methodology may have contributed to these discrepant findings. Additionally, none 
of the previous studies using BCAA have adopted twitch interpolation techniques 
to assess for central and peripheral contributors to fatigue. The main aim of the 
present study therefore, was to investigate the effect of acute BCAA 
supplementation on performance during a prolonged cycling time-trial (TT), and to 
determine the relative changes in peripheral and central factors contributing to 
fatigue. We hypothesised that acute supplementation of BCAA will reduce 
neuromuscular fatigue, delay onset of fatigue and thereby improve prolonged 
cycling performance. 
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5.4 Methods and procedures 
Participants  
Eighteen recreationally healthy and physically active men (≥90 min per week) 
volunteered to participate in the study after having been informed of the 
experimental procedures and they provided written informed consent. Participants 
were recruited from the community via local advertisement posted on public 
noticeboards. Table 5.1 shows the participant’s physical characteristics and 
physiological capacities.  
 
Table 5.1 Physical characteristics and physiological capacities of the participants. 
Parameters  Mean ± SD 
Age (years) 24.7 ± 4.8 
Standing height (cm) 171.7 ± 4.9 
Body mass (kg) 67.1 ± 6.1 
BMI (kg.m-2) 22.8 ± 2.2 
VO2peak (ml.kg.min-1) 40.9 ± 6.1 
 
Participants were pre-screened for eligibility, via email and telephone conversation 
using the Exercise and Sports Science Australia (ESSA). Potential participants with 
diabetes mellitus, uncontrolled hypertension, acute (i.e., viral infection) or chronic 
inflammatory disease, currently taking medicine for chronic health conditions, 
condition which may be exacerbated through exercise participations were excluded. 
Participants were also excluded if they presented with more than two risk factors in 
stage two or checked ‘Yes’ at stage one of the ESSA risk assessment questionnaire. 
The Murdoch University Human Research Ethics Committee has granted approval 
(No. 2013/206) and the study protocol and all experiments were performed in 






The present study consisted of 2 phases: i) preliminary and familiarisation session, 
and ii) an experimental phase which consisted of two cycling TT, which were 
conducted in double-blinded, randomised order and counterbalanced at least 3 days 
apart. Parts of this protocol and data have been previously presented (Chapter 3 and 
4). 
 
Preliminary testing and familiarisation 
Preliminary testing and familiarisation was identical to Chapter 4. Briefly, 
participants’ peak oxygen uptake (VO2peak; ParvoMedics, Utah, USA) was 
determined using a continuous step-wise incremental cycling protocol on a cycle 
ergometer (Velotron, Racermate Inc., Seattle, USA). Blood lactate (Lactate Plus, 
Nova Biomedical, Massachusetts, USA) was measured by finger prick blood 
samples collected at the end of each stage to determine the workload corresponding 
to a blood lactate concentration of 3 mmol.L-1 (W3mM). The ratings of perceived 
exertion (RPE) and heart rate (HR; Polar, Kempele, Finland) were measured in the 
last 10 s of each stage and data from the metabolic cart collected continuously and 
assessed in 15 s of epochs for determination of VO2peak. 
Preliminary testing and familiarisation with the cycling time-to-exhaustion (TTE) 
and neuromuscular assessments (maximal voluntary contraction, MVC; 
supramaximal electrical stimulation) was then conducted on the isokinetic 
dynamometer (Humac Norm, CSMI, Massachusetts, USA) as briefly outlined 
below and detailed in Chapter 4. In a subsequent visit to the laboratory at least 24 
h after this session, participants performed cycling TTE at W3mM until volitional 
exhaustion (unable to maintain a cadence of 60 rpm) despite verbal encouragement. 




Maximal voluntary contraction (MVC) 
Participants’ were secured into the isokinetic dynamometer (Humac Norm, CSMI, 
Massachusetts, USA) using thigh, pelvic, shoulder, and torso straps in order to 
minimise body movement during the test. The axis of the knee was aligned with the 
axis of the dynamometer arm and trials were performed on the dominant leg and 
participant’s ankle which the knee joint was adjusted at 60° of flexion (0° = leg 
fully extended) and the hip joint at an angle of 85°. Following a warm-up session 
using non-fatiguing submaximal contractions, participants then proceeded with 3x5 
s MVC of the dominant knee extensor muscles with 2 min gap between repetitions. 
 
Electrical stimulations 
Participant’s femoral nerve was stimulated (transcutaneous electrical stimulation) 
using a constant-current stimulator (model DS7AH; Digitimer, Hertfordshire, 
England) coupled with train/delay generator (model DG2A; Digitimer, 
Hertfordshire, England) to control frequency and duration of stimulus. The cathode 
was located on the femoral nerve of dominant limb, and anode in the gluteal fold 
opposite the cathode. The stimulation site was adjusted based on the greatest visible 
muscle contraction response. Voltage was set at maximal 400 V and duration of 1 
ms, and a 10 ms delay was used during doublet stimulations. The doublet with 10 
ms delay are perceived as being less painful compared to train stimulations [20]. 
The femoral nerve was stimulated starting from low intensity and then the intensity 
of the stimulus was increased until there was no further increase in twitch force and 
peak-to-peak M-wave amplitude of vastus lateralis (VL). Supramaximal stimulus 
intensities were determined by adding further 25% of obtained maximal stimulus 
and then maintained for single and doublet stimulations throughout the trials 




Electromyography (EMG) recordings 
Prior to electrode placement on the quadriceps region of the participant’s dominant 
leg, participant’s skin was shaved, rubbed and cleaned with alcohol to minimise 
skin impedance. A pair of self-adhesive silver chloride electrodes with a circular 
surface (Duo-Trode; Myotronics Inc., Seattle, WA, USA) of 10 mm diameter 
(interelectrode center-to-center distance of 21±1 mm) was placed on muscle belly 
of VL. Electromyography (EMG) activity was recorded from VL of every 
participant’s dominant limb using wireless transmitters (TeleMyo DTS EMG 
Sensor, Noraxon Inc., USA) which directly collected EMG activity from the 
transmitter and transmitted the data to the receiver (TeleMyo DTS Belt Receiver, 
Noraxon Inc., USA). Another receiver (TeleMyo 2400R G2 Receiver, USA) was 
used to receive data from isokinetic dynamometer (CSMI, Massachusetts, USA) 
and stimulator (Digitimer, Hertfordshire, England) which were then synchronized 
with EMG muscle activity for analysis. EMG signals were analog-to-digital (A/D) 
converted using a 16-bit A/D card with a ±2.5 V range and were sampled at 1500 
Hz. Raw EMG signals were analog bands pass filtered with a range of 10-500 Hz 
and were differentially amplified (common mode rejection ratio >90 dB at 60 Hz; 
impedance input =2 MΩ; gain 500) to maximise signal amplification. The data was 
stored for analysis with Noraxon’s Myoresearch XP – Basic Edition software 
(Noraxon Inc., USA).  
 
Experimental phase 
During the experimental phase, participants arrived at the laboratory in a fasted state 
and having avoided vigorous physical activity on the day prior to the trials. On the 
first trial, participants recalled their dietary intake from the prior day (24-h food 
diary/recall) and were asked to replicate the dietary intake prior to the second trial. 
The participants were provided with 7 ml.kg-1 body weight (BW) of either BCAA 
(leucine: valine: isoleucine; 2:1:1) or placebo (PLA; low calorie drink) 30 min prior 
to the initiation of exercise, and 5 ml.kg-1 BW of either BCAA or placebo 10 min 
prior to testing, to minimise pre-exercise dehydration. Participants were also 
provided with either BCAA or placebo every 15 min during cycling at the rate of 2 
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ml.kg-1 BW as well as ad libitum access to plain water. The same fluid consumption 
protocol was applied in every trial. Participants were asked to empty their bladder 
immediately before the initiation of exercise.  
Participants performed a warm-up session that included a series of submaximal 
contractions of the dominant knee extensor muscles (at ~50%, 60%, 70% of MVC 
for 5 s at each intensity with 15 s recovery in between) followed by ~10 non-
fatiguing submaximal contractions at participant’s own chosen intensity. 
Participants were then given 3 single supramaximal electrical stimulations 
separated by 3 s (total duration of 9 s) prior to the doublet supramaximal electrical 
stimulations separated by 3 s before (resting doublet), during (superimposed 
doublet over the MVC isometric plateau), and ~2 s after the MVC (potentiated 
doublet) with total duration of 15 s; followed by 3 single supramaximal electrical 
stimulation separated by 3 s [21, 22]. Participants were then transferred to the cycle 
ergometer (Velotron, Racermate Inc., Seattle, USA) where they performed self-
paced cycling TT completing the same amount of total work completed in the 
preliminary trial (cycling TTE). Immediately after the completion of the TT, 
participants were transferred back to the isokinetic dynamometer (Humac Norm, 
CSMI, Massachusetts, USA) for neuromuscular assessment. The experimental 
protocol is graphically presented in Figure 4.1 of Chapter 4 and has not been 
replicated here to minimise duplication. 
 
Data analysis 
Peak twitch (PT) torque was obtained from the average of three trials of single 
supramaximal electrical stimulation, and peak doublet (PD) torque was taken from 
potentiated doublet stimulations. Muscle activation was quantified using muscle 
Voluntary Activation Level (VAL) [22]. VAL was calculated as: [1 - 
(superimposed doublet amplitude/potentiated doublet amplitude)] x 100. The VAL 
equation was corrected when the superimposed doublet did not correspond with the 
real maximal torque, and in this case VAL was calculated as: [1 – (superimposed 
doublet amplitude x voluntary torque level just before or after superimposed 
doublet/maximal voluntary torque)/potentiated doublet amplitude] x 100. This 
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formula was used because superimposed amplitude tends to develop at torques 
lower than maximal [23], and has been and proven to be in linear relationship [21].  
 
Statistical analysis 
Results are expressed as mean ± standard deviation (SD) unless otherwise noted. A 
mixed model analysis has been used to examine the effects of different modes of 
cycling across time and the interaction between the two. Least significance 
difference (LSD) was used as Confidence Interval (CI) Adjustment. Significance 
level was set at p<0.05. Paired sample t-tests were used to determine if there is any 
difference in baseline (PRE) of neuromuscular fatigue parameters between the two 




Time to completion and physiological responses 
Time to completion was significantly (p=0.04) faster in the BCAA trial compared 
to PLA (Figure 5.1). The mean time to completion in PLA and BCAA was 
4266.6±192.4 and 3978.7±166.7 s, respectively (Table 5.2).  
 
 
Figure 5.1 Time to completion between PLA and BCAA trials; white and black 
columns, respectively. Mean ± SE. 
 
This represents a 6.7% improvement in time with the BCAA supplementation. 
Accordingly, mean power output (PWR) was significantly higher (main effect for 
trial: p≤0.001; 5.7 W, 95% CI [2.9W, 8.5W]) in the BCAA trial, although there was 
no significant time x trial interaction (p=0.81; Table 5.2; Figure 5.2). This 
difference was not due to differences in cadence (CDE), with no significant 





Table 5.2 Mean (± SD) values of total duration of exercise (s) and mean (± SE) of 
power output (PWR), cadence (CDE), heart rate (HR) and ratings of perceived 
exertion (RPE) for PLA and BCAA trials. * p<0.05, ** p<0.01, *** p<0.001 
between trials. 
Trial  Time to 
Completion (s) 









14.1 ± 0.4 









The mean HR was significantly (p=0.017) higher in BCAA compared to PLA, and 
increased with time (main effect: p≤0.001; Figure 5.2). Despite the higher PWR 
and HR, the mean RPE was significantly (p=0.003) lower in BCAA than compared 
to PLA (no interaction effect: p=0.950) and increased in time in both trials (main 




Figure 5.2 Changes in a) power output (PWR), b) cadence (CDE), c) heart rate 
(HR) and d) ratings of perceived exertions (RPE) between PLA and BCAA trials. 
These variables were recorded after the total duration of exercise was divided into 
10 blocks and each of the ten periods (10–100%) were data-averaged. *Significant 
time effect (p≤0.001). **Significant trial effect (p<0.05). 
 
Neuromuscular changes 
There was a significant main effect for time (p≤0.001) but not condition (p=0.119) 
for MVC torque, and there was no significant interaction between time and trial 
(p=0.994; Figure 5.3). The cycling TT was associated with a 15.5% decrement in 
MVC torque immediately post-exercise (POST; -23.5 Nm; 95%CI [-33.2 Nm, -13.9 
Nm]), and this remained 10.3% lower than baseline values at 20-min post exercise 
(POST20; -15.6 Nm; 95%CI [-25.2 Nm, -5.9 Nm]).  
There was a significant main effect for time (p≤0.001) but not condition (p=0.429) 
for VAL, and there was no significant interaction between time and trial (p=0.750; 
Figure 5.3). The cycling TT was associated with a 9.7% decrement in VAL 
immediately post-exercise (95% CI [-13.7, -5.6]), and this remained 7.4% lower 
than baseline values at 20-min post exercise (95% CI [-11.4, -3.3]). There was a 
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significant main effect for time (p=0.004) but not condition (p=0.369) for PD, and 
there was no significant interaction between time and trial (p=0.998). The PD 
decreased 22.6% as a result of the cycling TT (mean [95% CI]: -18.4 Nm [-29.6, -
7.2]) remained 17.3% lower than pre-exercise values at 20-min post exercise (mean 
[95% CI]: -14.0 Nm [-25.2, -2.8]). There was a significant main effect for time 
(p≤0.001) but not condition (p=0.180) for PT, and there was no significant 
interaction between time and trial (p=0.806). The PT decreased 53% as a result of 
the cycling TT (mean [95% CI]: -15.7 Nm [-18.2, -13.2]) and although the 20-min 
post-exercise value showed a significant (p=0.001; Figure 5.3) recovery from 
immediately post-exercise (mean [95% CI]: 4.34 Nm [1.82, 6.86], it remained 
38.4% lower than pre-exercise values (mean [95% CI]: -11.4 Nm [-13.9, -8.9]). 
 
 
Figure 5.3 a) Maximal voluntary contraction (MVC) torque b) muscle Voluntary 
Activation Level (VAL) c) peak twitch (PT) d) peak doublet (PD) for PLA and 
BCAA at baseline (PRE), immediately post-exercise (POST), and 20-min post-




This is to the authors’ knowledge, the first study to compare the effect of acute 
supplementation with BCAA on cycling performance and neuromuscular changes 
of quadriceps muscle compared to PLA. The findings showed that i) acute BCAA 
supplementation improved cycling performance by ~7% and this was associated 
with a significantly reduced RPE; ii) the MVC torque of knee extensors was 
significantly reduced in both trials, but there were no between-trial differences; iii) 
there was significant contribution of central and peripheral factors in the 
development of fatigue, but these were not different between trials. Overall, these 
findings suggest that acute supplementation of BCAA improved cycling 
performance and perception of effort during the cycling TT, without any notable 
difference in neuromuscular changes between trials. 
Supplementation with BCAA resulted in a significantly improved TT performance, 
with participants cycling for an average 66 min when ingesting BCAA versus 71 
min in the PLA trial. The power curves showed remarkably similar work 
distribution between trials, representing a combination of a reverse J-curve and U-
shaped power curve [24] with the highest power outputs produced in the first and 
last 10% periods. The improved performance with acute BCAA supplementation 
during prolonged exercise is in accord with some findings [7, 15] but not all [1, 18, 
25-27]. Our findings are in contrast to the findings of the elegant study conducted 
by van Hall et al. [1], who demonstrated no significant improvements in a time-to-
exhaustion task with BCAA supplements mixed into CHO (6% sucrose) beverages. 
This null-finding was despite the supplements raising BCAA concentrations and 
increasing estimated TRP uptake by up to 20-fold [1]. However, prolonged cycling 
time-to-exhaustion trials have been criticised as they may be confounded by 
psychological factors such as boredom and motivation, as well as not being as 
reproducible as closed-loop tasks such as a cycling TT [28].  However, a study by 
Blomstrand et al [25] which also reported no significant performance improvements 
with BCAA supplementation, adopted a 20-min maximal work capacity task as the 
primary outcome measure of performance and this was preceded by a 60-min 
constant power task. It is interesting to note however, that the BCAA 
supplementation improved performance in these seven endurance trained cyclists 
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by 9.9% (Cohen’s d: 0.36) and significantly reduced the RPE during the 60-min 
constant cycling period [25]; suggestive that the study may have been 
underpowered. Indeed, another study which concluded no benefits of BCAA 
supplementation [18], also demonstrated a 5.9% (Cohen’s d: 0.24) improvement in 
a time-to-exhaustion trial. The participants were in a glycogen depleted state and 
performed exercise in a warm environment (30.0°C), which was expected to 
enhance the effects of BCAA supplementation due to the possible reduced central 
drive associated with exercise in this condition [29]. 
Whilst multiple methodological differences between these studies exist and may 
help explain these discrepant findings, it is also clear that large inter-individual 
differences exist, which is evidenced by the large variance observed within studies. 
This has previously been noted [18] and may be due to individual differences in 
either TRP transport across the BBB, or sensitivity to serotonergic activity. It is also 
important to note, that the 5-HT receptor family is large, and differences in receptor 
expression may also largely account for the differences noted [30], particularly 
when dichotomising participants according to their performance characteristics 
(high versus low) [7].  
The percentage of MVC loss was similar (15.5%) in both trials after 71 minutes 
(PLA) and 66 minutes (BCAA) of self-paced cycling. The percentage of MVC loss 
was comparable to previous studies with shorter duration of exercise (30-33 
minutes); where MVC reduced by 12.8% [31] and 12.1% [32] following a variable 
intensity cycling at 70% of maximal aerobic power (MAP). MVC also remained 
significantly lower in both trials compared to the baseline following the 20 min of 
recovery. Interestingly, another study has also shown that MVC remains unchanged 
following 30 min of recovery after completing 27 min of cycling at 80% maximal 
power output [33].  
This study adopted the twitch interpolation technique to measure VAL, which has 
been used to assess neuromuscular changes following prolonged cycling exercise 
[3, 31, 32, 34, 35]. Prolonged exercise has been shown to increase serotonergic 
activities [36], and in turn, this leads to the reduction of corticospinal impulses 
reaching the motoneurons and consequently reduced central activation [3, 12, 13]. 
The significant decrease in VAL following prolonged exercise in this study was in 
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agreement with previous studies [3, 31, 32, 34, 35] and is in accord with the stated 
hypothesis. However, the decrement in VAL following prolonged cycling was 
similar in both trials, which was not expected, given that we hypothesised BCAA 
supplementation to lessen ‘central fatigue’ (as measured by VAL). It is important 
to note that increased BCAA supplementation is also associated with increased 
plasma concentrations of ammonia [1, 18], which may attenuate the ergogenic 
effects of BCAA supplementation [6], particularly as it relates to reduced central 
drive. Unfortunately, the current study did not measure changes in ammonia 
concentration.      
Electrically evoked torque was adopted in the current study to assess contractile 
fatigue (i.e., measure of peripheral fatigue) by using single (PT) and doublet (PD) 
stimulations. Similar contractile fatigue levels were observed in both trials; 
although PT also demonstrated significant recovery in the 20 min period following 
exercise. This more rapid response in PT is consistent with previous studies [22, 
37], although the mechanisms for these differences are unclear, it may relate to 
contrasting effects of potentiation on increasing phosphorylation of myosin and the 
concurrent fatigue-associated reduction in intra-myocellular calcium ions (Ca2+) 
concentration [38]. Therefore, although the adoption of PD over PT is generally 
recommended [22], interpretation of PD following fatiguing exercise has been 
cautioned [38]. The decrease in pH (or increase in hydrogen ions) is highly 
associated with force-reduction [39] and increases in hydrogen ions accompanied 
with inorganic phosphate [40-42] promotes muscle fatigue [32] and failure in 
excitation-contraction coupling (ECC). Excitation-contraction failure is likely due 
to decreased cross-bridge interactions [43] and Ca2+ release from sarcoplasmic 
reticulum [44]. Importantly, the current study also assessed M-wave characteristics 
which is a marker of muscle excitability [45] and there were no main-effects (time 
or trial) noted. Therefore, the reduced capacity of the excitation-contraction within 







The present study found that acute supplementation of BCAA during prolonged 
cycling exercise significantly improved performance in a cycling TT without any 
notable differences in neuromuscular parameters among recreationally active 
individuals. This finding suggests that BCAA can be used as an ergogenic aid to 
enhance cycle-exercise performance in non-cyclists. The current BCAA dose is 
recommended and higher BCAA dose should be avoided to prevent 
hyperammonaemia which could alter exercise performance [14]. Similar to 
previous findings, there were large inter-individual differences observed in 
performance outcomes.  Further studies to distinguish central fatigue at supra-spinal 
or spinal level is warranted in response to BCAA supplementation, and the inter-
individual differences to BCAA supplementation may yield important knowledge 
in this field. 
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Chapter 6 Metabolic and performance 
responses to the ingestion of 




6.1 List of abbreviations 
 
Abbreviation  Definition 
BMI   Body mass index 
Ca2+   Calcium ions 
CE   Cycling economy 
CHO   Carbohydrate 
CI    Confidence interval  
ES   EnergySmart® 
ESSA   Exercise and Sport Science Australia 
GLU   Glucose/monosaccharide  
H+   Hydrogen ions 
Hct   Haematocrit 
HR   Heart rate 
K+   Potassium ions 
LSD   Least significance difference 
Na+   Sodium ions 
pCO2   Partial pressure of carbon dioxide 
pO2   Partial pressure of oxygen 
RER   Respiratory exchange ratio 
RPE   Ratings of perceived exertion 
SD   Standard deviation 
TT   Time-trial 
VO2peak  Peak oxygen uptake 








Purpose: This study was undertaken to investigate the metabolic and performance 
effects of a mixed-carbohydrate (CHO; starch and sugars) product on prolonged 
endurance performance compared to a glucose control solution (GLU). 
Methods: Sixteen male cyclists (mean±SD; age: 30.5±7.4 years old; mass 76.2±9.7 
kg; height: 179.5±6.3 cm) participated in this cross-over, randomised and double 
blinded study. Each trial was performed at least 7 days apart and consisted of 120-
min of steady state cycling at 75% of ventilatory threshold (VT) followed by a 16.1-
km time-trial (TT). Participants ingested either the mixed CHO (EnergySmart; ES) 
or GLU in isocaloric (28.9 g of ES; 25 g GLU) and isovolumic (350 ml) portions 
at 45 min prior to steady state cycling and immediately following the TT. Blood 
samples (every 15 min) and expired gas was collected throughout the trials for 
measurement of blood electrolytes (K+, Na+, Ca2+), blood gases (pO2, pCO2), pH, 
calculation of fuel utilisation (Respiratory exchange ratio; RER) and cycling 
economy (CE). 
Results: No significant performance differences were observed in TT between ES 
and GLU (1647.6±28.8 s vs. 1672.4±28.8 s, ES and GLU respectively; [95%CI], [-
862, 366]); albeit that cyclists completed the TT 24.8 s faster with the ES. 
Consumption of GLU resulted in greater glycaemic variability compared to the ES. 
The exercise was associated with significant changes in blood gases, lactate, pH, 
electrolytes, but there were no significant differences in these outcomes, ratings of 
perceived exertion (RPE), RER between conditions or CE. 
Conclusion: Ingestion of ES resulted in a more stable blood glucose profile but did 




Carbohydrate (CHO) ingestion is associated with improved performance [1-5] 
during prolonged (>60 min) exercise.  Similarly, CHO ingestion in the days and 
hours prior to exercise has been associated with improved performance, specifically 
in exercise >90 min [6, 7]; yet, the strength of evidence supporting the ergogenic 
benefits of pre-exercise CHO supplementation is less convincing [8]. The influence 
of CHO intake within the final hours prior to exercise has been particularly 
controversial, with some studies demonstrating an improvement with CHO intake 
[6, 9], while others have shown no improvement [10-12], or even an impairment in 
endurance performance [13, 14].  
Pre-exercise CHO ingestion caused hyperglycaemia and hyperinsulinaemia 
followed by reduced fat oxidation [15] and the occurrence of rebound 
hypoglycaemia [16] at the onset of exercise which could theoretically impair 
exercise performance [17].  To explore the role of pre-exercise CHO ingestion (45 
min prior to exercise) on performance during a cycling time-trial (TT; ~40 min), a 
series of carefully designed studies were conducted in well-trained cyclists [11, 12, 
18, 19]. These studies revealed (i) performance in the TT was not affected by 
development of hypoglycaemia [18]; there were no significant differences in either 
TT performance or glucose responses when the CHO load (glucose: 0 g, 25 g, 75 
g, or 200 g; [11]) or type (trehalose, galactose, and glucose) was altered [12]; there 
was no significant difference in the TT performance when the timing of glucose 
ingestion was altered (15-min pre; 45-min pre; 75-min pre; [19]). These studies 
provide important insight into the role of pre-exercise CHO ingestion on during 
exercise <60 min (20 min sub-maximal cycling was performed prior to the TT). 
Whether acute CHO ingestion can improve performance in prolonged exercise (i.e., 
>90 min), remains equivocal.  
Studies on slow-digested starch showed the incremental area under the curve of 
plasma glucose and insulin produced remain stable up to 120 min [20]. 
Consumption of modified starch 30 min prior to exercise (66.4 % VO2peak) for 2 h 
revealed that CHO oxidation rate was high in simple sugar and modified starch but 
only modified starch sustained the CHO oxidation for the 120 min, while simple 
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sugar sustained the oxidation for 90 min only [21]. Studies on cycling performances 
following pre-exercise starch ingestion showed more stable blood glucose profiles 
without any improvement in performance [22, 23]. 
These studies mentioned above have typically focused on a particular type of CHO 
(i.e., individual monosaccharides, a mix of monosaccharides and disaccharides or 
group of starches). As such, the purpose of the current study was to determine 
whether the performance of a TT would improve in response to ingestion of a mixed 
CHO beverage containing starch and sugars compared to ingesting 
monosaccharides (i.e., glucose) alone. We hypothesised that the consumption of the 
mixed CHO beverage would improve performance in the prolonged exercise bout. 
The secondary aim was to determine differences in the glycaemic responses 
between the two supplements. We hypothesise that ingestion of the mixed CHO 
solution would demonstrate reduced glycaemic responses and minimise the risk of 
hypoglycaemia compared to ingestion of glucose. 
 
6.4 Methods and procedures 
Participants 
Sixteen well-trained male cyclists (mean±SD; age: 30.5±7.4 years old; height 
179.5±6.3 cm; mass 76.2±9.7 kg; VO2peak 61.1±6.7 ml.kg.min-1) with normal body 
mass index (BMI; 23.6±2.1 kg.m-2) were recruited for this study. Participants were 
pre-screened via email and telephone conversation using the Exercise and Sports 
Science Australia (ESSA) risk assessment questionnaire and excluded from 
participation if they presented with more than two risk factors. Participants were 
informed of the risks and benefits of their participation in the study and written 
informed consent was obtained prior to data collection. The present study was 
carried out in the Murdoch University Exercise Physiology Laboratory and was 





This study was conducted using a randomised and counterbalanced cross-over 
design. Randomisation and allocation to the experimental trials were conducted by 
someone not directly involved in the administration of the experimental trials (TJF), 
using a computer-generated number sequence of 1’s and 2’s. This study consisted 
of two phases. The initial phase consisted of a preliminary testing session and a 
familiarisation session. The second phase included two experimental trials 
completed seven days apart. During the experimental trials, participants consumed 
one of two different isocaloric beverages at two time points; 45 min before the 
commencement of exercise, and immediately after exercise. The drinks were pre-
prepared by someone not involved in the study. 
 
Preliminary trial (determination of peak oxygen uptake; VO2peak) and 
familiarisation (16.1-km TT) 
During the preliminary testing sessions, basic demographic data (height and body 
mass) were collected after which participants completed a graded exercise test for 
the assessment of peak oxygen uptake (VO2peak). The graded exercise tests were 
conducted using an electromagnetically braked Velotron cycle ergometer 
(Racermate Inc., Seattle, USA) starting at a power output of 60 W with 30 W 
increments (2 min.stage-1) until exhaustion. Expired ventilation was collected using 
a metabolic cart (TrueOne 2400, ParvoMedics, Utah, USA) from which VO2peak 
and the ventilatory threshold (VT) were assessed [24]. The workload corresponding 
to 75% VT was then calculated for later use during the experimental trials [24]. 
Familiarisation session was applied to participants who did not have any experience 
participating in a competition. In the present study, only one participant involved 





Both experimental trials were conducted in the morning with the participants in a 
fasted state (overnight fast; >10 h).  Participants were asked to maintain their 
normal physical activity and avoid heavy physical activity 24 h prior to the trials as 
well as record their 24-h dietary intake, with the assistance of a food diary.  After 
completing the first trial, participants were instructed to adhere to the same physical 
activity and dietary habits prior to the second trial.  
Upon arriving at the laboratory, a venous catheter (VasoFix Safety, B.Braun, 
Melsungen, Germany) was placed into a forearm and kept patent for the duration 
of the trial with a saline solution (0.9%, B.Braun, Melsungen, Germany). 
Participants then consumed the first bolus of the assigned isocaloric supplement, 
either 350 ml beverage containing 28.9 g of the mixed CHO beverage (ES; 
EnergySmart Soluble, Advanced Ingredients, LLC containing 46% of 
monosaccharides and 38% of mixed oligosaccharides and starches) or 25 g of 
monosaccharide (GLU; glucose, Glucodin)  (~7.1% CHO per 100 ml of solution), 
after which they rested quietly while respiratory gas was collected continuously for 
45 min using a calibrated metabolic measurement cart (TrueOne 2400, 
ParvoMedics, Utah, USA) and blood samples were collected every 15 min. 
Participants then completed a 120-min of steady state cycling bout at 75% VT on a 
Velotron cycle ergometer (Racermate Inc., Seattle, USA), while blood samples 
were taken at 15, 30, 60, 90 and 120 min. Expired ventilation was collected for the 
first 5 min after the start of exercise and subsequently for 5 min every 20 min during 
steady state cycling. At the completion of the 120-min of steady state cycling bout, 
participants immediately performed a 16.1-km TT. Blood samples were collected 
immediately after the completion of TT. Within 2 min of completing the TT, 
participants consumed the second dose of isocaloric beverage which was identical 
to the first dose (28.9 g of ES or 25 g of GLU) and rested quietly for 60 min. Fluid 
sensation scale [25] to measure subjective level of thirst, nausea, fullness and 
stomach upset were measured after ingesting the assigned isocaloric supplement 45 
min before exercise and immediately after completing TT. While resting, expired 
ventilation was continuously collected and blood samples were obtained every 15 
170 
min. Water was provided ad libitum during the initial trial and matched during the 
second trial.  
Participants wore a heart rate (HR) monitor (Polar, Kempele, Finland) throughout 
the experimental trials. Ratings of perceived exertion (RPE) 6-20 Borg scale [26] 
were measured every 15 min during resting prior to exercise, every 20 min during 
steady state cycling session, before and after TT and every 15 min during resting 
after completion of TT. 
 
Blood sampling and analysis 
Approximately 4 ml of venous blood was drawn at each time point and equally 
distributed into a lithium heparin containing tube (plasma; BD Vacutainer, 
Plymouth, UK) and a serum separating tub (serum; BD Vacutainer, Plymouth, UK). 
A small amount of blood sample (135 µl out of 2 ml) was immediately assayed 
using a blood gas analyzer (GEM 3500 Premier, Instrumentation Laboratory) for 
pH, partial pressure of oxygen (pO2), partial pressure of carbon dioxide (pCO2), 
sodium ions (Na+), potassium ions (K+), calcium ions (Ca2+), haematocrit (Hct), 
blood glucose and lactate. The remaining samples (plasma and serum) were then 
centrifuged at 1300 x g for 10 min before both plasma and serum samples were 
transferred into microcentrifuge tubes and stored in the freezer at -80 oC for 
subsequent insulin analysis. Plasma insulin concentrations were analysed using a 
commercially available Enzyme Linked Immunosorbent Assay kit (ELISA; 
Invitrogen Corp, MD, USA). 
 
Cycling economy 
The economy was obtained by dividing mean power output by mean oxygen 
consumption (VO2) during the last 30 s at first 5 min and at every 20 min during 





Results are expressed as means ± standard deviations (SD) unless otherwise noted. 
A paired sample t-test was first used to assess differences in the time taken to 
complete the TT in each trial and to compare fluid sensation. Absolute differences 
between the trials are demonstrated using the 95% confidence interval (CI) of the 
difference.  Linear Mixed modelling was then used to examine the effects of the 
supplement (condition) across time (repeated measures). Condition and time were 
modelled as random effects with the interaction being the primary outcome 
measure. Least Significance Difference (LSD) was used as Confidence Interval 
Adjustment. The significance level was set at p<0.05. All statistical procedures 





No differences were observed for the time to complete (p=0.403; 95% CI [-862, 
366]) or the average power output (p=0.726; 95%CI [-13.7, 19.2]) during the 16.1-
km TT between the ES (1647.6±28.8 s and 229.4±61.7 W; respectively) and GLU 
(1672.4±28.8 s and 226.6±64.8 W; respectively) conditions (Figure 6.1). 
 
 
Figure 6.1 Exercise duration (top panel) in the 16.1-km TT with EnergySmart (ES) 
and glucose (GLU) trials. Power output (bottom panel) during 16.1-km TT cycling 






Figure 6.2 a) Blood glucose and b) blood insulin concentration between 
EnergySmart (ES) and glucose (GLU) trials. Mean ± SE. *Significant time effect 
(p<0.05), **Significant trial effect (p≤0.001), ***Significant interaction effect 




Blood glucose and insulin 
There was a significant trial by time interaction in blood glucose and insulin 
response (p≤0.001; Figure 6.2). Blood glucose was lower during the ES trial at rest 
(pre- and post-exercise) compared to the GLU trial (p<0.001; 95%CI [-0.44, -0.21]) 
and demonstrated reduced variability (attenuated peaks and troughs; Figure 6.2a 
and 3). The blood insulin concentration (Figure 6.2b) was significantly elevated in 
the GLU trial compared to the ES trial (p≤0.001). 
 
 
Figure 6.3 Difference in blood glucose (mmol/L; GLU subtract ES) at each time 
point during trials. Solid line represents the mean difference while dotted lines 
provide the 95% CI of the mean. Significant difference is observed where all three 





Blood gas, electrolytes, lactate and pH 
There were no significant differences between trials and no significant interaction 
effect for any of the blood gases (pO2, pCO2), lactate or pH levels (Figure 6.4). 
There was, however, a significant effect of time, with each parameter demonstrating 
significant changes with exercise. When collapsed across time, the mean pCO2 
value was significantly (p=0.016) lower and pH significantly (p=0.001) higher in 
the ES trial compared to GLU trial, but no differences between trials observed in 
pO2 (p=0.303) or lactate (p=0.516). There were no significant differences between 
trials and no significant interaction effect in blood electrolytes (Na+ and Ca2+) or 
Hct, but there were significant main effects of time (Figure 6.5). Only K+ showed a 
significant trial (p=0.002) and time (p≤0.001) effect, however, without any 
significant interaction effect (p=0.692). 
 
 
Figure 6.4 a) Partial pressure of oxygen (pO2) between EnergySmart (ES) and 
glucose (GLU) trials. b) Partial pressure of carbon dioxide (pCO2) between 
EnergySmart (ES) and glucose (GLU) trials. c) Blood lactate concentration between 
EnergySmart (ES) and glucose (GLU) trials. d) Blood pH between EnergySmart 
(ES) and glucose (GLU) trials. Mean ± SE. *Significant time effect (p<0.05), 





Figure 6.5 a) Blood sodium ions (Na+) concentration between EnergySmart (ES) 
and glucose (GLU) trials. b) Blood potassium ions (K+) concentration between 
EnergySmart (ES) and glucose (GLU) trials. c) Blood calcium ions (Ca+) 
concentration between EnergySmart (ES) and glucose (GLU) trials. d) Haematocrit 
level (Hct) between EnergySmart (ES) and glucose (GLU) trials. Mean ± SE. 
*Significant time effect (p<0.05), **Significant trial effect (p≤0.001). 
 
Physiological, economy and perceptual responses 
Respiratory exchange ratio (RER) and HR differences are demonstrated in Figure 
6.6, along with subjective RPE during trials. These physiological parameters 
showed a significant effect of time (p≤0.001) without any interaction effect (RER: 





Figure 6.6 a) Respiratory exchange ratio (RER) between EnergySmart (ES) and 
glucose (GLU) trials. b) Heart rate (HR) between EnergySmart (ES) and glucose 
(GLU) trials. c) Rated perceived exertion (RPE) between EnergySmart (ES) and 
glucose (GLU) trials. Mean ± SE. *Significant time effect (p<0.05), **Significant 




Similar to physiological changes, there was a significant (p≤0.001) decrease in 
cycling economy (CE) over time but no differences between trials (p=0.843) and 
no significant interaction (p=0.715) (Figure 6.7). 
 
 
Figure 6.7 Cycling economy (CE) between EnergySmart (ES) and glucose (GLU) 
trials. Mean ± SE. *Significant time effect (p<0.05). 
 
There were no significant differences in participant’s levels of feelings of nausea, 
fullness stomach upset at the pre- and post-exercise time points (Table 6.1). 
However, participants in the GLU trial were prone to feel thirstier at the completion 




Table 6.1 Differences in subjective sensations of thirst, nausea, fullness and 
stomach upset during each trial. P represents differences (p-values) pre and post 
trials; Between represents differences in the change scores (post-pre) between trials.  
Supplement EnergySmart (ES) Glucose (GLU) Between 




























































The purpose of the current study was to determine whether an acute mixed CHO 
(ES; sugars and starch) solution consumed prior to prolonged exercise improves 
performance relative to consumption of a glucose (GLU) solution. The main 
findings in the current study were i)  blood glucose concentration was significantly 
higher at the start of exercise in the GLU trial compared to ES, which significantly 
decreased with the onset of exercise (GLU: 3.7±0.7 mmol/L; ES: 4.7±0.6 mmol/L) 
and remained lower than ES supplement until the 30 min period (Figure 6.2a and 
3); ii) while no between-trial differences were observed in ratings of perceived 
effort, economy, electrolyte concentrations, lactate or pH levels; these markers 
demonstrated significant changes in response to exercise which was consistent with 
previous research and iii) despite the ES supplement being associated with a slight 
improvement (24.8 s improvement) in TT performance, there were no significant 
differences in performance between trials.    
Initiation of exercise in the GLU trial resulted in a significant decrease in blood 
glucose concentration, resulting in values of 3.7±0.7 mmol/L, wherein three 
participants experienced blood glucose values below 3 mmol/L (at 5 min into 
cycling time) without reporting any symptoms of hypoglacaemia. These results are 
consistent with previous research, which observed a significant elevation in blood 
glucose in response to supplement ingestion, but then observed a significant drop 
in blood glucose in the early stages of exercise [11, 12, 18]. Consistent with the 
findings herein, participants with hypoglycaemia did not report feelings associated 
with a hypoglycemic condition and hypoglycaemia did not reduce exercise 
performance. Blood glucose in GLU remained significantly lower compared to ES 
until 30 min of exercise although one participant maintained low levels throughout 
the exercise bout and reported mild symptoms of hypoglycaemia towards the latter 
stages of the trial.  Accordingly, insulin concentration increased in response to 
increases in blood glucose (pre- and post-exercise) but was rapidly brought to 
baseline during exercise. Despite these differences in blood glucose, there were no 
significant differences in fuel utilization between trials (based on RER) as well as 
the cycling economy. The cycling economy was assessed by measuring oxygen 
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consumption per unit of power output [27, 28] to see whether consumption of ES 
could cause any effect to cycling efficiency compared to GLU. The present study 
did not show any significant differences between trials with ~7.8% decrease in 
average cycling economy during 120-min of steady state cycling and comparable 
to the previous study which has shown ~10% reduction in a 150-min of steady state 
cycling [29]. 
Electrolytes, and in particular K+, have long been implicated in the development of 
fatigue [30, 31]. Early experiments clearly demonstrated efflux of K+ from skeletal 
muscle both during electrical stimulation and voluntary contraction (swimming), 
with the greatest efflux of K+ occurring with longer swim-times (reviewed in [30, 
31]). This is consistent with findings in the current study where, despite no 
differences being observed between trials, K+ concentrations increased 
progressively with exercise. The underlying mechanisms linking K+ concentration 
with fatigue relates to (i) alterations in the skeletal muscle membrane potential 
arising from a decreased ratio of intracellular:extracellular K+; and (ii) increased 
intracellular hydrogen ions (H+) concentration in response to the loss of K+ [32]. 
Consistent with these hypotheses, the pH in the current study demonstrated a 
general increase concurrent with the increase in K+ concentrations.   
Generally, the present study showed that there were no significant differences in 
performance between the two trials (p=0.403), although the mean TT performance 
in the ES trial was 24.8 s faster (SD=115.3 s). Accordingly, there were no 
significant differences between trials in RPE, HR, lactate, electrolytes and cycling 
economy during the 120-min steady state exercise period, which immediately 
preceded the TT in the current study. The inter-individual variance in performance 
was large with nine of the 16 demonstrating an improvement in TT with the ES, 
and no clear trends presenting (i.e., the supplement benefiting the fastest or slowest 
cyclists). With respect to the supplements, it is important to note that the quantity 
of supplement provided was lower compared to other studies (i.e., 25 g of CHO 
versus 25-200 g CHO; [6, 9-11, 18, 19]). While dose (0 g, 25 g, 75 g, 200 g) has 
not previously been shown to have a significant effect on TT performance of shorter 
duration (TT: ~42 min; total exercise time: ~62 min; [11]) it may play a more 
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critical role in improving performance of prolonged exercise time, particularly 
when performed following an overnight fast. 
While the study had a number of strengths, including the number of participants, 
the training status of the participants, the adoption of the TT at the end of a 120-
min of steady state cycling protocol and the assessment of multiple markers related 
to fatigue, there were a number of factors which may have limited the interpretation 
of study findings. Firstly, while dietary records were maintained and participants 
reminded to repeat a similar dietary intake in the 24 h preceding the subsequent 
experimental trial, this may not have been adhered to. Secondly, the study was 
designed to compare the two supplements directly, however, the inclusion of a 
control condition would likely have yielded important information; in particular, 
whether consumption of CHO in this time-frame was superior to a no CHO 
condition. Thirdly, while not a limitation per se, the study was purposefully 
designed to provide 25g CHO, however, a higher dose (i.e., 50g-75g CHO) may 




In conclusion, consumption of a mixed CHO beverage (ES) resulted in a more 
stable blood glucose and insulin profile than consumption of an isocaloric 
monosaccharide beverage (GLU). However, performance during prolonged 
exercise was not different in response to ingestion of the ES beverage relative to 
the beverage containing only monosaccharides (GLU). Moreover, development of 
hypoglycaemia did not appear to alter performance in the subsequent exercise trial. 
Finally, traditionally markers associated with exercise-induced fatigue (i.e., 
potassium), demonstrated changes which were consistent with prior research.  
Considering the ES beverage resulted in a 24 s shorter TT than the GLU condition, 
future research may be warranted to explore the effects of increasing the CHO 
content on the performance of the prolonged exercise.   
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Chapter 7 General discussion 
7.1 Conclusions  
Multiple mechanisms have been identified as contributing to fatigue-onset in 
exercise, yet their relative contributions and importance are still unclear and 
intensely debated [1-18]. Therefore, the overarching aim of this dissertation was to 
assess and identify factors associated with the onset of fatigue during prolonged 
cycle-exercise, using techniques designed to assess both peripheral (i.e., 
metabolomics) and central (i.e., neuromuscular assessments) parameters of fatigue 
onset.  
The metabolomics approach adopted within Chapter 3, allowed the separation of 
plasma sampled at the point of fatigue (post-fatigue) from samples obtained either 
prior to or following fatigue. The metabolites contributing to the distinct profiles of 
plasma sampled at various time-points were then explored and free fatty acids 
(FFA) along with tryptophan (TRP) were identified as strongly influencing these 
distinct metabolic profiles and in so doing, lent support to the ‘Central Fatigue 
Hypothesis’. Additionally, the 87 identified metabolites which demonstrated 
significant changes over time generated alternate avenues for future investigation, 
including, for example, novel roles for FFA in exercise-induced fatigue onset which 
may be explored in subsequent studies. The ability of this technique to be able to 
discriminate the plasma samples obtained during exercise is somewhat surprising, 
given the relatively short time-frame between sampling points in the current study. 
When exploring the metabolites contributing to this separation, it does become 
apparent that multiple factors contributed to the unique plasma metabolic profile, 
particularly the FFA and amino acids.  
Chapter 4 compared the changes in neuromuscular fatigue following two modes of 
isoenergetic prolonged exercise, which were a constant paced cycling time-to-
exhaustion (TTE) and a self-paced cycling time-trial (TT). Performance in a self-
paced cycling TT was significantly improved compared to an isocaloric constant-
paced cycling TTE trial in young and recreationally active males. This 
improvement was not associated with any differences in perceived effort (RPE), 
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despite maintaining significantly higher power-outputs and working at a higher 
physiological load (HR). The neuromuscular assessments revealed no significant 
between-trial differences, but the MVC torque was reduced by nearly 12% 
immediately post-exercise. This reduction in MVC torque, was associated with a 
significant decrease in central fatigue (VALp: -11%), demonstrating a reduced level 
of neural drive to the muscle [19]. Additionally, peripheral factors contributed to 
the reduced MVC torque, with a significant decrease in the potentiated doublet (-
24%) demonstrating reduced excitation-contraction coupling; although 
neuromuscular propagation is unlikely to have significantly contributed to the 
fatigue. The recreationally active males recruited to the study and who were 
unaccustomed to cycling, demonstrated superior performance when completing a 
self-paced TT (closed-loop) compared to a constant-pace TTE (open-loop) trial.  
Based on the findings from Chapter 3 and Chapter 4, Chapter 5 compared the effect 
of acute supplementation with branched-chain amino acids (BCAA) on cycling 
performance and fatigue assessed using neuromuscular assessments. The use of 
BCAA supplementation was based on the ‘Central Fatigue Hypothesis’, with the 
specific aim of reducing the rate at which tryptophan enters the central nervous 
system (CNS) thereby reducing the rate of serotonin synthesis. Therefore, we 
anticipated an improvement in cycling performance with BCAA supplementation. 
The findings of Chapter 5 were that acute BCAA supplementation improved (~7%) 
cycling performance and reduced RPE. Although the neuromuscular assessments 
demonstrated significant peripheral and central fatigue in response to exercise, there 
were no differences observed between the BCAA supplementation and placebo 
protocols. Overall, these findings suggest that acute supplementation of BCAA 
improved cycling performance and perception of effort during the cycling TT, 
without any notable difference in neuromuscular changes between trials. 
Chapter 6 was designed to investigate the effectiveness of a mixed (starch and 
sugars) carbohydrate supplement (ES) and this was compared to an isocaloric 
glucose (monosaccharide) control solution (GLU). This study adopted a prolonged 
cycling protocol comprising a 2-h constant load cycling effort, followed by a 
16.1km TT, wherein performance in the TT was the primary outcome. The adoption 
of a carbohydrate supplement in the current study was based on the body of 
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evidence supporting a beneficial role of carbohydrates on sports performance; but 
with the knowledge that a gap in this evidence exists in relation to the possible 
ergogenic role of carbohydrates in the final 1 to 2 h prior to exercise.  The findings 
of Chapter 6 were that consumption of the ES beverage resulted in a more stable 
blood glucose and insulin profile than consumption of GLU, however, performance 
during prolonged exercise was not significantly different. Similar to others, we 
found the development of hypoglycaemia did not appear to alter performance in the 
TT. Finally, traditionally markers associated with exercise-induced fatigue (i.e., 
potassium), demonstrated changes which were consistent with prior research and 
suggested a possible role in the onset of fatigue. Financial constraints did not enable 
a complete metabolomics analysis to be completed on the plasma samples obtained 
in this study.   
 
7.2 Practical applications 
The practical recommendations based on the studies presented herein are: 
1. Individuals unaccustomed to either a time-trial (TT) or time-to-exhaustion 
(TTE) cycling task, demonstrate superior performance in the TT, whilst 
reporting no differences in their rating of perceived effort.  
2. Supplementation with branched-chain amino acids (BCAA) delayed fatigue 
onset and improved performance in a prolonged cycling TT.  
3. Supplementation with glucose in the final hour prior to exercise 
performance results in low blood glucose values however, this reduced 
blood glucose concentration does not appear to affect cycling performance 
even in prolonged cycling events. Large inter-individual variance in blood 
glucose profiles and subsequent cycling performance were identified, and 
carbohydrate manipulation in the final 1 to 2 h prior to competition will 
likely need to be tailored to individuals. 
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7.3 Future research directions 
The adopted metabolomics approach in Chapter 3 generated multiple possible 
research avenues for investigators in this field. In particular, the multiple roles 
which free fatty acids may play in the regulation of cellular energetics is an 
interesting prospective research direction which appears to link with findings from 
earlier work conducted in the 1970’s, but which has for some reason largely been 
ignored in the exercise and fatigue literature more recently. The concurrent 
application of metabolomics with changes in neuromuscular parameters (twitch 
interpolation technique and EMG) would enable a richer assessment of particular 
metabolites in the onset of fatigue, and it may be particularly interesting to assess 
the metabolites associated with the neurotransmitters (i.e., acetylcholine). It is 
important to acknowledge that the work in Chapter 3, 4 and 5, was conducted in 
healthy individuals, but not athletes; future research should therefore consider 
whether more highly trained individuals would have similar responses, in particular 
to the supplementation of BCAA.     
The effectiveness of mixed CHO beverage on prolonged exercise performance is 
worthy of further investigation, particularly with regard to the effects of a higher 
mixed CHO dose. This is based on the observation that hypoglycaemia does not 
appear to influence performance and that although insignificant, there was a 
tendency for improved performance with the mixed CHO beverage. This study used 
glucose as a comparator since glucose has previously been shown to be ergogenic, 
but the addition of a placebo condition and concurrent neuromuscular assessments 
would have been interesting; but this was not performed in the current study due to 
the demanding nature of the cycling task (i.e., a TT preceded by a 2 h cycling bout 
at the ventilatory threshold). 
Despite the depth of research conducted in this field, many questions remain. How 
these particular markers of fatigue identified during exercise may relate to markers 
of fatigue observed in clinical populations, remains to be explored. Further research 
adopting complimentary techniques are required, in order to better understand the 
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